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ABSTRACT
Pt(II) complexes bind preferentially at N7 of G residues of DNA, causing DNA structural
distortions associated with anticancer activity. Some distortions induced by difunctional cisplatin
are also found for monofunctional Pt(II) complexes with carrier ligands having bulk projecting
toward the guanine base. This ligand bulk can be correlated with impeded rotation about the Pt–
N7(guanine) bond. The objective of this study is to understand the influences of in-plane bulk of
Pt(Ltri)G adducts (Ltri = tridentate carrier ligand, G = guanine derivative bound to a metal, but
not tethered to another nucleobase).
NMR spectroscopy provided conclusive evidence that Pt(Ltri)G (Ltri = di-(2-picolyl)amine
(N(H)dpa),
picolyl)amine

N-(6-methyl-2-picolyl)-N-(2-picolyl)amine
(N(H)6,6!-Me2dpa),

(N(H)6-Medpa),

di-(6-methyl-2-

N-(6-methyl-2-picolyl)-N-(2-picolyl)amine

(N(H)6,6!-

Me2dpa), N(Me)-di-(6-methyl-2-picolyl)amine (N(Me)6,6!-Me2dpa), N(propionoic acid)-di-(6methyl-2-picolyl)amine (N(prop)6,6!-Me2dpa), and tri-(6-methyl-2-picolyl)amine (6,6!,6!!Me3tpa)) adducts exist as interconverting mixtures of syn and anti rotamers from the observation
of two sharp, comparably intense guanine H8 NMR signals. Rotational interchange is impeded
by Ltri, and the key interactions involved steric repulsions between the pyridyl and guanine rings.
When G is added to [Pt(N(H)6,6!-Me2dpa)Cl]Cl, the expected Pt(N(H)6,6!-Me2dpa)G mono
adduct forms having syn and anti conformers, but also the Pt(N(H)6,6!-Me2dpa)G2 bis adducts
consisting of ΛHT and ΔHT conformers (HT = head-to-tail). When G is added to Pt(N(R)6,6!Me2dpa)G adducts, the transformation of the bis adducts Pt(N(R)6,6!-Me2dpa)G2 are
dramatically lessened, particularly when the bulk of the R group is increased. The stability of the
Pt(N(R)6,6!-Me2dpa)G mono adducts are explained by the increased bulk of the N-substituent,
making the bidentate coordination mode of the carrier ligand unfavorable.
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CHAPTER 1. INTRODUCTION
Platinum(II) compounds and their interactions with nucleotides have been studied
extensively.1-8 The widely used anticancer drug, cisplatin (cis-Pt(NH3)2Cl2), is a compound that
has been known of since 1845,9,10 but its antitumor activity was not discovered until 1970.11-13
Cisplatin has been used to treat a variety of malignancies including ovarian, cervical, head and
neck, esophageal, and nonsmall cell lung cancer.3,14,15 The discovery of cisplatin triggered a
widespread search for related compounds with better or similar activity. Side effects, including
nephrotoxicity, emetogenesis and neurotoxicity, have limited cisplatin treatments.16-18 After
cisplatin is administered and enters the cells, hydrolysis occurs, and water replaces the chloride
ligands to form a species with aqua ligands (Figure 1.1).19,20-25 The aqua complex is known to be
the active form of the drug.19,20,21 The aqua complex can form coordinatively covalent adducts
with various cellular components like glutathione, proteins, DNA and RNA, but DNA has been
accepted as the critical molecular target responsible for antitumor activity of cisplatin.26,27,28

!
Figure 1.1: Schematic representation of cellular uptake and activation of cisplatin (cisPt(NH3)2Cl2) prior to DNA binding.
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Three main types of DNA adducts that are formed with platinum compounds: intrastrand
cross-links, interstrand cross-links, and monofunctional adducts.29-31 Cisplatin and related
Pt(Lbi)X2 analogues (Lbi = one bidentate or two cis-unidentate N-donors, X2 = anionic leaving
groups) attack the N7 of two adjacent G bases to form predominantly 1,2 intrastrand G*G*
cross-link lesion.

6,32,18,33-36

G residues in DNA or oligomers with a Pt(II) bound to N7 are

designated as G*. The distortions induced on the DNA structure upon formation of the 1,2intrastrand cisplatin-DNA lesion have been shown to inhibit the processes of replication and
transcription, resulting in cell death. Much attention has been focused on the G*G* cross-link
lesion as the active lesion responsible for anticancer activity of cisplatin.19,27
X-ray studies of an HMG-bound 16 oligomer duplex,37 and a subsequent X-ray/NMRderived model of a 9 oligomer duplex,38 both containing an intrastrand cisplatin lesion, revealed
an unusual XG* base pair (bp) step. The XG* bp step distortion involves the X•Y bp adjacent to
the 5!-G*•C bp in the 5! direction along the duplex (referred to as the Lippard bp step, Figure
1.2)39 and is characterized by a large positive shift and a large positive slide. Base pair steps are
characterized by using shift, slide, and rise values to describe the nature of the DNA helix.40 The
distortions caused by the G*G* cross-link bp step lesion and the XG* bp step lesion contain the
largest departure from the B-DNA form. The distorted XG* bp step could possibly be more
important towards anticancer activity than the distortion caused by the G*G* cross-link bp
step.39,41
X-ray studies of an oligomer adduct of a rather bulky monofunctional Pt anticancer agent,
cis-[Pt(NH3)2(pyridine)Cl]+ (cDPCP), revealed a similar shift and slide of the XG* bp step
(involving the X•Y bp that is adjacent to the G*•C bp in the 5! direction along the duplex), as
seen for the cisplatin lesions.42,43 The monofuctional drug cDPCP was bound to the N7 atom of a
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single guanosine residue in a DNA dodecamer duplex, and it was discovered that cDPCP blocks
transcription from DNA template carrying adducts of the complex.42 Thus, for monofunctional
drugs to be anticancer active, there needs to be enough bulk at one cis position to induce the
XG* bp step distortion in DNA.

Figure 1.2: Representation of the distorted XG* base pair step and G*G* cross-link base pair
step
1.1. Pt(Lbi)G2 Adducts
Guanine bases coordinated in positions cis to a metal can have a head-to-tail (HT) or a
head-to-head (HH) orientation (Figure 1.3). For Pt(Lbi)G2 adducts (G = guanine derivative bound
to a metal, but not tethered to another nucleobase, Lbi = one bidentate or two cis unidentate amine
N donors), the G bases preferentially adopt the HT orientation.44-48 In contrast, bases tethered by
a sugar phosphate backbone, such as in Pt(Lbi)(d(G*pG*)) cross-link adducts, are most often
found in the HH orientation, especially when a 5!-residue is present on the 5!-G* (for example, in
Pt(Lbi)(d(TG*G*T)) adducts).27,46-48 Interconversions of HH to HT conformations via rotation
about the Pt–N7 bonds in cis-Pt(Lbi)G2 and cross-link adducts are rapid on the NMR time scale
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unless the Lbi carrier ligand is bulky. Bulky bidentate ligands lower the rotation rate, allowing
observation of NMR signals of the conformers present in solution. Because the guanine H8
(Figure 1.3) 1H NMR H8 signals are singlets and downfield, they are the most useful signals for
assessing metal binding and the presence of rotamers that could arise from restricted rotation
about the Pt–N7 bonds of cis-Pt(Lbi)G2 adducts.27,46,49-54 The study of Pt(Lbi)G2 adducts provides
useful guidance and insight on ligand bulk and on whether such bulk can influence the properties
of the bound nucleobase.

Figure 1.3: Possible conformers for Pt(Lbi)G2 adducts (A) and possible rotamers for mono Pt(II)
adducts (B). A generic version of G is depicted, along with the guanine base numbering scheme.
Note that the nucleobase is represented by an arrow with the tip at the guanine H8 atom. N, N!,
and N!! represent a nitrogen donor ligand. For bis adducts (A), when (N ≠ N!), four rotamers
(HHu, HHd, ΛHT, ΔHT) are possible, whereas when (N = N!), only three conformers (HH,
ΛHT, ΔHT) are possible because HHu = HHd. For mono adducts (B), both possible base
orientations (arrow up and arrow down) lead to only one rotamer if R is not chiral, N, N!, and N!!
are symmetric with respect to the coordination plane, and N = N!!. If N is not equal to N!!, the
two orientations represent two rotamers. If N! is not symmetric with respect to the coordination
plane, then there are two rotamers regardless of whether or not N = N!!.
The number of observable NMR signals for Pt(Lbi)G2!adducts is determined by the local
symmetry of the carrier ligand and asymmetry of the G ribose residue. When Lbi = a C2symmetrical achiral bidentate ligand, up to three [one HH and two HT (ΛHT, ΔHT)] rotamers
may be observed in a Pt(Lbi)G2 adduct. For G = 9-ethylguanine (9-EtG), each base arrangement
!
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(HH or HT) gives rise to only one 1H NMR signal for each proton because the two G bases, in
either the HH or HT arrangement, are equivalent. However, in Pt(Lbi)G2 adducts, where Lbi = an
unsymmetrical achiral bidentate ligand, four rotamers (HHu, HHd, ΛHT, ΔHT) are possible
(Figure 2.1). The G ligands in all conformers are no longer equivalent; if G has either a chiral or
an achiral group at N9, two H8 signals per rotamer are expected. Thus, a maximum of eight H8
signals could possibly be observed if all four conformers exist and all are in slow exchange. If
the Lbi is both unsymmetrical and chiral and if G lacks a chiral group, the situation is the same,
i.e., a potential maximum of eight H8 signals could arise for such Pt(Lbi)G2 adducts.
1.2. Pt(Ltri)G Adducts
In Pt(Ltri)G adducts (Ltri = a tridentate, one bidentate and one monodentate, or three
monodentate ligands), the nucleobase orients roughly perpendicular to the coordination plane
(defined by the Pt and the four ligating atoms of the pseudo square planar complexes, Figure 1.3,
B). For the Pt(Ltri)G adducts, two possible base orientations are possible (arrow up and arrow
down). Both orientations lead to only one rotamer if R is not chiral, N, N!, and N!! are symmetric
with respect to the coordination plane, and N = N!!. If N is not equal to N!!, the two orientations
represent two rotamers. If N! is not symmetric with respect to the coordination plane, then there
are two rotamers regardless of whether or not N = N!!.
To assess whether Ltri is bulky enough to interact with a guanine residue, thereby
influencing the structure of the Pt DNA adduct, one must determine if G nucleobase rotation
around Pt–N7 bond in Pt(Ltri)G adducts is hindered sufficiently by Ltri bulk to allow observation
of separate sets of NMR signals for the rotamers. For non-bulky Ltri, rotation about the Pt–N7
bond is fast on the NMR time scale, and the single H8 NMR signal observed typically for each
unique G represents the time average of the two guanine orientations. For bulky Ltri, rotation
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about the Pt-N7 bond could be hindered enough to give two separate H8 NMR signals for the
two rotamers present in a mixture.
For monofunctional Pt(II) agents, understanding the steric effects of bulky carrier ligands
with guanine nucleobases can aid in understanding the effects of carrier ligand bulk on the
mechanism of action leading to the XG* distortion of DNA. Thus, in the studies presented here,
we assess the interactions of nucleic acid substituents with carrier ligands having in-plane bulk
and how these interactions influence the properties of Pt(Ltri)G adducts.
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CHAPTER 2. GUANINE NUCLEOBASE ADDUCTS FORMED BY [PT(DI-(2PICOLYL)AMINE)Cl]Cl: EVIDENCE THAT A TRIDENTATE LIGAND WITH ONLY
IN-PLANE BULK CAN SLOW GUANINE BASE ROTATION*
2.1 INTRODUCTION
Cisplatin (cis-Pt(NH3)2Cl2) and related difunctional PtLX2 analogues (L = one bidentate
or two cis-unidentate N-donors, X2 = anionic leaving groups) are among the most widely studied
anticancer agents.1-11 DNA is generally accepted as the primary target.12,13 Difunctional Pt drugs
attack G N7 of adjacent G residues, forming a G*G* intrastrand cross-link lesion.4,6,14-17 G
residues in DNA or oligomers with a Pt(II) center bound to N7 are designated as G*. Intense
interest over many years focused on the distortions caused in the G*G* base pair (bp) step,
namely the relationship of the 5!-G*•C bp to the 3!-G*•C bp.12 However, more recent
developments have shown that another bp step could be even more distorted. X-ray studies of an
HMG-bound 16-mer duplex in the solid state,18 and a subsequent X-ray/NMR-derived model of a
9-mer duplex in solution,19 both containing an intrastrand cisplatin lesion, revealed an unusual
XG* bp step. The distortion involving the X•Y bp adjacent to the 5!-G*•C bp in the 5!-direction
along the duplex (referred to as the Lippard bp step)20 is characterized by a large positive shift
and a large positive slide. X-ray studies of an oligomer adduct of a rather bulky monofunctional
Pt anticancer agent have revealed a similar shift and slide of the XG* bp step involving the X•Y
bp that is adjacent to the 5!-G*•C bp in the 5!-direction along the duplex.21,22 For a difunctional
agent, when L is bulky, activity decreases and toxicity increases.23-27 However, for a
monofunctional Pt(II) agent, the opposite situation may hold true: greater ligand bulk appears to
be correlated with enhanced activity.12,21,22,28
*Reproduced with permission from American Chemical Society: Andrepont, C.; Marzilli, P. A.;
Marzilli, L. G., “Guanine Nucleobase Adducts formed by [Pt(di-(2-picolyl)amine)Cl]Cl:
Evidence that a Tridentate Ligand with only In-plane Bulk Can Slow Guanine Base Rotation,”
Inorg. Chem., 2012, (51), 11961-11970. Copyright 2012 American Chemical Society
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In simple Pt(L)(G) [tridentate L] or Pt(L)(G)2 [bidentate L] adducts (boldface G is an N9
guanine or N9 hypoxanthine derivative not linked to another nucleobase, Figure 2.1), the
nucleobase orients roughly perpendicular to the coordination plane (defined by the Pt and the
four ligating atoms of the pseudo square planar complexes, Figure 2.2). In Pt(II) adducts with
DNA, the G* nucleobase orientation is strongly influenced by a combination of the DNA
structure and the steric interactions of the nucleobase with the carrier ligand.29,30 Considerable
effort has been expended in studying Pt(L)(G)2 models and in comparing results to related G*G*
intrastrand models with short oligonucleotides.12,20,29,31-33 Both model types can have as many as
two head-to-head (HH) and two head-to-tail (HT) rotamers, depending on the bulk and symmetry
of L (Figure 2.2).24,29,34-39 However, the monofunctional adducts have at most one syn and one
anti rotamer (Figure 2.2). Rotamers interconvert by rotation about the Pt–N7 bond.19,24,40-43

Figure 2.1: Adduct formation reactions of [Pt(N(H)dpa)Cl]+ with various purine derivatives.
Because a key aspect of designing new Pt(II) drugs is to learn the effects of carrier-ligand
bulk on the mechanism of action leading to distortion of DNA, on activity, and on toxicity,30,36 it
is important to gain a better understanding of steric effects in monofunctional adducts. One
method of assessing whether a carrier ligand is bulky enough to interact with a guanine residue,
10

thereby influencing the structure of the Pt drug DNA adduct, is to determine if G nucleobase
rotation around the Pt–N7 bond in Pt(L)(G) adducts is hindered sufficiently by L to allow
observation of separate sets of NMR signals for the rotamers.17,31,35-37,40,41,43-45 downfield G H8 1H
NMR signals have historically been the most useful signals for assessing the presence of
rotamers.33,46-49 With a non-bulky L, rotation about the Pt–N7 bond is fast on the NMR time
scale, and the single H8 NMR signal observed typically for each unique G represents the time
average of the two guanine orientations.43,45-48,50,51
DNA

adducts

of

the

monofunctional

complex,

[Pt(dien)Cl]Cl

(dien

=

diethylenetriamine), have been studied extensively as a “control” useful in understanding the
nature of DNA binding of difunctional Pt(II) anticancer drugs.51-56 From the data on Pt(dien)(G)
adducts,51 it is clear that dien is a rather small non-bulky carrier ligand. Unlike cisplatin, small
monofunctional agents do not greatly disrupt the DNA structure on adduct formation; for
example, minimal change in the DNA CD spectrum was caused by [Pt(dien)Cl]Cl57 and
[Pt(NH3)3Cl]Cl58 agents. Cisplatin, in contrast, causes large CD spectral changes.57,59,60 Likewise,
evidence exists from 31P NMR data on DNA adducts that the DNA structure is distorted by cis
difunctional Pt agents, but not by small monofunctional Pt agents.61,62 To assess how interactions
of nucleic acid substituents (bases, phosphate groups, etc.) with a carrier ligand having in-plane
bulk influence the properties of Pt(L)(G) adducts, we have used NMR techniques to study
Pt(N(H)dpa)(G) adducts containing a tridentate carrier ligand, di(2-picolyl)amine (N(H)dpa),
with G = 5!-GMP, 5!-GDP, 5!-GTP, guanosine, 9-EtG, and 5!-IMP (Figure 2.1). Limited studies
of Pt and Pd N(H)dpa complexes have shown evidence for cytotoxicity.63,64 However, the
mechanism of anticancer activity is not known.
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Figure 2.2: Possible rotamers for mono and cis bis Pt(II) adducts of purine ligands illustrated
using guanine nucleobase N9 derivatives as an example. Note that the nucleobase is represented
by an arrow with the tip at the H8 of the purine. For the monoadducts (top two drawings), both
possible base orientations (arrow up and arrow down) lead to only one isomer if R is not chiral,
A, B, and C are symmetric with respect to the coordination plane, and A = C. If A is not equal to
C, the two orientations represent two rotamers. If B is not symmetric with respect to the
coordination plane, then there are two rotamers regardless of whether or not A = C. The middle
two drawings show the HH orientation (left) and the HT orientation (right). For a given purine
nucleobase derivative, as many as four rotamers are possible depending on whether or not A = B.
2.2 EXPERIMENTAL SECTION
2.2.1 Starting Materials
K2[PtCl4], N(H)dpa, guanosine (Guo), 5!-guanosine monophosphate disodium salt (5!GMP), 5!-guanosine diphosphate sodium salt (5!-GDP), 5!-guanosine triphosphate sodium salt
(5!-GTP), 5!-inosine monophosphate (5!-IMP), and 9-ethylguanine (9-EtG) were obtained from
Aldrich. cis-Pt(DMSO)2Cl265 and [Pt(N(H)dpa)Cl]Cl66 were synthesized as described in the
literature.
2.2.2 NMR Measurements
NMR spectra were recorded on a 400 MHz Bruker spectrometer, typically with 10 mM
samples in a D2O/DMSO-d6 mixture (pH adjusted with 0.5 M solutions of DCl or NaOD in
12

D2O). For 1H NMR and
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C NMR spectra in D2O/DMSO-d6, peak positions are referenced

relative to TMS by using the signals at 2.50 ppm (residual) and 39.5 ppm, respectively, of
DMSO-d6.67 A presaturation pulse to suppress the water peak was used when necessary. ROESY
experiments were performed at 5 °C by using a 200 ms mixing time. 1H–13C HSQC NMR spectra
were recorded in order to assign the signals of the adducts. NMR data were processed with
TopSpin and MestreNova software.
2.2.3 Pt(N(H)dpa)(5!-GMP) Adduct
A 28.6 mM solution of [Pt(N(H)dpa)Cl]Cl in DMSO-d6 (210 μL) was treated with a 38.5
mM solution of 5!-GMP in 390 μL of D2O to give a 1:2.5 ratio (10 mM:25 mM) of Pt:5!-GMP,
and the solution (pH ~4) was kept at 25 °C. A solution of D2O and DMSO-d6 (65:35) was
employed to improve the solubility of the reactants. The reaction mixture was monitored by 1H
NMR spectroscopy until there was no change in the bound vs. free H8 signal intensity, or until
the [Pt(N(H)dpa)Cl]+ signals completely disappeared.
2.2.4 Other Pt(N(H)dpa)(G) Adducts
Adducts of 5!-GDP, 5!-GTP, Guo, 9-EtG, and 5!-IMP were formed in D2O/DMSO-d6 in a
manner similar to that used for 5!-GMP. Reactions were monitored at various intervals from 10
min to 6 d by 1H NMR spectroscopy as described above.
2.3 RESULTS AND DISCUSSION
2.3.1 Background
Two rotamers differing with respect to the G base orientation (Figure 2.2) are
conceivable for Pt(II) complexes of the type, Pt(L)(G), when L = a tridentate carrier ligand that
is unsymmetrical with respect to the coordination plane but symmetrical about a plane
perpendicular to the coordination plane. The Pt(N(H)dpa)(G) adducts fall into this category
13

because the central N–H of the N(H)dpa carrier ligand projects out of the coordination plane
(Figure 2.3). In the present study, we adopt a known stereochemical convention44 as follows: the
rotamer with the H atom of the central N–H group and the guanine O6 on the same side of the
coordination plane is named syn, and the rotamer with these groups on the opposite side of this
plane is named anti (Figure 3). In a study of Pt(Me5dien)(G) adducts (Me5dien = N,N,N!,N!!,N!!pentamethyldiethylenetriamine), Carlone et al.44 found that the Pt(Me5dien)(5!-GMP) adduct
gave two sharp H8 NMR signals ~0.8 ppm downfield from the free 5!-GMP H8 signal. This
result indicates that the adduct exists as a mixture of both possible rotamers. In contrast,
Pt(dien)(G) adducts show only one sharp H8 signal,51,52,56,68,69 indicating unimpeded rotation of
the nucleobase, as would be expected from the low dien bulk. Thus, it is clear that the terminal
dimethylamino groups of Me5dien have enough bulk to hinder rotation of the guanine base about
the Pt–N7 bond. Christoforou et al.45 later showed that having either one or two unsubstituted
terminal NH2 groups in the tridentate carrier ligand was not sufficient to hinder G rotation about
the Pt–N7 bond.

Figure 2.3: The two possible rotamers (syn and anti) for Pt(L)(G) complexes with tridentate
ligands unsymmetrical with respect to the coordination plane but symmetrical about a plane
perpendicular to the coordination plane are illustrated for L = N(H)dpa. Also illustrated are the
anisotropic pyridyl rings, showing the shielding of the H8 in the syn rotamer by the pyridyl rings.
This shielding results in an upfield shift of the syn H8 signal. The H8 in the anti rotamer points
away from the pyridyl rings, resulting in a downfield shift of the anti H8 signal compared to the
shift of the syn H8 signal.
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The 1H NMR spectra of all Pt(N(H)dpa)(G) adducts formed in the present study are
consistent with impeded rotation of the purine nucleobase around the Pt–N7 bond. For example,
the spectrum of the Pt(N(H)dpa)(5!-GMP) adduct shows two downfield H8 signals (Figure 2.4).

Figure 2.4: The aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of
[Pt(N(H)dpa)Cl]+ (bottom) and the Pt(N(H)dpa)(5!-GMP) adduct (top) (shifts in ppm).
2.3.2 NMR Assignment Strategy
1

H and
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C NMR data and assignments for the Pt(N(H)dpa)(G) adducts and the

[Pt(N(H)dpa)Cl]+ complex are collected in Tables 2.1, 2.2, and 2.3. In Figure 2.4, the bottom
trace for [Pt(N(H)dpa)Cl]+ shows an H6/6! signal at ~8.6 ppm, but the spectrum of the
Pt(N(H)dpa)(5!-GMP) adduct (top) has no doublets in this region. As discussed below, the
anisotropy of the N7-coordinated guanine nucleobase shifts the H6/6! doublets into the same
narrow shift region as the H3/3! doublets, and as many as four signals could conceivably be
resolved for each type of proton in the Pt(N(H)dpa)(G) adducts. Shifts of the 13C NMR signals of
C6/6! and C3/3! are likely to be in distinctive widely dispersed regions for both the simpler
[Pt(N(H)dpa)Cl]+ complex and the Pt(N(H)dpa)(5!-GMP) adduct; therefore, we elected to use
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HSQC spectroscopy to assign the [Pt(N(H)dpa)Cl]+ 13C NMR signals and to use these shifts as a
guide in assigning the Pt(N(H)dpa)(5!-GMP) 13C NMR signals.
Table 2.1: Selected 1H NMR Shifts (ppm) for G in Pt(N(H)dpa)(G) Adducts in D2O/DMSO-d6 at
25 °C
G
H8 free H8 anti H8 syn H1! free H1! anti H1! syn
9-EtGa

7.67

8.73

8.40

-

-

-

Guo

7.91

8.95

8.61

5.71

5.93

5.85

5!-GMPb

7.96

9.08

8.72

5.71

5.98

5.91

5!-GDP

7.98

9.15

8.79

5.70

5.97

5.90

5!-GTP

7.97

9.21

8.79

5.70

5.98

5.91

5!-IMPc

8.33

9.44

9.09

5.93

6.19

6.13

a

CH2: 4.16 (anti), 4.05 (syn), and 3.90 ppm (free); CH3: 1.44 (anti), 1.34 (syn), and 1.24 ppm
(free). b H2!: 4.69 ppm, 4.53 ppm (free). c H2: 8.26 (syn), 8.17 (anti), and 8.05 ppm (free).
!
2.3.3 [Pt(N(H)dpa)Cl]Cl Assignments
The pyridyl 1H NMR signals for [Pt(N(H)dpa)Cl]+ (H6/6!, H5/5!, H4/4!, and H3/3!) are
shown in Figure 2.4. The H6/6! signal must be a doublet and also the most downfield pyridyl
signal because of the proximity of the H6/6! protons to the endocyclic nitrogen. The difference in
coupling constants for the H6/6! doublet (J = 5.8 Hz) and the more upfield H3/3! doublet (J = 8.0
Hz) allows assignments of the two pyridyl triplets: the triplet at 7.98 ppm with J = 7.8, ~7.7 Hz
is H4/4!, and the triplet at 7.34 ppm with J = 5.8, ~7.7 is H5/5!. After the proton assignments of
[Pt(N(H)dpa)Cl]+ were confirmed with a COSY experiment, the
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C NMR signals of

[Pt(N(H)dpa)Cl]+ were assigned through an HSQC experiment (Table 2.3, Figure A.1, Appendix
A). An HSQC cross-peak from the H6/6! signal at 8.61-150.4 ppm assigns the C6/6! 13C NMR
signal. Cross-peaks to the H3/3! (7.48-124.1 ppm), H4/4! (7.98-142.5 ppm), and H5/5! (7.34126.6 ppm) signals assign the C3/3!, C4/4!, and C5/5! signals, respectively. Cross-peaks from the
16

H7/7! signals at 4.73 and 4.49 ppm to the 13C NMR signal at 60.79 ppm assign the C7/7! signal.
The 1D 13C NMR spectrum (shown in Figure A.1, Appendix A, and used for obtaining more
precise shifts) reveals that the C2/2! signal (with no HSQC cross-peak) is the most downfield 13C
NMR signal (Table 2.3), as expected from its proximity to the pyridyl nitrogen.
Table 2.2: 1H NMR Shifts (ppm) and Coupling Constants (J, Hz) for the N(H)dpa Carrier Ligand
in Pt(N(H)dpa)(G) and in [Pt(N(H)dpa)Cl]Cl in D2O/DMSO-d6 at 25 °C
!
Cl or G
H6/6!
H5/5!
H4/4!
H3/3!
Cla
5!-GMPb, c

8.61 (5.8)
d

7.57 (5.4)

7.34

7.98

7.48 (8.0)

7.21

7.97 (7.8)

7.51 (8.0)

7.23

7.98 (7.8)

7.50 (8.0)

7.23

7.97 (7.8)

7.49 (7.8)

7.19

7.97 (7.9)

7.52 (7.7)

7.25

8.02 (7.9)

7.54 (7.8)

7.25

8.02 (7.8)

7.56 (8.0)

7.51e
7.44f (5.4)
5!-GDPc

7.58d (5.8)
7.50e
7.45f (5.8)

5!-GTPc

7.57d (5.8)
7.49e
7.43f (5.8)

5!-IMPc

7.52g
7.45f (5.6)
7.37f (5.6)

Guoc

7.61d
7.50f (5.7)

9-EtGc

7.56g
7.48f (5.4)

a

J values for H5/5! (5.8, ~7.7) and for H4/4! (8.0, ~7.7); H7/7!, endo-CH and exo-CH,
respectively, 4.73 and 4.49 ppm. In DMSO-d6, ppm (Hz): NH, 9.03; H6/6!, 8.81 (5.8); H5/5!,
7.63 (~6.8); H4/4!, 8.24 (~7.9); H3/3!, 7.77 (7.9); and H7/7!, endo-CH and exo-CH, respectively,
4.92 (15.9, 8.9) and 4.60 (15.9, 5.1). b H7/7!, endo-CH and exo-CH, respectively, 4.80 and 4.57
ppm. c J values not determined for H5/5! because of overlap of rotamer signals, and the H4/4!
values are generally an approximate average value for coupling to H3/3! and H5/5!. d anti. e syn,
but overlapped with the H3/3! signal. f syn. g anti, but overlapped with the H3/3! signal.
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For [Pt(N(H)dpa)Cl]Cl, thc C7 and C7! methylene groups are equivalent, but in each the
protons are not equivalent and are designated as endo-CH and exo-CH protons, respectively
(Figure 2.5). From the Karplus equation, the N–H-C–H coupling constant should be larger for
the endo-CH signal than for the exo-CH signal, owing to the larger dihedral angle between the
N–H and the endo-CH protons. Because N–H exchange with D2O occurs in the D2O/DMSO-d6
mixture, a 1H NMR spectrum of [Pt(N(H)dpa)Cl]Cl in DMSO-d6 was recorded. The downfield
H7/7! signal at 4.92 ppm has a higher N–H-C–H coupling constant (8.9 Hz) and is assigned to
endo-CH. The upfield H7/7! signal at 4.60 ppm (5.1 Hz) is assigned to exo-CH. Thus, in the 1H
NMR spectrum of [Pt(N(H)dpa)Cl]Cl in D2O/DMSO-d6, we assign the downfield H7/7! signal at
4.73 ppm to endo-CH and the upfield H7/7! signal at 4.49 ppm to exo-CH.
Table 2.3: 13C NMR Spectral Data (ppm) for [Pt(N(H)dpa)Cl]Cl and the Pt(N(H)dpa)(5!-GMP)
adduct in D2O/DMSO-d6 at 25 °C
!
carbons

[Pt(N(H)dpa)Cl]Cl

Pt(N(H)dpa)(5!-GMP)a

C6/6!

150.4

150.4
150.0
149.9

C5/5!

126.6

126.9
126.8

C4/4!

142.5

142.8

C3/3!

124.1

124.3

C2/2!

167.5

167.2

C7/7!

60.79

60.83
60.77

a

C8: 141.0 (anti), 141.6 (syn), and 138.8 ppm (free); C1!: 89.72 (anti), 89.76 (syn), and 88.21
ppm (free); C2!: 75.98 and 75.80, 75.22 ppm (free).
!
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Figure 2.5: Orientation of the pyridyl rings in the [Pt(N(H)dpa)Cl]+ cation, viewed along the
coordination plane. Also shown, the designation of the endo-CH and the exo-CH protons.
2.3.4 Pt(N(H)dpa)(5!-GMP) Adduct
The reaction of [Pt(N(H)dpa)Cl]+ with 2.5 molar equiv of 5!-GMP was monitored in
D2O/DMSO-d6 by 1H NMR spectroscopy at 10 min, 7 h, and 49 h after mixing. Even at 10 min,
the spectrum (Figure A.2, Appendix A) exhibited two small, sharp, downfield singlets. These
singlets provide evidence for restricted rotation of the adduct and clearly belong to H8, the only
type of aromatic proton in the reaction mixture (Figure 2.1) that can give a singlet signal. The
large downfield shift change of the product H8 singlets, relative to the free 5!-GMP H8 singlet at
7.96 ppm, can be explained only by coordination of the 5!-GMP to Pt(II) via N7. The singlets at
9.08 and 8.72 ppm (Figure 2.4) are assigned to the anti and syn rotamers (Figure 2.3),
respectively (see below). The H1! doublets of the rotamers are also in a quite distinctive region
(~5.9-6.0 ppm); these signals are shifted downfield of the H1! doublet of free 5!-GMP at 5.71
ppm (Table 2.1 and Figure A.2, Appendix A). As commonly observed, the inductive effect of the
Pt(II) shifts the H8 and H1! signals of Pt(L)(5!-GMP) adducts downfield compared to these
signals for free 5!-GMP.43-45,52
Two downfield H8 singlets were found for all of the Pt(N(H)dpa)(G) adducts (see
below). Thus, G base rotation about the Pt–N7 bond is impeded in all adducts. We attribute the
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cause of this restricted rotation to steric impedance of nucleobase rotation by the H6/6! protons,
which are in a fixed position projecting toward the coordinated G nucleobase. However, the shift
difference between the two H8 signals, Δδ, is ~0.36 ppm, considerably larger than the typical
value, such as Δδ = 0.04 found for Pt(Me5dien)(5!-GMP).44!The pyridyl rings of the Pt(N(H)dpa)
moiety do not lie exactly in the coordination plane (Figure 2.5), and the plane of the G
nucleobase in adducts lies more or less perpendicular to the planes of the pyridyl rings and to the
coordination plane. In the syn rotamer, the shielding region of the pyridyl rings projects over the
guanine H8; hence, the syn H8 signal will be shifted upfield from the anti H8 signal because of
the anisotropic effect of the N(H)dpa pyridyl rings (Figure 2.3). Thus, the anisotropy of the
pyridyl rings not only explains the large Δδ, but also allows us to assign the rotamers by using
H8 shifts. These rotamer assignments are also supported by analysis of the relative shifts of the
N(H)dpa signals as described below.
The ~1 ppm upfield shift of the H6/6! signals (Table 2.2) is the other large shift change
accompanying adduct formation. The upfield shift of the H6/6! pyridyl signals of N(H)dpa upon
Pt(N(H)dpa)(5!-GMP) adduct formation is similar to that of the H6/6! signals (~1.0-1.4 ppm)
accompanying formation of Pt(5,5!-Me2Bipy)(5!-GMP)2 from the starting complex, Pt(5,5!Me2Bipy)Cl2 (5,5!-Me2Bipy = 5,5!-dimethylbipyridine).35 For both types of adducts, the H6/6!
protons have a similar relationship to the guanine nucleobase.
In contrast to the H6/6! protons, the H3/3! protons are the pyridyl protons of the
Pt(N(H)dpa)(5!-GMP) adduct farthest from the coordinated guanine nucleobase. Thus, the H3/3!
doublets of the adduct should have shifts (~7.50 ppm) similar to that of the H3/3! signal of the
starting [Pt(N(H)dpa)Cl]+ complex. As a result, the H3/3! and the H6/6! doublets of the
Pt(N(H)dpa)(5!-GMP) adduct have similar shifts (Table 2.2). An additional complicating feature
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in making N(H)dpa assignments is the fact that the Pt(N(H)dpa)(5!-GMP) adduct has no mirror
plane because of the chiral sugar group; thus, the left and right sides of the N(H)dpa carrier
ligand are magnetically inequivalent for both rotamers. Hence, each rotamer could have two 1H
NMR signals for each type of pyridyl proton, raising the possibility that four signals could be
resolved for each type of pyridyl proton, e.g., four H6/6! signals in a spectrum of a given adduct.
Therefore, as mentioned, assigning which signals are H3/3! doublets and which signals
are H6/6! doublets in a crowded spectral region with overlapping signals is difficult on the basis
of 1H NMR shift values alone. We relied on [Pt(N(H)dpa)Cl]+ assignments to make the 1H and
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C NMR assignments for the Pt(N(H)dpa)(5!-GMP) adduct (Figure 2.6, Tables 2.2 and 2.3). The

1D carbon spectrum shows three resolved C6/6! peaks at 150.4, 150.0, and 149.9 ppm. In the
HSQC spectrum of the Pt(N(H)dpa)(5!-GMP) adduct, three closely spaced 1H6/6!-13C6/6! crosspeaks have a characteristic carbon shift of ~150.0 ppm. One cross-peak involves the quasi-triplet
at 7.57 ppm and the two C6/6! peaks at 150.0 and 149.9 ppm; these signals are attributable to the
anti rotamer. The other two cross-peaks involve the two doublets at 7.51 and 7.44 ppm and the
single C6/6! peak at 150.4 ppm; these signals are attributable to the syn rotamer. The C3/3!
pyridyl signal of the Pt(N(H)dpa)(5!-GMP) adduct at a characteristic shift (124.3 ppm) has a
cross-peak with the broad doublet peak at 7.51 ppm; this cross-peak arises from overlapped
H3/3! and C3/3! signals of the syn and anti rotamers. This 7.51 ppm peak also has a cross-peak
to the syn C6/6! peak, indicating that this peak also contains one syn H6/6! signal. In summary,
the assignment of the four H6/6! signals involves the quasi-triplet (containing two overlapped
anti H6/6! doublets) at 7.57 ppm, the syn H6/6! signal overlapped with the H3/3! doublets at 7.51
ppm, and the syn H6/6! doublet at 7.44 ppm.
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The H5/5! quasi-quartet at 7.21 ppm has a single elongated cross-peak to the C5/5!
pyridyl signals of the Pt(N(H)dpa)(5!-GMP) adduct at a characteristic shift [126.8 and 126.9
ppm], indicating that the signals attributable to each rotamer have slightly different chemical
shifts, forming a quasi-quartet. Assigning the H5/5! signals specifically to the syn or anti rotamer
is difficult to assess because these signals overlap. The C4/4! pyridyl signal of the
Pt(N(H)dpa)(5!-GMP) adduct at a characteristic shift (142.8 ppm) has a cross-peak with the
overlapped triplets at 7.97 ppm, thus assigning the peak to H4/4! signals from both rotamers.
Two C7/7! peaks at 60.83 and 60.77 ppm in the 1D 13C NMR spectrum have cross-peaks to the
cluster of H7/7! signals at 4.80 ppm and to the suppressed H7/7! signals overlapped with the
HOD solvent peak at 4.57 ppm (Figure A.3, Appendix A).

Figure 2.6: HSQC spectrum of the aromatic region of the Pt(N(H)dpa)(5!-GMP) adduct (shifts in
ppm).
A comparison of J values for the H6/6! and H3/3! signals of [Pt(N(H)dpa)Cl]+ (5.8 and 8.0 Hz,
respectively, Table 2.2) with those for the Pt(N(H)dpa)(5!-GMP) adduct was used to support the
assignments of the rotamer signal types. The two H6/6! peaks (the quasi-triplet and the upfield
doublet) both had J ~5.4 Hz, values consistent with the expected H6/6! J value (Table 2.2). The J
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value (~8.0 Hz) for the H3/3! signal (broad doublet) is also consistent with the value expected for
an H3/3! signal (Table 2.2).
A ROESY experiment allowed us to assign the H6/6! signals specifically to syn and anti
Pt(N(H)dpa)(5!-GMP) rotamers because the N(H)dpa H6/6! protons are close to the 5!-GMP H8
protons in both Pt(N(H)dpa)(5!-GMP) rotamers. Thus, H8-to-H6/6! NOE cross-peaks were
expected. The ROESY spectrum (Figure 2.7) showed a very intense cross-peak from the anti H8
signal to the quasi-triplet (a peak composed of two overlapping downfield H6/6! doublets). The
syn H8 signal had cross-peaks to the most upfield H6/6! doublet and to the H6/6! signal that
overlaps with the H3/3! signal. These findings confirm that the most downfield H6/6! peak is
composed of the two H6/6! signals from the anti rotamer and that the two H6/6! signals of the
syn rotamer are relatively upfield. The relationships of these shifts to the structure of the
rotamers are explained next.

Figure 2.7: 1H-1H ROESY spectrum of the aromatic region of the Pt(N(H)dpa)(5!-GMP) adduct
(shifts in ppm).
The relative values of large upfield shift changes of the H6/6! signals on formation of the
Pt(N(H)dpa)(5!-GMP) adduct arising from the anisotropy of the guanine nucleobase provide
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confirmation of our assignment of the rotamers. The Pt–N7 bond restricts how closely the fivemembered ring can approach the H6/6! protons as the nucleobase wags back and forth from
thermal motion. The H6/6! protons are not in the coordination plane (Figure 2.5), as mentioned
above. The nucleobase H8 proton is closer to the H6/6! protons in the anti rotamer, and this
restricts the degree of base wagging because the partial positive charge of these protons leads to
mutual electrostatic repulsion. In addition, the H6/6! protons and the six-membered ring are on
opposite sides of the coordination plane. Thus, as suggested in Figure 2.8, the nucleobase is
probably not tilted on average. Overlap of the two anti H6/6! doublets (appearing as a quasitriplet) at 7.57 ppm results from the similar environments of the two H6/6! protons; the
environments are similar because the anti H6/6! protons are relatively far from the six-membered
ring (Figure 2.8), the smaller anisotropic effects lead to similar shifts for the two H6/6! signals
and result in a relatively downfield pair of overlapping signals. For the syn rotamer, H8 is on the
side of the coordination plane opposite to the H6/6! protons. Thus, base tilting is not hindered by
H8-to-H6/6! electronic repulsion. Wagging leads to a closer proximity of the nucleobase
anisotropic six-membered ring to the H6/6! protons of the syn rotamer than of the anti rotamer
(Figure 2.8), accounting for the more upfield shift of the syn H6/6! signals than the anti H6/6!
signals.
The above interpretations of shift relationships are consistent in all adducts studied here
and also with the conclusion reached by using the H8 signals. Furthermore, the H8 and H1!
protons are both associated with the five-membered ring of the guanine base. Thus, the syn H8
and H1! signals are affected by the anisotropy of the pyridyl rings in a similar manner: both have
H8 and H1! signals with shifts upfield from those of the anti rotamer.
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Figure 2.8: Possible orientations of the guanine base represented by an arrow. The anisotropy is
indicated by cones emanating from the six-membered ring. Illustrated is the proximity of the sixmembered ring to the H6/6! protons in the syn rotamer, resulting in a more upfield shift of the
H6/6! signals of the syn rotamer compared to the anti rotamer, in which the six-membered ring is
farther away from the H6/6! protons.
Anisotropy can be used to analyze the small shift changes found for the Pt(N(H)dpa)(5!GMP) H4/4! and H5/5! triplets, which are expected to have similar chemical shifts for both
rotamers. Because the H4/4! pyridyl protons are positioned away from the coordinated 5!-GMP
site, no significant shift change takes place; therefore, we can assign the most downfield broad
triplet at 7.97 ppm to the H4/4! signals for both rotamers. The H5/5! protons are the secondclosest pyridyl protons to the 5!-GMP nucleobase. Thus, owing to the anisotropy of the sixmembered ring of the guanine base, the H5/5! triplets are shifted upfield, as compared to the
H5/5! triplet of the starting [Pt(N(H)dpa)Cl]+ complex. The H5/5! peak of the adduct appears as a
distorted quartet attributable to overlapping signals of the syn and anti rotamers.
The methylene protons (H7/7!) are far from the nucleobase and were not assigned to a
particular rotamer, mainly because of close overlap of the syn and anti rotamers. The methylene
signals reside in the same region as the HOD solvent peak. Presaturation of the HOD signal
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precludes using the NOE cross-peaks to assess the endo-CH and exo-CH signals. However, we
can confidently assign the cluster of downfield signals at 4.80 ppm to the endo-CH protons and
the suppressed signals at 4.57 ppm to the exo-CH protons because the downfield H7/7! signal of
[Pt(N(H)dpa)Cl]Cl is the endo-CH signal, as discussed above.
2.3.5 Pt(N(H)dpa)(5!-GTP) and Pt(N(H)dpa)(5!-GDP)
In past work, rotamer distribution was found to be influenced by H-bonding interactions
between phosphate and N–H groups. In addition, either the N–H group was cis to G in an amine
ligand of Pt(L)(G) and Pt(L)(G)2 adducts or the G N1–H group was on an adjacent cis G residue
in Pt(L)(G)2 adducts.34,38-41,70-72 Because the adducts investigated here have only one G and no N–
H protons cis to this G, the Pt(N(H)dpa)(G) adducts offer the opportunity to assess the role of a
trans N–H group in influencing rotamer abundance. Toward this goal, adducts of 5!-GTP and 5!GDP were compared to the Pt(N(H)dpa)(5!-GMP) adduct, for which the ratio of the two rotamers
was ~1:1 (Table 2.4). In Pt(N(H)dpa)(5!-GTP), the long triphosphate chain of the 5!-GTP can
extend far enough for the γ-phosphate group to form a hydrogen bond with the trans N–H of the
carrier ligand when the 5!-GTP nucleotide has the anti conformation (Figure 2.9). Such hydrogen
bonding would increase the abundance of the anti rotamer. However, such hydrogen bonding
would not occur for the 5!-GDP adduct because the diphosphate chain is too short to reach the
trans N–H.
The reactions of [Pt(N(H)dpa)Cl]+ with 2.5 molar equiv of 5!-GDP or 5!-GTP were
essentially complete in one to two days at pH ~4.1. For both adducts, sharp product H8 singlets
were observed for the anti rotamer (the downfield H8 and H1! signals) and the syn rotamer (the
upfield H8 and H1! signals) (Figure 2.10, Tables 2.1 and 2.2, Figure A.4, Appendix A). For the
Pt(N(H)dpa)(5!-GTP) solution at pH 4.1, the anti H8:syn H8 ratio was 1.22:1 (Table 2.4); this is
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the only adduct having an anti H8:syn H8 ratio greater than one. The slightly larger value of Δδ
~0.42 ppm for the 5!-GTP rotamers than for the 5!-GMP rotamers is accounted for by the
deshielding of H8 by the overhanging phosphate groups of 5!-GTP. This chain should be close to
H8 when a hydrogen bond is formed between the phosphate chain and the central N(H)dpa N–H
group in the anti rotamer (Table 2.1). The H8 signal of the syn rotamer shows a similar
downfield shift compared to that of the 5!-GMP adduct mainly because the phosphate chain has
more conformational freedom in the absence of an H-bond interaction. The N(H)dpa aromatic
signals in the Pt(N(H)dpa)(5!-GTP) adduct have shifts similar to those of the 5!-GMP adduct
(Table 2.2 and Figure A.5, Appendix A).

Figure 2.9: Proposed hydrogen bonding of the γ-phosphate group of 5!-GTP with the N–H in the
anti rotamer of the Pt(N(H)dpa)(5!-GTP) adduct (lower left). The figure also illustrates that the
distance between the N–H group and the closest phosphate group is too long to support hydrogen
bonding in the corresponding syn 5!-GTP rotamer (bottom right) and in the anti rotamers of the
5!-GMP and 5!-GDP adducts (top).
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Table 2.4: Anti H8:Syn H8 Intensity Ratios for Pt(N(H)dpa)(G) Adducts
G

pH

anti:syn ratio

5!-GMP

4.0

1:1.14

5!-GDP

4.1

1:1.04

7.5

a

1:1.05

2.7b

1:1.04

4.1

1.22:1

7.3c

1.37:1

5!-IMPd

4.0

1:1.25

Guo

4.1

1:1.34

9-EtG

4.1

1:1.28

5!-GTP

a

H8: 9.15 (anti), and 8.79 ppm (syn). b H8: 9.16 (anti), and 8.75 ppm (syn). c H8: 9.22 (anti), and
8.79 ppm (syn). d H2: anti H2:syn H2 ratio (1.21:1).
!
In the ROESY spectrum of the Pt(N(H)dpa)(5!-GTP) adduct (Table 2.2 and Figure A.6,
Appendix A), the anti H8 signal has a cross-peak to the most downfield H6/6! signal, which
contains two H6/6! signals overlapping as a broad doublet, assigning both downfield H6/6!
signals to the anti rotamer. The syn H8 signal has cross-peaks to the H6/6! signal overlapped
with the H3/3! signal and to the most upfield H6/6! signal, thus assigning these two H6/6! signals
to the syn rotamer.
To obtain further evidence that the anti rotamer of Pt(N(H)dpa)(5!-GTP) has a hydrogen
bond from the γ-phosphate to the central N–H, the pH of the solution was raised in order to
deprotonate more fully the γ-phosphate group, favoring hydrogen bonding and thereby
increasing the abundance of the anti rotamer. When the pH was raised from 4.1 to 7.3, the anti
H8:syn H8 ratio increased from 1.22:1 to 1.37:1 (Table 2.4). On the other hand, when the pH
was lowered to 2.7, the ratio decreased to 1:1.04, and some signals shifted noticeably (Table
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2.4). The Pt(N(H)dpa)(5!-GDP) adduct was used as a “control” because models suggest that the
diphosphate chain of 5!-GDP is too short to form a hydrogen bond. For Pt(N(H)dpa)(5!-GDP)
solutions at pH 4.1 and 7.5, the anti H8:syn H8 ratio was essentially unchanged at ~1:1. This
adduct, like all other adducts except Pt(N(H)dpa)(5!-GTP), favors the syn rotamer. These
findings and the relatively downfield H8 signal of the Pt(N(H)dpa)(5!-GTP) anti rotamer provide
evidence for a hydrogen bond between the γ-phosphate and the N(H)dpa N–H of this adduct.

Figure 2.10: H8 and H1! regions of the 1H NMR spectra of the Pt(N(H)dpa)(5!-GMP) adduct (A)
and the Pt(N(H)dpa)(5!-GTP) adduct (B) (shifts in ppm). The H1! doublet of the free nucleotide
is also shown at ~5.7 ppm.
2.3.6 Pt(N(H)dpa)(5!-IMP)
The reaction of [Pt(N(H)dpa)Cl]+ with 5!-IMP (molar ratio = 1:2.5) was complete after 50
h (Figure A.7, Appendix A). The Pt(N(H)dpa)(5!-IMP) adduct provides another approach for
confirming the assignment of rotamer signals because the proton of the six-membered ring of the
hypoxanthine base has a signal that can be affected by the pyridyl ring anisotropy. For a given
rotamer, the H2 and H8 signals are influenced in an opposite manner by this anisotropy. The H8
singlets for the two rotamers are at 9.44 (anti) and 9.09 (syn) ppm, with an anti H8:syn H8
intensity ratio of 1:1.25 (Figure 2.11, Table 2.4). The H2 signals were shifted downfield to 8.26
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(syn) and 8.17 (anti) ppm from the H2 signal of free 5!-IMP at 8.05 ppm. The relationship of the
signals agrees with the prediction based on the effects of pyridyl ring anisotropy, thus confirming
the assignments of the anti and syn rotamer signals. The N(H)dpa aromatic signals of the
Pt(N(H)dpa)(5!-IMP) adduct exhibit a pattern of shift changes very similar to that observed for
other adducts (Table 2.2). However, the syn H6/6! signal does not overlap with the H3/3! signal.
Hence both H6/6! signals for the syn rotamer are resolved (Table 2.2).

Figure 2.11: 1H NMR spectra (25 °C, D2O/DMSO-d6) of [Pt(N(H)dpa)Cl]+ (bottom) and of the
Pt(N(H)dpa)(5!-IMP) adduct (top) (shifts in ppm). The spectral region was selected to show the
H8 and H2 signals, which for free 5!-IMP are respectively labeled a and b.
2.3.7 [Pt(N(H)dpa)(Guo)]2+
The large Δδ between the H8 signals of the syn and anti rotamers of the nucleotide
adducts could be the result of different anisotropic effects of the phosphate groups in the two
rotamers; in order to assess this possibility, we prepared the [Pt(N(H)dpa)(Guo)]2+ adduct.
After the reaction of [Pt(N(H)dpa)Cl]+ with Guo (molar ratio = 1:2.5) was complete
(Figure A.8, Appendix A), the two sharp H8 signals (anti H8:syn H8 ratio = 1:1.34, Table 2.4)
had a Δδ value of ~0.34 ppm, about the same as observed for the 5!-GMP adduct. These results
indicate that phosphate groups at the 5! position have at best a small influence on Δδ and on
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impeding nucleobase rotation. The N(H)dpa signals were assigned by comparison to the shift
values for the nucleotide adducts (Table 2.2).
2.3.8 [Pt(N(H)dpa)(9-EtG)]2+
To definitively exclude the possibility that the sugar moiety could be contributing to the large
Δδ and to the slow nucleobase rotation of the adducts described above, we explored the
properties of the [Pt(N(H)dpa)(9-EtG)]2+ adduct, which has a small alkyl group in place of the
sugar.
After the reaction was complete (Figure A.9, Appendix A), two sharp H8 1H NMR
signals (Table 2.1) had a Δδ of 0.33 ppm, indicating slow rotation around the Pt–N7 bond. Thus,
the sugar residue is not responsible for the slow rotation, nor for the large Δδ observed. The anti
H8:syn H8 intensity ratio is 1:1.28 (Table 2.4). Correlating the abundance of the two sets of CH2
and CH3 signals with that of the H8 signals establishes that the anti rotamer has the more
downfield signals for all of the protons associated with the five-membered guanine ring (Table
2.1).
Because of the absence of the chiral sugar group, only one signal for each pyridyl proton
type was observed for each rotamer. The pyridyl signals of the [Pt(N(H)dpa)(9-EtG)]2+ adduct
have shifts very similar to those of the corresponding signals of the [Pt(N(H)dpa)(Guo)]2+ adduct
(Table 2.2).
2.3.9 Other Information Derived from the NMR Data
The observation of H8-H1! cross-peaks having an equal intensity for both the syn and
anti rotamers indicates that the nucleotide in both rotamers has conformational freedom and that
syn and anti nucleotide conformations co-exist. Because of the high concentration of 5!-GMP
anion in the reaction mixture, stacking interactions between the 5!-GMP base and the pyridyl
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rings of positively charged [Pt(N(H)dpa)Cl]+ starting material cause a similar upfield shifting of
all of the pyridyl signals immediately after the addition of 5!-GMP. For example, the H6/6!
signal (Figure A.10, Appendix A) of the starting complex is shifted upfield by 0.08 ppm. As the
reaction progressed, the concentration of 5!-GMP decreased, and the resulting decrease in the
stacking interaction causes the H6/6! signal of [Pt(N(H)dpa)Cl]+ to shift downfield toward its
original value prior to 5!-GMP addition. All of the other adducts with an anionic G (G = 5!-GDP,
5!-GTP, 5!-IMP) showed a similar upfield shift of the pyridyl signals of the starting complex
upon addition of G, as observed for the 5!-GMP adduct. However, when 9-EtG (an N9 guanine
derivative) was added, no upfield shifting was observed for the [Pt(N(H)dpa)Cl]+ signals.
2.4 CONCLUSIONS
Two sharp 1H NMR H8 signals observed for all Pt(N(H)dpa)(G) adducts studied here (G
= 5!-GMP, 5!-GDP, 5!-GTP, Guo, 9-EtG, and 5!-IMP) provided evidence that they all exist as
interconverting mixtures of syn and anti rotamers. The bulk of the tridentate N(H)dpa carrier
ligand is sufficient to impede the rotation of G about the Pt–N7 bond for these adducts. We
conclude that the close proximity of the anisotropic pyridyl rings of N(H)dpa in Pt(N(H)dpa)(G)
adducts to the H8 of the nucleobase accounts for the large Δδ observed for all adducts. From
NMR data, we conclude that the pyridyl H6/6! atoms strongly impede the rotation of G in these
adducts. The 1H NMR spectra of these Pt(N(H)dpa)(G) adducts had four potentially resolvable
H6/6! signals because the chiral sugar group makes the left and right sides of N(H)dpa
magnetically inequivalent for both rotamers. In the syn rotamer of Pt(N(H)dpa)(G), the relative
proximity of the six-membered ring of G to the H6/6! pyridyl protons accounts for the upfield
shift observed for these resonances compared to those of the anti rotamer. Tilting of G occurs in
each of the rotamers, but a more noticeable effect is seen in the syn rotamer because of the larger
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chemical shift difference between the two H6/6! signals for the syn rotamer, indicating that G is
tilted, with the six-membered ring closer to one H6/6! proton than the other. Evidence was
observed for a weak hydrogen bond between the γ-phosphate group of 5!-GTP and the central
N–H of the carrier ligand in the Pt(N(H)dpa)(5!-GTP) adduct. From results for the
[Pt(N(H)dpa)(9-EtG)]2+ adduct, we concluded that the guanine base alone, not the sugar or
phosphate group, slowed the rate of nucleobase rotation about the Pt–N7 bond in nucleotide
adducts. [Pt(N(H)dpa)Cl]Cl and its analogues should have enough bulk to be anticancer active;
however, further studies will be necessary to evaluate their potential anticancer properties.
2.5 REFERENCES
1. Arnesano, F.; Natile, G. Coord. Chem. Rev. 2009, 253, 2070-2081.
2. Kelland, L. Nature (London) 2007, 7, 573-584.
3. Klein, A. V.; Hambley, T. W. Chem. Rev. 2009, 109, 4911-4920.
4. Reedijk, J. J. Eur. J. Inorg. Chem. 2009, 2009, 1303-1312.
5. Jakupec, M. A.; Galanski, M.; Arion, V. B.; Hartinger, C. G.; Keppler, B. K. Dalton Trans.
2008, 183-194.
6. Ober, M.; Lippard, S. J. J. Am. Chem. Soc. 2007, 129, 6278-6286.
7. Hostetter, A. A.; Osborn, M. F.; DeRose, V. J. Chem. Biol. 2012, 7, 218-225.
8. Wilson, J. J.; Lippard, S. J. J. Med. Chem. 2012, 55, 5326-5336.
9. Liskova, B.; Zerzankova, L.; Novakava, O.; Kostrhunova, H.; Travnicek, Z.; Brabec, V.
Chem. Res. Toxicol. 2012, 25, 500-509.
10. Yin, R.; Gou, S.; Liu, X.; Lou, L. J. Inorg. Biochem. 2011, 105, 1095-1101.
11. Sun, Y.; Gou, S.; Yin, R.; Jiang, P. Eur. J. Inorg. Chem. 2011, 46, 5146-5153.
12. Saad, J. S.; Natile, G.; Marzilli, L. G. J. Am. Chem. Soc. 2009, 131, 12314-12324.
13. Zoldakova, M.; Beirsack, B.; Kostrhunova, H.; Ahmad, A.; Padhye, S.; Sarkar, F. H.;
Schobert, R.; Brabec, V. Med. Chem. Commun. 2011, 2, 493-499.

33

14. Todd, R. C.; Lippard, S. J. J. Inorg. Biochem. 2010, 104, 902-908.
15. Malina, J.; Novakava, O.; Vojtiskova, M.; Natile, G.; Brabec, V. Biophys. Chem. 2007, 93,
3950.
16. Kasparkova, J.; Vojtiskova, M.; Natile, G.; Brabec, V. Chem. - Eur. J. 2008, 14, 3950.
17. Bhattacharyya, D.; Marzilli, P. A.; Marzilli, L. G. Inorg. Chem. 2005, 44, 7644-7651.
18. Ohndorf, U.-M.; Rould, M. A.; He, Q.; Pabo, C. O.; Lippard, S. J. Nature 1999, 399, 708712.
19. Marzilli, L. G.; Saad, J. A.; Kuklenyik, Z.; Keating, K. A.; Xu, Y. J. Am. Chem. Soc. 2001,
123, 2764-2770.
20. Sullivan, S. T.; Saad, J. S.; Fanizzi, F. P.; Marzilli, L. G. J. Am. Chem. Soc. 2002, 124, 15581559.
21. Lovejoy, K. S.; Todd, R. C.; Zhang, S.; McCormick, M. S.; D'Aquino, J. A.; Reardon, J. T.;
Sancar, A.; Giacomini, K. M.; Lippard, S. J. Proc. Natl. Acad. Sci. 2008, 105, 8902-8907.
22. Todd, R. C.; Lippard, S. J. In In Platinum and Other Heavy Metal Compounds in Cancer
Chemotherapy; Bonetti, A., Leone, R., Muggia, F. M., Howell, S. B., Eds.; Humana Press:
New York, 2009, p 67-72.
23. Hambley, T. W. Dalton Trans. 2001, 2711-2718.
24. Beljanski, V.; Villanueva, J. M.; Doetsch, P. W.; Natile, G.; Marzilli, L. G. J. Am. Chem.
Soc. 2005, 127, 15833-15842.
25. Orbell, J. D.; Taylor, M. R.; Birch, S. L.; Lawton, S. E.; Vilkins, L. M.; Keefe, L. J. Inorg.
Chim. Acta 1988, 152, 125-134.
26. Benedetti, M.; Malina, J.; Kasparkova, J.; Brabec, V.; Natile, G. Environ. Health Perspect
2002, 110, 779-782.
27. Hirano, T.; Inagaki, K.; Fukai, T.; Alink, M.; Nakahara, H.; Kidani, Y. Chem. Pharm. Bull.
1990, 38, 2850-2852.
28. Wang, D.; Zhu, G.; Huang, X.; Lippard, S. J. Proc. Natl. Acad. Sci. 2010, 107, 9584-9589.
29. Saad, J. A.; Benedetti, M.; Natile, G.; Marzilli, L. G. Inorg. Chem. 2010, 49, 5573-5583.
30. Saad, J. S.; Benedetti, M.; Natile, G.; Marzilli, L. G. Inorg. Chem. 2011, 50, 4559-4571.
31. Williams, K. M.; Cerasino, L.; Natile, G.; Marzilli, L. G. J. Am. Chem. Soc. 2000, 122, 80218030.

34

32. Ano, S. O.; Intini, F. P.; Natile, G.; Marzilli, L. G. J. Am. Chem. Soc. 1998, 120, 1201712022.
33. Kiser, D.; Intini, F. P.; Xu, Y.; Natile, G.; Marzilli, L. G. Inorg. Chem. 1994, 33, 4149-4158.
34. Ano, S. O.; Intini, F. P.; Natile, G.; Marzilli, L. G. Inorg. Chem. 1999, 38, 2989-2999.
35. Maheshwari, V.; Marzilli, P. A.; Marzilli, L. G. Inorg. Chem. 2008, 47, 9303-9313.
36. Maheshwari, V.; Marzilli, P. A.; Marzilli, L. G. Inorg. Chem. 2011, 50, 6626-6636.
37. Sullivan, S. T.; Ciccarese, A.; Fanizzi, F. P.; Marzilli, L. G. J. Am. Chem. Soc. 2001, 123,
9345-9355.
38. Saad, J. S.; Scarcia, T.; Natile, G.; Marzilli, L. G. Inorg. Chem. 2002, 41, 4923-4935.
39. Wong, H. C.; Intini, F. P.; Natile, G.; Marzilli, L. G. Inorg. Chem. 1999, 38, 1006-1014.
40. Sullivan, S. T.; Ciccarese, A.; Fanizzi, F. P.; Marzilli, L. G. Inorg. Chem. 2001, 40, 455-462.
41. Carlone, M.; Marzilli, L. G.; Natile, G. Inorg. Chem. 2004, 43, 584-592.
42. Carlone, M.; Marzilli, L. G.; Natile, G. Eur. J. Inorg. Chem. 2005, 1264-1273.
43. Sandlin, R. D.; Starling, M. P.; Williams, K. M. J. Inorg. Biochem. 2010, 104, 214-216.
44. Carlone, M.; Fanizzi, F. P.; Intini, F. P.; Margiotta, N.; Marzilli, L. G.; Natile, G. Inorg.
Chem. 2000, 39, 634-641.
45. Christoforou, A. M.; Marzilli, P. A.; Marzilli, L. G. Inorg. Chem. 2006, 45, 6771-6781.
46. Cramer, R. E.; Dahlstrom, P. L. J. Am. Chem. Soc. 1979, 101, 3679-3681.
47. Cramer, R. E.; Dahlstrom, P. L. Inorg. Chem. 1985, 24, 3420-3424.
48. Cramer, R. E.; Dahlstrom, P. L.; Seu, M. J. T.; Norton, T.; Kashiwagi, M. Inorg. Chem.
1980, 19, 148-154.
49. Xu, Y.; Natile, G.; Intini, F. P.; Marzilli, L. G. J. Am. Chem. Soc. 1990, 112, 8177-8179.
50. Ndinguri, M. W.; Fronczek, F. R.; Marzilli, P. A.; Crowe, W. E.; Hammer, R. P.; Marzilli, L.
G. Inorg. Chim. Acta. 2010, 363, 1796-1804.
51. Marcelis, A. T. M.; Erkelens, C.; Reedijk, J. Inorg. Chim. Acta. 1984, 129-135.
52. Kong, P.-C.; Theophanides, T. Bioinorg. Chem. 1975, 5, 51-58.
53. Benedetti, M.; Ducani, C.; Migoni, D.; Antonucci, D.; Vecchio, V. M.; Ciccarese, A.;
Romano, A.; Verri, T.; Ciccarella, G.; Fanizzi, F. P. Angew. Chem. 2008, 120, 517-520.
35

54. Murdoch, P. S.; Guo, Z.; Parkinson, J. A.; Sadler, P. J. J. Bioinorg. Chem. 1999, 4, 32-38.
55. Guo, Z.; Sadler, P. J.; Zang, E. Chem. Commun. 1997, 27-28.
56. Mikola, M.; Klika, K. D.; Hakala, A.; Arpalahti, J. Inorg. Chem. 1999, 38, 571-578.
57. Macquet, J.-P.; Butour, J.-L. Eur. J. Biochem. 1978, 83, 375-387.
58. Bursova, V.; Kasparkova, J.; Hofr, C.; Brabec, V. Biophys. J. 2005, 88, 1207-1214.
59. Horacek, P.; Drobnik, J. Biochim. Biophys. Acta 1971, 254, 341-347.
60. Srivastava, R. C.; Froehlich, J. In Recent Results in Cancer Research. Platinum Coordination
Complexes in Cancer Chemotherapy; Connors, T. A., Roberts, J. J., Eds.; Springer-Verlag:
Heidel-berg, 1974; Vol. 48, p 75-77.
61. Marzilli, L. G.; Reily, M. D.; Heyl, B. L.; McMurray, C. T.; Wilson, W. D. FEBS Lett. 1984,
176, 389-392.
62. Reily, M. D.; Marzilli, L. G. J. Am. Chem. Soc. 1985, 107, 4916-4924.
63. Guney, E.; Yilmaz, V. T.; Ari, F.; Buyukgungor, O.; Ulukaya, E. Polyhedron 2011, 30, 114122.
64. Ulukaya, E.; Ari, F.; Dimas, K.; Sarimahmut, M.; Guney, E.; Sakellaridis, N.; Yilmaz, V. T.
J. Cancer Res. Clin. Oncol. 2011, 137, 1425-1434.
65. Price, J. H.; Williamson, A. N.; Schramm, R. F.; Wayland, B. B. Inorg. Chem. 1972, 11,
1280-1284.
66. Pitteri, B.; Annibale, G.; Marangoni, G.; Bertolasi, V.; Ferretti, V. Polyhedron 2002, 21,
2283-2291.
67. Gottleib, H. E.; Kotlyar, V.; Nudelman, A. J. Org. Chem. 1997, 62, 7512-7515.
68. Barnham, K. J.; Djuran, M. I.; Murdoch, P. S.; Sadler, P. J. J. Chem. Soc., Chem. Commun.
1994, 721-722.
69. van Boom, S. S. G. E.; Chen, B. W.; Tueben, J. M.; Reedijk, J. Inorg. Chem. 1999, 38, 14501455.
70. Natile, G.; Marzilli, L. G. Coord. Chem. Rev. 2006, 250, 1315-1331.
71. Benedetti, M.; Tamasi, G.; Cini, R.; Marzilli, L. G.; Natile, G. Chem. - Eur. J. 2007, 13,
3131-3142.
72. Williams, K. M.; Cerasino, L.; Intini, F. P.; Natile, G.; Marzilli, L. G. Inorg. Chem. 1998, 37,
5260-5268.

36

CHAPTER 3. UNUSUAL EXAMPLE OF CHELATE RING OPENING UPON
COORDINATION OF THE 9-ETHYLGUANINE NUCLEOBASE TO [PT(DI-6METHYL-2-PICOLYL)AMINE)Cl]Cl]*
3.1 INTRODUCTION
Difunctional platinum compounds of the type, cis-Pt(Lbi)X2 [Lbi = one bidentate or two
cis unidentate amine N-donors; X2 = one bidentate or two monodentate anionic leaving groups],
including cisplatin (cis-Pt(NH3)2Cl2) and its analogues, are among the most effective and most
studied anticancer agents.1-7 Pt(II) compounds interact with DNA to form a 1,2-intrastrand G*G*
cross-link, with Pt linking the N7 of two guanines in adjacent G residues of DNA5,6,8-13 (G*
identifies N7-platinated G residues in DNA or oligonucleotides). An X-ray/NMR-derived model
of a duplex 9-oligomer10 and an X-ray structure of an HMG-bound 16-oligomer,11 both
containing the intrastrand cisplatin lesion, led us to focus on the distortions involving the X•Y
base pair (bp) adjacent to the 5!-G*•C bp in the 5! direction along the duplex.10,14-16 The X•G* bp
has a large positive slide and a large positive shift.10,14 An oligomer adduct of a rather bulky
monofunctional Pt anticancer agent showed a similar shift and slide of the XG* bp step adjacent
to the 5!-G*•C bp along the 5! direction of the duplex.13,17
Guanine bases coordinated in positions cis to a metal can have a head-to-tail (HT) or a
head-to-head (HH) orientation (Figure 1). For Pt(Lbi)G2 adducts (bold G = guanine derivative
bound to a metal, but not tethered to another nucleobase), the G bases preferentially adopt the
HT orientation.18-22 In contrast, bases tethered by a sugar phosphate backbone, such as in
Pt(Lbi)(d(G*pG*)) cross-link adducts, are most often found in the HH orientation, especially
when a 5!-residue is present on the 5!-G* (for example, in Pt(Lbi)(d(TG*G*T)) adducts).15,20-22
*Reproduced with permission from American Chemical Society: Andrepont, C.; Pakhomova, S.;
Marzilli, P. A.; Marzilli, L. G., “Unusual Example of Chelate Ring Opening upon Coordination
of the 9-Ethylguanine Nucleobase to [Pt(di(6-methyl-2-picolyl)amine)Cl]Cl,” Inorg. Chem,
2015, 4895-4908. Copyright 2015 American Chemical Society
!
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Because the guanine H8 (Figure 3.1) 1H NMR signals are singlets and downfield, they
are the most useful signals for assessing metal binding and the presence of rotamers.15,16,23-28
Interconversions of HH to HT conformations via rotation about the Pt–N7 bonds in cis-Pt(Lbi)G2
and cross-link adducts are rapid on the NMR time scale unless the Lbi carrier ligand is bulky.
Bulky bidentate ligands lower the rotation rate, allowing observation of NMR signals of the
conformers present in solution. For a difunctional agent, activity decreases and toxicity increases
when Lbi is bulky.5,29-32 The study of Pt(Lbi)G2 adducts provides useful guidance and insight on
ligand bulk and on whether such bulk can influence the properties of the bound nucleobase.

Figure 3.1: Possible conformers for Pt(Lbi)G2 adducts with two bound monodentate guanine N9
derivatives (referred to with a bold G). A generic version of G is depicted in the center, along
with the guanine base numbering scheme. Note that the nucleobase is represented by an arrow
with the tip at the guanine H8 atom. N and N! represent a nitrogen donor ligand. When (N ≠ N!),
four rotamers (HHu, HHd, ΛHT, ΔHT) are possible, whereas when (N = N!), only three
conformers (HH, ΛHT, ΔHT) are possible because HHu = HHd. Regardless of whether the
nitrogen donors are unidentate ligands or are part of a chelate (N–N or N–N!), the same number
of conformers can exist.

!
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In contrast, monofunctional Pt(II) agents, Pt(Ltri)X (Ltri = a tridentate, one bidentate and
one monodentate, or three monodentate ligands; X = a monodentate monoanionic leaving group),
have higher activity when carrier-ligand bulk is greater.13,15,17,33-36 These monofunctional agents
also preferentially bind to G residues in DNA. It is important to gain a better understanding of
the fundamental features of such adducts. One approach to achieve this goal is to study Pt(Ltri)G
models to assess the effects of steric interactions between the carrier ligand and the guanine base.
We previously studied the interactions of a tridentate carrier ligand having in-plane bulk, di-(2picolyl)amine (N(H)dpa, Figure 3.2), in Pt(N(H)dpa)G adducts with several G derivatives [e.g.,
9-ethylguanine (9-EtG), 5!-guanonsine monophosphate (5!-GMP), etc.].23

Figure 3.2: Numbering scheme for [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+.
In such adducts, the guanine base has two orientations with respect to the coordination
plane, leading to the presence of syn and anti rotamers (Figure 3.3), which can interconvert by
rotation about the Pt–N7 bond. As shown in the figure, the rotamer with the H atom of the
central N-H group and the guanine O6 on the same side of the coordination plane is designated
as syn, and the rotamer with these groups on opposite sides of this plane is designated as anti.23,37
For all Pt(N(H)dpa)G adducts studied, each rotamer showed a sharp 1H NMR G H8 signal,
indicating that guanine base rotation about the Pt–N7 bond was impeded by the tridentate ligand
bulk.23
!
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Figure 3.3: Two possible rotamers (syn, top; anti, bottom) for Pt(Ltri)G complexes with tridentate
ligands unsymmetrical with respect to the coordination plane but symmetrical about a plane
perpendicular to the coordination plane are illustrated for Ltri = N(H)dpa and G = 9-EtG. The H8
proton of 9-EtG is highlighted with yellow circles. Protons in the chelate ligand N–CH2 groups
are called exo if they project up toward the NH and endo if they project down and away from the
NH.
In the present study, we examine Pt(Ltri)G adducts formed from [Pt(Ltri)Cl]Cl (Figure
3.2) with Ltri possessing in-plane bulk greater than that of N(H)dpa by introducing methyl groups
at the 6/6! positions, namely Ltri = N(H)6,6!-Me2dpa (di-(6-methyl-2-picolyl)amine). The methyl
substituents project in the direction of the guanine base in the [Pt(N(H)6,6!-Me2dpa)G]2+
adducts. We have employed NMR techniques to understand the influence of increased in-plane
bulk on the properties of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct. The mono adduct was
found to convert readily to the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ bis adduct (Figure 3.4). This
process involves an unusual transformation of the Pt-bound N(H)6,6!-Me2dpa ligand from the
tridentate to the bidentate coordination mode. Because the bidentate ligand has an asymmetric
racemic secondary amine and because GMP nucleotides are chiral, we undertook a very brief
study of adduct formation by 5!- and 3!-GMP with [Pt(N(H)6,6!-Me2dpa)Cl]Cl. We found
compelling evidence that 5!- and 3!-GMP also promote the unusual tridentate-to-bidentate

!
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coordination mode transformation accompanying formation of a bis adduct from the initially
formed mono adduct.

Figure 3.4: Transformation of the initially monofunctional complex, [Pt(N(H)6,6!-Me2dpa)Cl]+,
to the bis adduct, [Pt(N(H)6,6!-Me2dpa)G2]2+, upon addition of G. Note that the atoms in the
dangling chain are designated by a prime after the number. The methylene group protons are
designated as exo and endo (see text) for the chelated but not for the dangling 6-methyl-2-picolyl
chains.
3.2 EXPERIMENTAL SECTION
3.2.1 Starting Materials
K2[PtCl4], 3!- and 5!-GMP, and 9-EtG were obtained from Aldrich. cis-Pt(DMSO)2Cl238
and N(H)6,6!-Me2dpa39 were synthesized as described in the literature. The 1H NMR chemical
shifts in CDCl3 for N(H)6,6!-Me2dpa prepared here match the reported values. 1H and 13C NMR
shifts assigned by 2D NMR methods for N(H)6,6!-Me2dpa in a D2O/DMSO-d6 (64:36) mixture at
pH 4.1 and 11.2 are reported in Table B.1, Appendix B.
3.2.2 NMR Measurements
NMR spectra were recorded on an Avance-III Prodigy 500 MHz Bruker spectrometer,
typically with 10 mM samples in DMSO-d6 or in a D2O/DMSO-d6 (64:36) mixture (pH adjusted
with 0.5 M solutions of DNO3 or NaOD in D2O). For 1H and 13C NMR spectra in D2O/DMSO!
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d6, peak positions are referenced relative to TMS by using the signals of DMSO-d6 at 2.50 ppm
(residual) and 39.5 ppm, respectively.40 A presaturation pulse to suppress the water peak was
employed when necessary. ROESY experiments were performed at 15 °C by using a 200 ms
mixing time. 1H–13C HSQC and HMBC NMR spectra were recorded in order to assign the
signals of the adducts. NMR data were processed with TopSpin and MestreNova software. The
atom-numbering system shown in Figure 3.2 is used in reporting or discussing 1H and 13C NMR
data when the chelate ligand is tridentate. When the chelate ligand is bidentate, protons in the
chelated 6-methyl-2-picolyl chain!are labeled as H3, H4, H5, endo-H7, exo-H7, and 6-Me, and
protons in the dangling 6-methyl-2-picolyl chain! are labeled as H3!, H4!, H5!, H7!, and 6!-Me
(Figure 3.4).
3.2.3 X-ray Data Collection and Structure Determination
Single crystals were placed in a cooled nitrogen gas stream at 90 K on a Bruker Kappa
Apex-II DUO diffractometer equipped with Mo Κα radiation (λ = 0.71073 Å). Refinement was
performed by full-matrix least squares methods using SHELXL,41 with H atoms in idealized
positions. The N(2) atom of the cation in [Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O is disordered over
two positions with occupancies of 0.485:0.515 (A:B).! The cation in the [Pt(N(H)6,6!Me2dpa)Cl]Cl molecule is positioned on a mirror plane with the exception of the N(2) and Cl(1)
atoms, which are out of the plane and consequently disordered over two equivalent positions.
3.2.4 Synthesis of [Pt(N(H)6,6!-Me2dpa)Cl]Cl
Acetonitrile solutions of cis-Pt(Me2SO)2Cl2 (10.6 mg, 0.025 mmol in 1 mL) and
N(H)6,6!-Me2dpa (5.68 mg, 0.025 mmol in 1 mL) were mixed and allowed to stand at 25 °C.
After 2 h, thin, yellow, X-ray quality crystals were collected on a filter and washed with
acetonitrile; yield, 6.85 mg (56%). 1H NMR signals (ppm) in DMSO-d6: 8.45 (bs, 1H, NH), 8.03
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(t, J = 7.8 Hz, 2H, H4/4!), 7.50 (d, J = 7.7 Hz, 2H, H5/5!), 7.47 (d, J = 7.7 Hz, 2H, H3/3!), 5.12
(dd, J = 16.1, 9.1 Hz, 2H, endo-H7/7!), 4.65 (dd, J = 16.0, 5.2 Hz, 2H, exo-H7/7!), 2.94 (s, 6H,
6/6!-CH3).
3.2.5 [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+Adduct
A 10 mM solution of [Pt(N(H)6,6!-Me2dpa)Cl]Cl [2.96 mg in 600 µL of a 64:36
D2O/DMSO-d6 (385 µL:215 µL) mixture] was treated with 2.5 equiv of 9-EtG (2.69 mg) to give
a 1:2.5 ratio (10 mM:25 mM) of Pt:9-EtG, and the solution (pH ~4) was kept at 25 °C. (The
D2O/DMSO-d6 mixture was employed to improve the solubility of the reactants.) The reaction,
which was repeated several times, was monitored by 1H NMR spectroscopy until no change was
observed in the bound vs free 9-EtG H8 signal intensity, or until [Pt(N(H)6,6!-Me2dpa)(9EtG)2]2+ adduct formation was complete, usually ~4.5 h.
3.3 RESULTS AND DISCUSSION
3.3.1 Structural Results. Overall Aspects
Summarized in Table 3.1 are the crystal data and details of the structural refinement of
[Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O and [Pt(N(H)6,6!-Me2dpa)Cl]Cl. Selected bond lengths and
angles are reported in Table 3.2. ORTEP plots of the cations of these two complexes and the
numbering scheme used to describe the solid-state data are shown in Figure 3.5. All other
references (e.g., NMR discussion) to these ligands and complexes will employ the atomnumbering scheme shown in Figure 3.2.
3.3.2 Coordination Parameters
The [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+ cations exhibit pseudo square planar
geometry, with the three N atoms of the tridentate ligand bound to the Pt; a Cl atom trans to the
N(2) atom completes the Pt coordination sphere (Figure 3.5).
!
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Table 3.1: Crystal Data and Structure Refinement for [Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O and
[Pt(N(H)6,6!-Me2dpa)Cl]Cl
empirical formula

[C12H13ClN3Pt][H2PO4]•H3PO4 •H2O

[C14H17ClN3Pt]Cl

fw

642.79

493.29

crystal system

triclinic

orthorhombic

space group

Pī

Pnma

a (Å)

6.9872(2)

15.6698(9)

b (Å)

12.0630(4)

6.8167(4)

c (Å)

12.8337(4)

14.2516(8)

α

114.212(2)

90

β (deg)

91.530(2)

90

γ

102.012(2)

90

V (Å3)

957.31(5)

1522.30(15)

T (K)

100

98

Z

2

4

ρcalc (Mg/m3)

2.230

2.152

abs coeff (mm-1)

7.69

9.56

2θmax (°)

75.8

52.7

R [I> 2σ(I)]a

0.032

0.034

wR2b

0.068

0.075

data/param

10174/288

1689/129

res. dens (eÅ-3)

3.45/-1.35

1.27, -1.55

a

R = (∑||Fo| - |Fc||)/∑|Fo|. bwR2 = [∑[w(Fo2 - Fc2)2]/∑[w(F 2)2]]1/2, in which w = 1/[σ2(Fo2) + (dP)2 +
(eP)] and P = (Fo2 + 2Fc2)/3.
ο
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Table
3.2:
Selected
Bond
Distances
(Å)
and
Angles
(deg)
[Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O and [Pt(N(H)6,6!-Me2dpa)Cl]Cl
!
[Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O [Pt(N(H)6,6!-Me2dpa)Cl]Cl

for

bond distances
Pt–N(1)

2.012(2)

2.048(7)

Pt–N(2)A

2.014(5)

1.973(8)

Pt–N(3)

2.015(2)

2.047(7)

Pt–Cl(1)

2.3148(6)

2.421(3)
bond angles

N(1)–Pt–N(3)

166.16(8)

166.3(3)

N(1)–Pt–Cl(1)

97.17(6)

95.96(18)

N(2)A–Pt–Cl(1)

169.5(2)

159.1(3)

N(3)–Pt–Cl(1)

96.67(6)

95.34(18)

N(2)A–Pt–N(1)

85.02(16)

83.2(3)

N(2)A–Pt–N(3)

81.28(16)

83.4(3)

For [Pt(N(H)dpa)Cl]+ and [Pt(N(H)6,6!-Me2dpa)Cl]+, the central N(2) atoms are
disordered over two positions, N(2)A and N(2)B, above and below the coordination planes,
respectively. All bond lengths and angles discussed below are for the A form. Both complexes
have comparable N(1)–Pt–N(3) bite angles (Table 3.2); these are similar to the 167.7(2)° bite
angle reported for [Pt(N(H)dpa)(OH2)](ClO4)2•H2O.42 The Pt–N(1) and Pt–N(3) bond distances
(Table 3.2) for both chloro complexes compare well with reported Pt–N(sp2) bond distances
ranging from 1.99–2.08 Å.43,44 The Pt–N(2) bond distance for [Pt(N(H)6,6!-Me2dpa)Cl]+ is
shorter than that for [Pt(N(H)dpa)Cl]+ (Table 3.2) and for most relevant reported Pt–N(sp3) bond
distances (2.01–2.12 Å).45-47
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The consequences of replacing protons on C(1) and C(12) with bulkier methyl groups are
best assessed by comparing bond distances and angles in Table 3.2 involving the Pt–Cl bond.
The N(2)–Pt–Cl bond angle differs from 180° significantly more in [Pt(N(H)6,6!-Me2dpa)Cl]+
(159.1(3)°) than in [Pt(N(H)dpa)Cl]+ (169.5(2)°). This large departure from 180° in
[Pt(N(H)6,6!-Me2dpa)Cl]+ (Figure 3.6) arises from the large steric repulsion between the
coordinated Cl and the nearby 6/6!-Me groups.

Figure 3.5: ORTEP plots showing the cations of [Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O (top) and
of [Pt(N(H)6,6!-Me2dpa)Cl]Cl (bottom). Thermal ellipsoids are drawn with 50% probability. The
crystals are disordered, and the cation in only one of the positions is shown.
This steric interaction between the Cl and the Me groups results in a significantly longer
Pt–Cl bond in [Pt(N(H)6,6!-Me2dpa)Cl]+ than in [Pt(N(H)dpa)Cl]+ (Table 3.2). This longer
distance suggests that the Cl ligand is bound slightly more weakly in [Pt(N(H)6,6!-Me2dpa)Cl]+
!
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than in [Pt(N(H)dpa)Cl]+. Such weaker binding may contribute to the greater reactivity toward G
adduct formation exhibited by [Pt(N(H)6,6!-Me2dpa)Cl]+ compared to [Pt(N(H)dpa)Cl]+.
Furthermore, the shorter length of the Pt–N bond trans to Cl (Pt–N(2)) (Table 3.2) in
[Pt(N(H)6,6!-Me2dpa)Cl]+ compared to [Pt(N(H)dpa)Cl]+; this shorter bond could indicate that
the Cl trans influence is reduced as a consequence of the weaker Pt–Cl bond. The length of the
Pt–N(2) bond in [Pt(N(H)6,6!-Me2dpa)Cl]+ (1.973(8) Å) is not significantly different from the
Pt–N(2) bond (1.952(7) Å) reported42 for [Pt(N(H)dpa)(OH2)](ClO4)2•H2O, in which the
secondary amine nitrogen is trans to the aqua ligand, which has a weak trans influence.

Figure 3.6: Orientation of the pyridyl rings in the cation of [Pt(N(H)6,6!-Me2dpa)Cl]Cl, viewed
along the coordination plane and showing designations of the endo-H7/7! and exo-H7/7! protons.
The figure also illustrates the large departure of the N(2)–Pt–Cl angle from 180°.
3.3.3 [Pt(N(H)6,6!-Me2dpa)Cl]Cl NMR Signal Assignments
The 1H NMR signals for [Pt(N(H)6,6!-Me2dpa)Cl]+ in a 64:36 D2O/DMSO-d6 mixture
are presented in Table 3.3, and the aromatic region is shown in Figure 3.7. The equivalent
[Pt(N(H)6,6!-Me2dpa)Cl]+ methylene groups have equivalent carbon atoms (C7 and C7!), but
each carbon bears inequivalent methylene protons (designated as endo-H7/7! and exo-H7/7!,
Figures 3.6 and B.2).
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Table 3.3: 1H NMR Shifts (ppm) for [Pt(N(H)6,6!-Me2dpa)Cl]Cl and [Pt(N(H)6,6!-Me2dpa)(9EtG)]2+ in D2O/DMSO-d6 (pH 4.0) at 25 °C
proton a

[Pt(N(H)6,6!-Me2dpa)Cl]Cl

[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+

9-EtG H8

-

8.84b, 8.54c

H4/4!

7.80

7.81

H3/3!

7.23

7.31

H5/5!

7.27

7.12

endo-H7/7!

4.87

4.88

exo-H7/7!

4.47

4.50

6/6!-Me

2.80

2.05b, 1.75c

a

Free 9-EtG signals (ppm): H8 7.72, CH2 3.91, and CH3 1.25; bound 9-EtG signals (ppm): CH2
4.10 (anti), 4.01 (syn); CH3 1.26 (anti), 1.30 (syn). bSignals from the anti rotamer. cSignals from
the syn rotamer.
The signals for the corresponding protons of the parent [Pt(N(H)dpa)Cl]Cl complex were
assigned by using the Karplus equation and the H–N–C–H coupling constants measured in
DMSO-d6 (because the carrier-ligand N–H exchanges with D2O in the D2O/DMSO-d6
mixture).23 The 4.92 ppm signal with the larger H–N–C–H coupling constant (8.9 Hz) for
[Pt(N(H)dpa)Cl]+ was assigned to the endo-H7/7! signal because from the Karplus equation and
from the H–N–C–H torsion angle, the endo-H7/7! proton would have the larger coupling
constant. The exo-H7/7! signal at 4.60 ppm has a smaller H–N–C–H coupling constant (5.1 Hz).
For [Pt(N(H)6,6!-Me2dpa)Cl]+, however, the H–N–C–endo-H7/7! (~149°) and H–N–C–exoH7/7! (~30°) torsion angles in the solid do not permit such a confident assignment as was made
for [Pt(N(H)dpa)Cl]Cl. Nevertheless, similarities in the NH–CH coupling constants for the two
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complexes in DMSO-d6 allow us to assign the signal of [Pt(N(H)6,6!-Me2dpa)Cl]Cl at 5.12 ppm
(J = 9.1 Hz) to endo-H7/7! and the signal at 4.65 ppm (J = 5.2 Hz) to exo-H7/7!.
From the assignments in DMSO-d6, we can assign the following signals for [Pt(N(H)6,6!Me2dpa)Cl]Cl in D2O/DMSO-d6 (64:36 mixture): the downfield H7/7! signal at 4.87 ppm to
endo-H7/7!, and the upfield signal at 4.47 ppm to exo-H7/7!. The respective shifts in
D2O/DMSO-d6 for [Pt(N(H)dpa)Cl]Cl are 4.73 and 4.49 ppm.23 The exo-H7/7! signals have very
similar shifts in these two complexes, probably because the exo-H7/7! protons project away from
the coordination sphere (Figures 3.6 and B.1, Appendix B).
In the 1H NMR spectrum of [Pt(N(H)6,6!-Me2dpa)Cl]+ in D2O/DMSO-d6 (64:36 mixture),
the triplet at 7.80 ppm (Figure 3.7) is assigned to H4/4!, the only type of aromatic proton that can
give a triplet. In a ROESY spectrum (not shown), an NOE cross-peak from the 6/6!-Me signal
assigns the H5/5! doublet, and thus the other doublet is assigned to H3/3! (Table 3.3).
Assignments of the

13

C NMR signals for [Pt(N(H)6,6!-Me2dpa)Cl]+ were made through an

HSQC experiment (Table 3.4 and Figure B.2, Appendix B). Cross-peaks (ppm) involving H3/3!
(7.23-120.6), H4/4! (7.80-142.0), H5/5! (7.27-128.5), and 6/6!-Me (2.80-27.5) signals assign the
C3/3!, C4/4!, C5/5!, and C(6/6!-Me) 13C NMR signals, respectively. Cross-peaks from the endoH7/7! and exo-H7/7! signals assign the 13C NMR signal at 63.3 ppm to C7/7!. Compared to the
free ligand C7/7! shift at 52.0 ppm (Appendix B), the shift change of over 11 ppm can be
attributed to a combination of strain induced by chelation to Pt(II) and the Pt(II) electronwithdrawing inductive effect.
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!
Figure 3.7: Aromatic region of the 1H NMR spectra (shifts in ppm) of a solution of [Pt(N(H)6,6!Me2dpa)Cl]+ (25 °C, D2O/DMSO-d6) before (bottom), 15 min after (middle), and 4.5 h after (top)
mixing with 2.5 molar equivalents of 9-EtG (pH 4.0). Signals for the mono-adduct intermediate,
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+, are labeled in the middle trace, and those for the final bisadduct [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ product are labeled in the top trace, where the ΛHT and
ΔHT labels designate the two H8 signals of each conformer.
The two very downfield signals in the 13C NMR spectrum of [Pt(N(H)6,6!-Me2dpa)Cl]Cl
(Figure B.3, Appendix B) do not have HSQC cross-peaks; these features are expected for C2/2!
and C6/6!. The shifts for these carbons attached to the pyridyl nitrogen are expected to be
downfield, and they are not directly attached to a proton, accounting for the absence of an HSQC
cross-peak. The C2/2! and C6/6! signals were assigned with HMBC cross-peaks to H3/3! and
H5/5! signals (Figure B.3, Table 3.4). At pH 4.1, the shift of the C2/2! signal at 166.7 ppm is ~16
ppm more downfield than that of the free ligand at 151.1 ppm (Table B.1, Appendix B). The
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results in this investigation (see below) indicate that at pH ~4 a C2/2! shift downfield of 160 ppm
is characteristic of a bound 6-methyl-2-picolyl chain, whereas a signal upfield of 155 ppm
indicates a dangling 6-methyl-2-picolyl chain.
Table 3.4: 13C NMR Shifts (ppm) for [Pt(N(H)6,6!-Me2dpa)Cl]Cl and [Pt(N(H)6,6!-Me2dpa)(9EtG)]2+ in D2O/DMSO-d6 (pH 4.0) at 25 °C
carbon a

[Pt(N(H)6,6!-Me2dpa)Cl]Cl

[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+

9-EtG C8

-

142.6b, 142.7c

C4/4!

142.0

142.0

C3/3!

120.6

121.2b, 121.1c

C5/5!

128.5

128.6

C7/7!

63.3

62.6b, 62.2c

6/6!-Me

27.5

26.1b, 24.8c

C6/6!

164.8

163.9b, 163.8c

C2/2!

166.7

167.3b, 167.7c

a

Free 9-EtG signals (ppm): C8 140.8, CH2 40.2, and CH3 16.3; bound 9-EtG signals (ppm): CH2
41.63 (anti), 41.59 (syn); CH3 16.4 (anti), 16.0 (syn). bSignals from the anti rotamer. cSignals
from the syn rotamer.
3.3.4 [Pt(N(H)6,6!-Me2dpa)Cl]Cl Adducts with 9-EtG
The reaction of [Pt(N(H)6,6!-Me2dpa)Cl]Cl with 2.5 molar equiv of 9-EtG in
D2O/DMSO-d6 (64:36) was monitored by using the H8 NMR signal of 9-EtG. At 15 min, the
spectrum (Figure 3.7) contained a total of six new H8 signals, and only 17% of the starting
complex remained. As discussed below, two of the six new H8 signals (Figure 3.7) are assigned
to the syn and anti rotamers (see Figure 3.3) of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct
(accounting for ~65% of the product). The remaining four H8 signals arise from a mixture of two
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[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ conformers. At 2.5 h, the starting [Pt(N(H)6,6!-Me2dpa)Cl]Cl
signals had completely disappeared. In contrast, under identical conditions, complete
disappearance of the starting [Pt(N(H)dpa)Cl]Cl signals required ~49 h.23 The greater reactivity
of [Pt(N(H)6,6!-Me2dpa)Cl]Cl will be discussed below. Furthermore, the reaction of
[Pt(N(H)dpa)Cl]Cl with 9-EtG studied previously led to only the mono adduct, [Pt(N(H)dpa)(9EtG)]2+ (Figure 3.3).23 Finally, the H8 signals of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ had completely
disappeared by 4.5 h (Figure 3.7), indicating that all of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+
mono adduct had converted to bis adduct, [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+, having a now
bidentate chelate ligand (Figure 3.4).
3.3.5 [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+Adduct
As just mentioned, two of the six H8 signals observed at 15 min (Figure 3.7) are assigned
to the two conformers of the mono adduct, [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+. NMR spectra were
recorded on fresh solutions to characterize the mono adduct because it converted to the bis
adduct with time under the reaction conditions employed. Signals in the 1H and 13C NMR spectra
for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct (Tables 3.3 and 3.4) were assigned by using
procedures similar to those detailed above for the simpler spectrum of the [Pt(N(H)6,6!Me2dpa)Cl]Cl complex and those described below for the more complicated spectrum of the
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct.
As expected from the inductive effect of Pt(II),48-50 the H8 signals at 8.84 and 8.54 ppm
are downfield of the free 9-EtG H8 signal at 7.72 ppm (Figure 3.7 and Table 3.3). As we
reported for the [Pt(N(H)dpa)(9-EtG)]2+ adduct,23 the tilting of the anisotropic pyridyl ring
relative to the Pt(II) coordination plane positions this shielding region closer to the H8 proton of
the syn conformer than to that of the anti conformer (Figure 3.3). The syn H8 signal (8.54 ppm)
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is upfield relative to the anti H8 signal (8.84 ppm). The shift difference between the two H8
signals (Δδ) is ~0.30 ppm, a value similar to the Δδ of ~0.33 ppm for the [Pt(N(H)dpa)(9-EtG)]2+
adduct.23
For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct, the syn H8:anti H8 signal intensity ratio
of 1:1.42 indicates that the syn rotamer is less favored. In this adduct, the 6/6!-Me groups create
a sterically crowded 9-EtG coordination site. Crowding will most likely have an unfavorable
effect on the syn rotamer because, as a consequence of the tilting of the pyridyl ring relative to
the coordination plane, the bulky guanine six-membered ring and the 6/6!-Me groups are on the
same side of the coordination plane (Figure B.4). This guanine ring in the syn rotamer of
[Pt(N(H)dpa)(9-EtG)]2+ is in a less crowded environment (A, Figure B.4), and the syn:anti ratio
is 1.28:1, indicating that the syn rotamer is more stable.
In the syn and anti rotamers of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct, guanine base
canting is likely to be minimal because of steric interactions between the guanine base and the
6/6!-Me groups. However, for the syn and anti rotamers of the [Pt(N(H)dpa)(9-EtG)]2+ adduct, in
the absence of the bulky methyl groups, guanine base canting is likely to occur (Figure B.4).
Canting could lead to greater shielding of H8 by the pyridine ring. The syn (8.54 ppm) and anti
(8.84 ppm) H8 signals for [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ are farther downfield than the syn
(8.40 ppm) and anti (8.73 ppm) H8 signals of [Pt(N(H)dpa)(9-EtG)]2+.23 The more downfield
shift of the H8 signals for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ rotamers may arise from a lower
degree of guanine base canting (Figure B.4).
In a ROESY spectrum of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ at 15 °C (Figure B.5,
Appendix B), NOE cross-peaks to the assigned syn and anti H8 signals allow assignments of the
6/6!-Me signals at 1.75 and 2.05 ppm to the syn and anti conformers, respectively (Table 3.3).
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These shifts are upfield by 1.05 and 0.75 ppm, respectively, relative to the 6/6!-Me signal for
[Pt(N(H)6,6!-Me2dpa)Cl]Cl (Table 3.3). An upfield shift is expected from the close proximity of
these Me groups to the anisotropic 9-EtG base (Figure B.4). The more upfield shift position of
the syn 6/6!-Me signal is consistent with these 6/6!-Me groups being on the same side of the
coordination plane as the more shielding guanine six-membered ring. The intensity of the H86/6!-Me NOE cross-peak is much lower for the syn rotamer than for the anti rotamer (Figure
B.5), a finding consistent with the greater H8-to-6/6!-Me group distance in the syn rotamer than
in the anti rotamer. This result also confirms our shift-based assignments of the syn and anti H8
signals.
The absence of H8-H8 EXSY cross-peaks in the ROESY spectrum at 15 °C of
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ (Figure B.6) indicates that interconversion between the
rotamers is slower than for [Pt(N(H)dpa)(9-EtG)]2+, an adduct that exhibits H8-H8 EXSY crosspeaks at 15 °C.23 Thus, as expected, the methyl groups at the 6/6!-positions of the pyridyl rings
are more effective than 6/6! protons in impeding rotation of 9-EtG about the Pt–N7 bond.
3.3.6 [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+Adduct
As mentioned, four of the six product H8 signals (Figure 3.7) arise from at least two
conformers of a bis adduct, [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+. The two H8 signals of each
conformer have very similar intensities, and the four bis adduct H8 signals are easily grouped
into two pairs. The minor:major ratio of these pairs of signals remained equal to 1:1.6 throughout
their formation, consistent with facile equilibration between the conformers. For this bis adduct
to form, one 6-methyl-2-picolyl chain must be dangling, and the chelate ligand must convert
from a tridentate to a bidentate coordination mode (Figure 3.4). Before discussing the signal
assignments, we note that the finding of two pairs of H8 signals maintaining a constant ratio is
!
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evidence for at least two conformers, but the situation is more complex than might appear, as
discussed beginning in the next paragraph.
To explain our analysis of the two pairs of H8 signals, we first review the number of
conformers possible for such cis bis adducts, Pt(N–N)G2 and Pt(N–N!)G2 (Figure 3.1). When N–
N = a C2-symmetrical achiral bidentate ligand, up to three [one HH and two HT (ΛHT, ΔHT)]
rotamers may be observed in a Pt(N–N)G2 adduct. Both G ligands in each conformer are
equivalent if G lacks a chiral group (e.g., 9-EtG), and only one H8 signal per rotamer is possible.
However, in Pt(N–N!)G2 adducts having an unsymmetrical achiral bidentate ligand, four
rotamers (HHu, HHd, ΛHT, ΔHT) are possible (Figure 3.1). The G ligands in all conformers of
such Pt(N–N!)G2 adducts are no longer equivalent; if G has either a chiral or an achiral group at
N9, two H8 signals per rotamer are expected. Thus, a maximum of eight H8 signals could
possibly be observed if all four conformers exist and all are in slow exchange. If the N–N!
chelate ligand is both unsymmetrical and chiral and if G lacks a chiral group, the situation is the
same, i.e., a potential maximum of eight H8 signals could arise for a Pt(N–N!)G2 adduct such as
the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct.
In [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ conformers, the bidentate ligand is unsymmetrical,
and the secondary nitrogen is an asymmetric center. In the perspective used in Figure 3.8, two
configurations of the asymmetric center are possible. In one configuration, the NH is above the
coordination plane and the dangling 6-methyl-2-picolyl chain is below the coordination plane
(left sketch in Figure 3.8).
In the other, the NH is below the coordination plane and the dangling 6-methyl-2-picolyl
chain is above the coordination plane. Because 9-EtG has no chiral group, each conformer exists
as an enantiomeric pair with signals that have identical shifts for each enantiomer; hence, at most
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two H8 signals are expected for each conformer. Another consequence of the fact that 9-EtG
lacks a chiral group is that the two configurations at the asymmetric nitrogen are formed in equal
abundance. For the purposes of this article, we have chosen to depict only one configuration of
the asymmetric center (the one illustrated on the right in Figure 3.8) in figures illustrating the
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ HT conformers, such as in Figure 3.9.

Figure 3.8: The two configurations of the asymmetric secondary nitrogen center of [Pt(N(H)6,6!Me2dpa)G2]2+ adducts, with the methylene group of the dangling pyridyl chain below (left) and
above (right) the coordination plane. Because 9-EtG is not chiral, these two configurations are
formed in equal abundance in the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct. Because the HT
conformers are chiral, the ΔHT and ΛHT conformers with the chelate configuration on the left
have equal abundance and are the mirror images of the respective ΛHT and ΔHT conformers
with the chelate configuration on the right. These enantiomers cannot be distinguished by typical
NMR methods for adducts of G = 9-EtG. The configuration of the asymmetric center illustrated
on the right is used to discuss results in this study.
For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, three H8 signals (at 8.15, 8.03, and 7.94
ppm) are downfield, and one H8 signal (at 7.61 ppm) is actually slightly upfield from the free 9EtG H8 signal at 7.72 ppm (Table 3.5). In contrast, the H8 shifts of the mono adduct (8.54 and
8.84 ppm) are relatively downfield. This shift pattern, which is characteristic of shifts observed
on mono vs bis adduct formation, can be attributed to the counterbalancing effects of the Pt(II)
inductive effect versus the anisotropic effect of the adjacent guanine. A pattern attributable to the
same effects can be seen in shifts of signals for protons on the carbon attached to the guanine N9.
Thus, the shifts of the 9-EtG CH2 signal in the bis adduct (averaging ~3.85 ppm) are slightly
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upfield of that for the free 9-EtG (3.91 ppm), whereas those for the mono adduct (averaging
~4.05 ppm) are slightly downfield (Tables 3.3 and 3.5).

Figure 3.9: Possible orientations of the guanine bases in the ΔHT (top) and ΛHT (bottom)
conformers of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adducts. As illustrated, in the ΔHT conformer
the 9-EtG base is in close proximity to the dangling pyridyl ring; this proximity could cause the
anisotropic 9-EtG base to induce a more upfield shift in the pyridyl ring signals (particularly H3!,
upper right) for the ΔHT conformer, as compared to the ΛHT conformer. The illustration for the
ΛHT conformer depicts the canting of the 9-EtG base expected when a hydrogen bond (dashed
red line) is formed between O6 and NH. The canting positions the H8 closer to the shielding
region of the six-membered ring of the adjacent 9-EtG base. The shift of the H8 signal of the
canted 9-EtG base is relatively upfield.
The four H8 signals of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct can be grouped into
minor (8.15 and 7.94 ppm) and major (8.03 and 7.61 ppm) pairs. These pairs are always present
in a 1:1.6 ratio, as mentioned above. At this point, to simplify discussion, we state that the minor

!

57

and major rotamers are the ΔHT and ΛHT conformers (Figure 3.9), respectively, when the
configuration on the right in Figure 3.8 is used.
Table 3.5: 1H NMR Shifts (ppm) for [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ in D2O/DMSO-d6
(pH 4.0) at 25 °C
proton a

ΛHT (major)

ΔHT (minor)
9-EtGb

G H8 cis B

8.03

8.15

G H8 cis D

7.61

7.94

G CH2 cis!B

3.84

3.88

G CH2 cis D

3.83

3.85

G CH3 cis B

1.11

1.16

G CH3 cis D

1.15

1.20
6,6!-Me2dpa

H4

7.86

7.85

H4!

7.65

7.56

H3 (overlapped)

7.48

7.48

H3!

7.55

7.28

H5 (overlapped)

7.12

7.12

H5!

7.07

7.03

endo-H7

5.00

5.12

exo-H7

4.57c

4.57c

H7!

3.72, 3.86d

3.68, 3.82d

6-CH3

1.75

1.88

6!-CH3

2.15

2.13

a

G = 9-EtG; cis B = signal in G bound cis to bound chain; cis D = signal in G bound cis to
dangling chain. bfree 9-EtG 1H NMR signals: H8 7.72, CH2 3.91, and CH3 1.25 ppm. cSignals are
masked by the HOD signal. dSignals are masked by the CH2 signals of the 9-EtG ethyl group.
Because one 6-methyl-2-picolyl chain is dangling, the corresponding protons of the two
halves of the now bidentate chelate ligand are not equivalent in all [Pt(N(H)6,6!-Me2dpa)(9-
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EtG)2]2+ conformers (Figures 3.4, 3.8, and 3.9). Four 6-Me signals of the adduct can be observed,
and all are upfield compared to the 6/6!-Me signal of [Pt(N(H)6,6!-Me2dpa)Cl]Cl at 2.80 ppm.
However, not all of the other types of chelate ligand signals can be resolved. [The aromatic and
aliphatic 1H NMR spectral regions for the reaction mixture forming [Pt(N(H)6,6!-Me2dpa)(9EtG)2]2+ are presented in Figures 3.7 and B.7.] Two of the four Me signals [1.88 (minor, ΔHT)
and 1.75 (major, ΛHT) ppm] have upfield shifts similar to those of the syn (1.75 ppm) and anti
(2.05 ppm) 6-Me signals of the mono adduct, [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+. These 6-Me
signals of the two [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ conformers are assigned to the 6-Me of the
chelated 6-methyl-2-picolyl chain because such a 6-Me group is close to the anisotropic purine
rings of the coordinated cis 9-EtG in both the ΔHT and ΛHT conformers (Figure 3.9). By
complementary reasoning, the downfield 6!-Me signals at 2.13 (ΔHT) and 2.15 (ΛHT) ppm
(Table 3.5), which have shifts closer to that of the 6/6!-Me signal of the free N(H)6,6!-Me2dpa
ligand (2.40 ppm), are assigned to the 6!-Me group in the dangling chain.
A key type of information allowing us to determine the conformations of each
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ rotamer is provided by the H8 signal shifts for the minor ΔHT
conformer (8.15 and 7.94 ppm) and for the major ΛHT conformer (8.03 and 7.61 ppm). The very
upfield 7.61 ppm shift is characteristic of the H8 signal of a highly canted guanine base. A high
degree of guanine base canting is characteristic of a 9-EtG coordinated cis to the NH group of
the carrier ligand with its O6 on the same side of the coordination plane as the NH. The resulting
O6-to-NH hydrogen bonding leads to guanine base canting.51 Canting positions the H8 closer to
the shielding region of the six-membered ring of the adjacent guanine base (Figure 3.9). This
positioning of H8 results in an upfield H8 signal for the canted 9-EtG. Such NH-to-G O6 Hbonding is possible for only one HT conformer. For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct
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with an unresolved asymmetric bidentate ligand, the enantiomer with the asymmetric
configuration at nitrogen shown in Figure 9 has the ΛHT conformation. The guanine base of the
other 9-EtG (cis to the bound pyridyl ring) in the ΛHT conformer is expected to have a low
degree of canting because of the steric interaction between the guanine six-membered ring and
the 6-Me group. Also, this H8 is positioned far from the shielding region of the cis 9-EtG base
(Figure 3.9). As a result, the H8 signal of this less canted 9-EtG base is relatively downfield at
8.03 ppm. From the foregoing, it follows that the less abundant HT conformer, with H8 signals at
8.15 and 7.94 ppm, is the ΔHT conformer. The lower abundance of this conformer may be a
result of a steric clash of the guanine O6 with the dangling 6-methyl-2-picolyl chain or of the
lack of any stabilizing O6-to-NH hydrogen bonding.
For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, as mentioned above, the 6-Me protons
of the bound pyridyl ring are close to the cis 9-EtG H8 in both [Pt(N(H)6,6!-Me2dpa)(9-EtG)2] 2+
conformers. H8-to-6-Me NOE cross-peaks are expected from the H8 signals of the cis 9-EtG.
H8-to-6!-Me NOE cross-peaks could be expected for both the ΛHT and ΔHT conformers
because rotation about the bond between the asymmetric N and CH2! positions the 6!-Me in the
dangling chain close to the H8 of the 9-EtG cis to the secondary amine in each rotamer.
However, the H8-to-6!-Me NOE cross-peak should be more intense for the ΛHT rotamer
because the 9-EtG H8 and the dangling chain are on the same side of the coordination plane.
From this reasoning, we can use NOE data to assign the H8 and Me signals to a specific
conformer. The ROESY spectrum (Figure 3.10) has very intense NOE cross-peaks from the H8
signal at 8.15 ppm to the 6-Me signal at 1.88 ppm and from the H8 signal at 8.03 ppm to the 6Me signal at 1.75 ppm. From this information, we assign the H8 signals at 8.15 and 8.03 ppm to
the 9-EtG cis to the chelated 6-methyl-2-picolyl chain, consistent with our shift-based
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assignment of the signals at 1.88 and 1.75 ppm to the 6-Me group of this chain in the two
rotamers, as discussed above.

Figure 3.10: The H8 and 6-Me region of the 1H-1H ROESY spectrum of the [Pt(N(H)6,6!Me2dpa)(9-EtG)2]2+ adduct (25 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm). The singlet labeled X
at left is a solvent impurity.
The H8 signals at 8.15 and 8.03 ppm are connected by an EXSY cross-peak (Figure
3.11), confirming that the H8 signals are from the 9-EtG coordinated cis to the chelated 6methyl-2-picolyl chain in the two conformers. An EXSY cross-peak between H8 signals at 7.94
and 7.61 ppm indicates that the two H8 signals are from the 9-EtG in the other coordination site,
cis to the secondary amine. The presence of these H8-H8 EXSY cross-peaks further indicates
that rotation about the Pt–N bonds is occurring but not at a rate fast enough to average the signals
of all conformers.
The H8 signal at 7.94 ppm of the minor [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ rotamer does
not have an NOE cross-peak to a Me signal, but the H8 signal of the major rotamer at 7.61 ppm
has a weak NOE cross-peak to the 6!-Me signal at 2.15 ppm (Figure 3.10). This information
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allows assignment of the 6!-Me signals (Table 3.5) and also confirms that the major rotamer is
the ΛHT conformer, with the H8 of the 9-EtG cis to the secondary amine on the same side of the
coordination plane as the dangling 6-methyl-2-picolyl chain.

Figure 3.11: Aromatic region of the 1H-1H ROESY spectrum of the [Pt(N(H)6,6!-Me2dpa)(9EtG)2]2+ (15 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm). The peak labeled H5 contains
overlapped H5 signals of both HT rotamers. Cross-peaks shown in red are NOE cross-peaks and
those in blue are EXSY cross-peaks.
As shown in Figure 3.1, interconversion between the two HT rotamers of the
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct can pass through either one or both HH conformers.
The 9-EtG cis to the bound chain with the 6-Me group projecting toward the guanine base would
surely undergo slower rotation than would the 9-EtG adjacent to the dangling chain. If either of
the two HH conformers existed in relatively high abundance, but if the HT-to-HH interchange
were fast, separate signals for the HH/HT pair would not be observed. Thus, our observation of
only four H8 signals does not rule out the presence of some of both HH conformers. A
significant amount of an HH conformer could be present but not detectable in 1D NMR spectra;
however, the HH conformer could be detectable in 2D NMR spectra. For example, a ROESY
!
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spectrum would contain an H8-H8 NOE cross-peak linking H8 signals from 9-EtG cis to the
bound pyridyl N with H8 signals from 9-EtG cis to the dangling chain because these protons are
close in both HH conformers (Figures 3.1 and B.8). No H8-H8 NOE cross-peak was observed
for either pair of H8 signals (minor or major) (Figure 3.11), a finding consistent with a low
abundance of HH conformers and a dominant abundance of ΛHT and ΔHT conformers.
Furthermore, a low abundance of HH conformers of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+
adduct is fully consistent with extensive past studies with various bidentate ligands having two
sp2 N donors in heterocyclic aromatic rings or two sp3 N donors.20,52 Regardless of the type of N
donor in the bidentate ligand, the HH conformer was either absent or else present in low
abundance, except for adducts of guanine nucleotides that possess a phosphate group.26,51,53
To further confirm our conclusions about the conformation of the HT rotamers of
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+, we assessed the effect of pH on conformer abundance. At high
pH, the N1H of guanine (Figure 3.1) becomes deprotonated, making the O6 a stronger hydrogen
bond acceptor.51 As mentioned, only the ΛHT conformer is capable of forming a G O6–NH
hydrogen bond (Figure 3.9). Thus, the abundance of the ΛHT conformer is expected to increase
with pH. At low pH (4.3), the ΛHT:ΔHT ratio of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ conformers
was 63:37, which increased to 69:31 at pH 8.3 and to 88:12 at pH 10.3 (Figure 3.12). Thus, the
ΛHT conformer (which can form an O6–NH hydrogen bond) has an even higher abundance than
the ΔHT conformer at high pH, in agreement with previous studies of the (rac)-BipPt(9-EtG)2
(Bip = 2,2!-bipiperidine)20 and (rac)-Me2DABPt(9-EtG)2 (Me2DAB = N,N-dimethyl-2,3diaminobutane)21 adducts. For both of these adducts at high pH, the HT conformer that can form
O6–NH hydrogen bonds becomes highly favored.
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Figure 3.12: Aromatic region of 1H NMR spectra of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct
(25 °C, D2O/DMSO-d6, shifts in ppm) at pH 4.3 (bottom), pH 8.3 (middle), and pH 10.3 (top).
3.3.7 Further Analysis Using NMR Data
The foregoing analysis of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct utilized H8 and
Me signals that are well resolved. The unusual nature of the bis adduct draws further support
from 1H NMR and 13C NMR assignments for the carrier ligand of the [Pt(N(H)6,6!-Me2dpa)(9EtG)2]2+ adduct (Tables 3.5 and 3.6). The carrier-ligand assignments are explained here and in
more detail in the Supporting Information. COSY (not shown), HSQC and HMBC (Supporting
Information, Figures B.9-B.12) experiments were among the NMR experiments employed. As a
reminder, protons in the chelated 6-methyl-2-picolyl chain!are labeled as H3, H4, H5, endo-H7,
exo-H7, and 6-Me, and protons in the dangling 6-methyl-2-picolyl chain!are labeled as H3!, H4!,
H5!, H7!, and 6!-Me (Figure 3.4). This labeling scheme is also used for the
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13

C NMR signals.

Also, designations for the endo-H7, exo-H7, and H7! protons are shown in Figure B.13
(Appendix B).
Table 3.6: 13C NMR Shifts (ppm) for [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ in D2O/DMSO-d6 (pH
4.0) at 25 °C
carbon a

ΛHT (major)

ΔHT (minor)
9-EtG

b

G C8 cis B

142.3

141.5

G C8 cis D

141.8

141.8

G CH2 cis B (overlapped)

41.36

41.42

G CH2 cis D (overlapped) 41.36

41.42

G CH2 cis B

15.5

15.6

G CH2 cis D

15.8

16.0
6,6!-Me2dpa

C4 (overlapped)

142.0

142.0

C4! (overlapped)

139.8

139.8

C3

121.7

121.8

C3!

124.0

123.2

C5 (overlapped)

127.7

127.7

C5!

125.0

124.8

C7 (overlapped)

63.2

63.2

C7!

59.5

59.6

6-CH3

25.0

24.7

6!-CH3

24.3

24.4

C6

162.4

162.5

C6!

159.6

159.5

C2

162.8

162.6

C2!

153.4

153.3

a

G = 9-EtG; cis B = signal in G bound cis to bound chain; cis D = signal in G bound cis to
dangling chain. b free 9-EtG 13C NMR signals: C8 140.8, CH2 40.2, and CH3 16.2 ppm.
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For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, the shifts of the 1H NMR (H4! and H5!)
and 13C NMR (C3!, C4!, C5!, 6!-Me, and C7!) signals of the dangling chain are similar to those of
the free N(H)6,6!-Me2dpa ligand (Appendix B), evidence that a bis adduct has formed. The
pyridyl ring in the dangling chain should still experience slight inductive effects from the Pt(II)
because the anchoring central nitrogen is bound.
In the ΔHT conformer, the proximity of the six-membered ring of the adjacent guanine
base to the pyridyl ring of the dangling 6-methyl-2-picolyl chain! (Figure 3.9) could result in
slight shielding of the H3!, H4!, H5!, and 6!-Me signals. In the ΛHT conformer, the dangling
chain and the adjacent guanine six-membered ring are on opposite sides of the coordination
plane (Figure 3.9); thus, no shielding is expected. This reasoning explains the relatively upfield
shifts of the H3!, H4!, H5!, and 6!-Me signals of the ΔHT conformer as compared to the
corresponding signals of the ΛHT conformer (Table 3.5). Also, an inspection of models (Figure
3.9) suggests that the most likely location of the dangling chain of the ΔHT conformer will
position the H3! proton in the upfield-shifting region of the anisotropic guanine base, and indeed
this H3! signal does have the most upfield H3! shift (Table 3.5).
We now consider how the chemical shifts of the signals of [Pt(N(H)6,6!-Me2dpa)(9EtG)2]2+ chelated 6-methyl-2-picolyl chain! differ for the two HT conformers. The shifts of
signals (H3, H4, and H5) for the bound pyridyl group are similar for the ΛHT and ΔHT
conformers (Table 3.5). These protons are far from the cis coordinated 9-EtG base and should
have signals unaffected by the guanine base orientation. As expected from the close proximity
of the 6-Me group to the cis 9-EtG base (Figure 3.9), the 6-Me signals are upfield and have shifts
similar to those of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct (Table 3.3). The more upfield
shift of the 1.75 ppm 6-Me signal of the ΛHT conformer of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+
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compared to the 1.88 ppm 6-Me signal of the ΔHT conformer (Table 3.5) is consistent with the
expectation that the anisotropic six-membered ring of the cis-bound 9-EtG is on the same side of
the coordination plane and positioned close to the 6-Me group, resulting in a greater upfield shift
of this 6-Me signal. This close positioning arises from the tilting of the pyridine ring resulting
from the chelate ring pucker (Figure 3.9). The pucker is dictated by the favored equatorial
position of the dangling chain.
We report the

13

C NMR shifts of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct in Table

3.6 and those for the free chelate ligand in Table B.1, Appendix B. The C7 shift (overlapped at
63.2 ppm) of the chelated 6-methyl-2-picolyl chain is similar to that in the starting [Pt(N(H)6,6!Me2dpa)Cl]Cl complex (Table 3.4) and thus probably reflects strain and inductive effects as we
discussed above. The C7! shifts at 59.5 and 59.6 ppm for the dangling chain of the conformers
have values close to that of the free ligand, as expected for a dangling chain. Compared to the
C2/2! shift value of the free ligand (151.1 ppm, Table B.1), the C2! signals of the dangling chains
have relatively similar shifts (~153.5 ppm), whereas the C2 shifts (~163 ppm) of the chelated
chain are quite downfield. Likewise, the overlapped C6! shift is close to that of the free ligand
(Table B.1). These 13C NMR data are fully consistent with the structure and properties proposed
here for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct.
3.3.8 Relative Reactivity of [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+ with 9-EtG
Comparison of the times required for the complete formation of [Pt(N(H)dpa)(9-EtG)]2+
(~49 h) vs the complete formation of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ is complicated by the fact
that the latter converts to the bis adduct on a comparable time scale. The time required for the
formation of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ is best assessed by the time needed for
consumption of [Pt(N(H)6,6!-Me2dpa)Cl]+. The approximate times for the complete
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disappearance of starting [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+ in D2O/DMSO-d6
(64:36) on addition of 2.5 equiv of 9-EtG were 2.5 h and 49 h, respectively. This order of relative
reactivity is opposite to that expected from steric impedance of the attack by 9-EtG on the Pt(II)
centers because the tridentate N(H)6,6!-Me2dpa ligand has greater steric bulk than the tridentate
N(H)dpa ligand. The order found suggests that the dissociation of the Pt–N(pyridyl ring) bond
may be responsible for the high reactivity. Studies of PtI2(Me2phen) (Me2phen = 2,9-dimethyl1,10-phenanthroline) show that the steric interactions between the methyl groups of the carrier
ligand and the coordinated iodides cause one end of the carrier ligand to dissociate and become
monodentate, allowing a nucleophile to coordinate trans to the now-monodentate Me2phen.54
This process is promoted by the presence of a methyl group ortho to the ring N of Me2phen.
A detailed kinetic and mechanistic study is outside the scope of the present work.
However, we did conduct a simple set of experiments to see if dissociation of the Pt–N(pyridyl
ring) bond might be a process deserving further study in future. In order to assess if the
analogous situation (a methyl group ortho to the ring N of N(H)6,6!-Me2dpa) promotes
dissociation of the Pt–N(pyridyl ring) bond, concentrated HCl (10 µL) was added to 10 mM
solutions of [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+ in D2O/DMSO-d6 (64:36). A 1H
NMR spectrum recorded 10 min after addition of HCl to the [Pt(N(H)6,6!-Me2dpa)Cl]+ solution
revealed new sets of signals (Figure B.14); these signals can be attributed to an intermediate with
a bidentate ligand and to free protonated ligand (designated as N(H)6,6!-Me2dpaHxm+ because the
extent and the sites of protonation were not evaluated). Over time, the set of signals of the
protonated free ligand, N(H)6,6!-Me2dpaHxm+, became the most abundant. The ratio of signals
for [Pt(N(H)6,6!-Me2dpa)Cl]+:N(H)6,6!-Me2dpaHxm+ was ~1:1 at 1 h. Because formation of free
ligand involves dissociation of both pyridyl rings, dissociation of one ring must require less than
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1 h. The 1H NMR spectra for a [Pt(N(H)dpa)Cl]+ solution under the same reaction conditions
revealed no new set of signals after one day (Figure B.15) and even longer (3 d), indicating that
pyridyl rings lacking a methyl group ortho to the ring N do not dissociate.
The results above suggest that one pyridyl ring in [Pt(N(H)6,6!-Me2dpa)Cl]+ dissociates,
forming a “bidentate intermediate” with the chelate having one 6-methyl-2-picolyl chain!bound
as part of a five-membered chelate ring and the other 6-methyl-2-picolyl chain!dangling with an
uncoordinated pyridyl ring N. Although overlap of one aromatic signal in the crowded region
near 8.7 ppm (Figure B.14) precludes the observation of all six aromatic signals expected for the
“bidentate intermediate,” the five signals clearly resolved integrate to the correct 1:1 ratio. The
shifts of the 1H NMR signals for the bound 6-methyl-2-picolyl chain!are similar to those of the
corresponding signals for [Pt(N(H)6,6!-Me2dpa)Cl]+, and the dangling 6-methyl-2-picolyl chain!
signals are downfield because of protonation of the pyridyl ring nitrogen, as found for the free
N(H)6,6!-Me2dpaHxm+ ligand (shown in the top trace of Figure B.14, Appendix B). The
“bidentate intermediate” never builds up to a high abundance, but the H4 triplet is readily
observed downfield and undergoes informative changes in shift. The shift of the triplet is at ~7.8
ppm for H4 in the bound chain and at ~8.3 ppm for H4 in the N(H)6,6!-Me2dpaHxm+ ligand. The
“bidentate intermediate” has triplets at ~7.9 ppm for H4 in the bound chain and ~8.4 ppm for H4
in the dangling chain. Thus, there is clear evidence that the intermediate contains the chelate in a
bidentate coordination mode.
The time required for a “bidentate intermediate” to form is comparable to or less than the
time needed to form the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct (2.5 h). Such a process forming
this intermediate could account for the shorter time needed to form [Pt(N(H)6,6!-Me2dpa)(9-
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EtG)]2+ than to form [Pt(N(H)dpa)(9-EtG)]2+. The HCl experiment indicates that no such reactive
“bidentate intermediate” is formed by [Pt(N(H)dpa)Cl]+.
3.3.9 Pt(N(H)6,6!-Me2dpa)(GMP) and Pt(N(H)6,6!-Me2dpa)(GMP)2 Adducts
The reaction of [Pt(N(H)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!- or 3!-GMP in
D2O/DMSO-d6 (64:36) at pH 4.1 was monitored by following the H8 NMR signal. As found for
9-EtG, these GMP nucleotides form a mono adduct that converts with time completely to a bis
adduct (Figure 3.4). Because the charge on the GMP adducts is not known, we specify them with
no brackets or charge.
Each GMP mono adduct can form at most two rotamers, as is true for the achiral 9-EtG
mono adduct. A mirror plane perpendicular to the coordination plane and passing through the Pt
and secondary NH group bisects the Pt(N(H)6,6!-Me2dpa) moiety. Thus, the N9 chiral ribose
group of the GMP’s does not increase the number of rotamers for a GMP mono adduct. For both
nucleotides, the Pt(N(H)6,6!-Me2dpa)(GMP) mono adduct has the expected two very downfield
H8 singlets, as shown for Pt(N(H)6,6!-Me2dpa)(3!-GMP) in Figure B.16, and slightly downfield
H1! doublets, as shown for Pt(N(H)6,6!-Me2dpa)(5!-GMP) in Figure B.17. The chiral N9 ribose
group of these nucleotides causes the corresponding protons in the two halves of the tridentate
ligand to be magnetically inequivalent. In principle, four signals could be seen for each type of
chelate proton, two from each of the two rotamers. However, because the ribose projects away
from the chelate, the signals of such corresponding protons are usually not resolved. The ribose
signals also create signal overlap problems. Nevertheless, the shifts of the H8 and H1! signals
leave no doubt that two rotamers of each GMP mono adduct are formed as expected.23
For both the 5!-GMP and the 3!-GMP reactions, the signals of the mono adduct diminish
and are fully replaced by upfield-shifted H8 and H1! signals (Figures B.16 and B.17), leaving no
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doubt that both GMP’s form a Pt(N(H)6,6!-Me2dpa)(GMP)2 bis adduct. In the cases of bis
adducts with chiral GMP ligands or the nonchiral 9-EtG ligand, the same number of conformers
(8) is possible. In contrast to the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, which has
enantiomers, the combination of the asymmetric secondary amine and the N9 chiral ribose group
of GMP makes both GMP ligands in all Pt(N(H)6,6!-Me2dpa)(GMP)2 conformers magnetically
inequivalent. Therefore, a maximum of sixteen H8 signals could be observed if all four
conformers exist and all are in slow exchange. If the rate of conformer interchange is too fast to
observe H8 signals for the minor HH conformers, as found for the [Pt(N(H)6,6!-Me2dpa)(9EtG)2]2+ adduct, then a maximum of eight H8 signals could be observed for each Pt(N(H)6,6!Me2dpa)(GMP)2 adduct. Assigning the H8 signals to a particular conformer and configuration of
the secondary amine is not feasible, especially because aromatic NMR signals from the chelate
fall in the same spectral region as the H8 signals. Indeed, only six of the probable eight H8
signals could be found for the Pt(N(H)6,6!-Me2dpa)(5!-GMP)2 adduct in 1H NMR spectra (not
shown). However, we can identify eight H8 signals (Figure B.16) from the Pt(N(H)6,6!Me2dpa)(3!-GMP)2 adduct, consistent with the anticipated presence of four dominant HT
conformers.
Although the 1H NMR evidence for the Pt(N(H)6,6!-Me2dpa)(GMP)2 bis adducts is
compelling, we also obtained

13

C NMR data supporting the existence of such adducts. For

example, HSQC cross-peaks at ~3.8–59.5 ppm identify C7! in dangling 6-methyl-2-picolyl
chains, and HSQC cross-peaks at ~4.6–62.5 ppm and at ~5.0–62.5 ppm identify C7 in bound
chains. Thus, the overlapped 1H NMR signals at ~3.80 ppm in a crowded, overlapped 1H NMR
spectral region for adducts of both nucleotides give HSQC cross-peaks to a 13C NMR signal at
59.4 ppm (5!-GMP) and at 59.6 ppm (3!-GMP), assigning the dangling chain C7! signals. Both
!
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GMP adducts thus have C7! signals with shifts that are very similar in value to the 59.6 ppm of
the dangling chain C7! signal in the 9-EtG bis adduct. This similarity is further confirmation that
the GMP’s form a bis adduct similar to the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ bis adduct
characterized in depth above. As found with 9-EtG, the GMP nucleotides clearly transform the
N(H)6,6!-Me2dpa chelate ligand coordination mode from tridentate to bidentate.
3.4 CONCLUSIONS
The bulk of the 6/6!-Me groups of [Pt(N(H)6,6!-Me2dpa)Cl]Cl causes the chelate ligand
to convert from a tridentate to a bidentate coordination mode, having one pyridyl chain dangling,
facilitating coordination of 9-EtG, first to a mono adduct and then to a bis adduct. Much less
time is required to form the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ mono adduct than to form the
[Pt(N(H)dpa)(9-EtG)]2+ mono adduct. The bulk of the methyl groups on the carrier ligand causes
one of the pyridyl rings to dissociate, thus promoting faster formation of the mono adduct.
Conversion to a bis adduct produces an asymmetric center at the secondary nitrogen, which for
each conformer present gives rise to an enantiomeric pair having signals that cannot be resolved
by ordinary NMR methods. The bulk of the 6-Me groups is sufficient to impede rotation of the
guanine base about the Pt–N7 bond of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct; thus, H8
signals for conformers could be resolved and assigned. The nature of both the guanine base and
the carrier ligand in the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct influences the distribution of
conformers and their characteristics. The ΛHT conformer of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ is
more abundant than the ΔHT conformer, most probably because of the formation of a weak
hydrogen bond between the NH of the bidentate carrier ligand and the 9-EtG O6. The 5!- and 3!GMP nucleotides form Pt(N(H)6,6!-Me2dpa)(GMP)2 adducts, in which the chelate ligand
coordination mode was transformed from tridentate to bidentate.
!
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The abundance of the syn rotamer relative to the anti rotamer is less for the [Pt(N(H)6,6!Me2dpa)(9-EtG)]2+ adduct than that reported for the [Pt(N(H)dpa)(9-EtG)]2+ adduct.23 The syn
rotamer of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ is probably destabilized by steric interaction of the
bulky guanine six-membered ring and the 6/6!-Me groups; these groups are on the same side of
the coordination plane in the syn rotamer. We also conclude from the absence of H8-H8 EXSY
cross-peaks for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct that the bulk of the methyl groups is
sufficient to significantly decrease the ease of interconversion between rotamers as compared to
the [Pt(N(H)dpa)(9-EtG)]2+ adduct, for which H8-H8 EXSY cross-peaks were observed in the
previous study.23
Our study was motivated by the desire to understand the effect of steric bulk of the carrier
ligand on the bound guanine derivative. Clearly the Pt(N(H)6,6!-Me2dpa) moiety does interact
sterically with the guanine base more than the Pt(N(H)dpa) moiety does. However, it is also clear
that the 6/6!-Me groups weaken the Pt–N bond to such an extent that the tridentate ligand
converts to a bidentate ligand. This chemistry showing the facile opening of chelate rings by
nucelobase addition to Pt(II) compounds is interesting and unusual. Furthermore, our work
provides a caveat: a monofunctional Pt(II) complex with bulky carrier ligands that are chelates
forming Pt–N bonds of normal length may not necessarily contain Pt–N bonds strong enough to
prevent bifunctional binding to DNA.
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CHAPTER 4. GUANINE NUCLEOBASE ADDUCTS FORMED BY A
MONOFUNCTIONAL COMPLEX: [PT(N-(6-METHYL-2-PICOLYL)-N-(2PICOLYL)AMINE)Cl]Cl
4.1 INTRODUCTION
Clinically used anticancer agents, such as cisplatin and its Pt(Lbi)X2 analogues (Lbi = one
bidentate or two cis-unidentate N-donor carrier ligands, X2 = anionic leaving groups), function
by forming a 1,2-intrastrand G*G* cross-link between two adjacent guanines of d(GpG)
sequences in DNA (G* identifies N7-platinated G residues in DNA or oligonucleotides).1-8 NMR
and X-ray studies of duplex oligomers containing such an intrastrand cross-link lesion9,10 and an
oligomer adduct of a rather bulky monofunctional Pt anticancer agent11,12 have all revealed a
similar and unusual location of the X•Y base pair (bp) adjacent to the 5!-G* bp. (This location
creates an unusual slide and shift in the XpG* bp step.) Solution studies established that this
unusual XpG* bp step exists in solution for most duplexes with a G*pG* intrastrand cross-link.9
The XpG* bp step structural distortion may be even more important in anticancer activity than
the G*pG* bp step distortion.13,14
Monofunctional Pt(II) agents, Pt(Ltri)X (Ltri = a tridentate, one bidentate and one
monodentate, or three monodentate ligands; X = a monodentate, monoanionic leaving group),
have higher activity when carrier-ligand bulk is greater.11,12,15-19 These monofunctional agents also
preferentially bind to G residues in DNA. Recent work suggests that monofunctional and
bifunctional agents can have similar biological effects.20 Unlike monofunctional Pt(II) agents,
however, bifunctional Pt(II) agents, Pt(Lbi)X2, have lower activity and higher toxicity when the
carrier-ligand bulk is greater.5,21-24 Thus, it is important to gain a better understanding of the
fundamental features of such adducts. One approach toward achieving this goal is to assess the
effects of steric interactions between the carrier ligand and the guanine base in Pt(Ltri)G models
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(G = guanine derivative bound to platinum, but not tethered to another nucleobase, Figure
4.1).6,25-30

!
Figure 4.1: Possible conformers for Pt(Lbi)G2 adducts with two bound monodentate guanine N9
derivatives (referred to with bold G). A generic version of G is depicted in the center, along with
the guanine base numbering scheme. R can be an alkyl group, ribose, or a ribose phosphate. Note
that the nucleobase is represented by an arrow with the tip at the guanine H8 atom. N and N!
represent a nitrogen donor ligand. When (N ≠ N!), four rotamers (ΛHT, ΔHT, HHu, HHd) are
possible, whereas when (N = N!), only three conformers (ΛHT, ΔHT, HH) are possible because
HHu = HHd. The same number of conformers can exist regardless of whether the nitrogen
donors are unidentate ligands or are part of a chelate (N–N or N–N!).
We previously studied the interactions of several G derivatives [e.g., 9-ethylguanine (9EtG), 5!-guanosine monophosphate (5!-GMP), etc.] in Pt(Ltri)G mono adducts with a carrier
ligand having low in-plane bulk, di-(2-picolyl)amine (N(H)dpa)31 and a related ligand, N(H)6,6!Me2dpa (di-(6-methyl-2-picolyl)amine), having high in-plane bulk, Figure 4.2.32
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Figure 4.2: Line drawing and numbering scheme for the [Pt(N(H)dpa)Cl]+, [Pt(N(H)6Medpa)Cl]+, and [Pt(N(H)6,6!-Me2dpa)Cl]+ cations.
In such Pt(Ltri)G mono adducts, the guanine base has two orientations with respect to the
coordination plane, leading to the presence of syn and anti rotamers (Figure 4.3), which can
interconvert by rotation about the Pt–N7 bond. As shown in Figure 4.3, the rotamer with the H
atom of the central N-H group and the guanine O6 on the same side of the coordination plane is
designated as syn, and the rotamer with these groups on opposite sides of this plane is designated
as anti.26,31 The observation of two sharp 1H NMR G H8 signals for all Pt(N(H)dpa)G and
Pt(N(H)6,6!-Me2dpa)G mono adducts indicates that these rotamers do indeed exist and that
guanine base rotation about the Pt–N7 bond is impeded by the bulk of the tridentate carrier
ligands, even by the small pyridyl H6/6! atoms of N(H)dpa, which are bulky enough to prevent
time-averaging of the two H8 signals.31 We noted in this study of the Pt(N(H)dpa)G adducts that
the tilting of the pyridyl rings relative to the Pt(II) coordination plane positions the anisotropic
pyridyl ring shielding region closer to the H8 proton of the syn conformer than to that of the anti
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conformer (Figure 4.3). The syn H8 signal is upfield relative to the anti H8 signal. As a
consequence of this pyridyl ring tilting, the bulky guanine 6-membered ring is on the same side
of the coordination plane as the pyridyl H6/6! atoms in Pt(N(H)dpa)G and as the pyridyl 6/6!-Me
groups in Pt(N(H)6,6!-Me2dpa)G mono adducts in the syn rotamer.31,32

!
Figure 4.3: Two possible rotamers (syn, top; anti, bottom) for Pt(Ltri)G complexes with tridentate
ligands unsymmetrical with respect to the coordination plane but symmetrical about a plane
perpendicular to the coordination plane are illustrated for Ltri = N(H)dpa and G = 9-EtG. The
anisotropic pyridyl rings shields the H8 in the syn rotamer.31 This shielding results in an upfield
shift of the syn H8 signal. The H8 in the anti rotamer points away from the pyridyl rings,
resulting in a downfield shift of the anti H8 signal compared to the shift of the syn H8 signal.
Protons in the chelate ligand N–CH2 groups are called endo if they project down and away from
the NH and exo if they project up toward the NH. The H8 proton of 9-EtG and the NH proton are
highlighted with a magenta circle.
Despite some similarity in properties of the Pt(N(H)dpa)G and Pt(N(H)6,6!-Me2dpa)G mono
adducts, an excess of G has no effect on the Pt(N(H)dpa)G mono adduct,31 but an excess of G
readily converts the Pt(N(H)6,6!-Me2dpa)G mono adduct unexpectedly and completely to the
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Pt(N(H)6,6!-Me2dpa)G2 bis adduct (Figure 4.4).32 Unlike Pt(Ltri)G mono adducts, which have
just two rotamers, Pt(Lbi)G2 adducts can have as many as two head-to-head (HHu and HHd) and
two head-to-tail (ΛHT and ΔHT) conformers, depending on the bulk and symmetry of the carrier
ligands (Figure 5.1).5,13,33-38 Formation of the bis adduct (Figure 4.4) involved an unusual
transformation of the Pt-bound N(H)6,6!-Me2dpa ligand from the tridentate to the bidentate
coordination mode. The design of a monofunctional Pt(II) drug with bulky carrier ligands should
ensure that the Pt–N bonds are strong enough to allow the agent to remain monofunctional when
bound to DNA. For this reason, we examined Pt(N(H)6-Medpa)G mono adducts formed from
[Pt(N(H)6-Medpa)Cl]Cl (N(H)6-Medpa = N-(6-methyl-2-picolyl)-N-(2-picolyl)amine), Figure 2.
Our overall goal was to obtain a rough scale of the effect of the systematic increase in carrierligand bulk from N(H)dpa to N(H)6-Medpa to N(H)6,6!-Me2dpa.

Figure 4.4: Transformation of the initially monofunctional complex, [Pt(N(H)6,6!-Me2dpa)Cl]+,
to the bis adduct, [Pt(N(H)6,6!-Me2dpa)G2]2+, upon addition of G. The methylene group protons
are designated as exo and endo (see text).
In this study, we have employed NMR techniques to assess the influence of intermediate
in-plane bulk on the properties of Pt(N(H)6-Medpa)G mono adducts. Because of the
unsymmetrical nature of the carrier ligand, the [Pt(N(H)6-Medpa)Cl]Cl complex is chiral, the
chiral center being the central NH of the tridentate ligand. The coordinated ligand is
unsymmetrical both with respect to the coordination plane and across a plane perpendicular to
the coordination plane. When G contains a chiral group (e.g., 5!-GMP), each of the syn and anti
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rotamers could have two 1H NMR signals for each type of proton. This situation raises the
possibility that four signals could be resolved for each type of proton [e.g., four H8 or four H6!
signals in the 1H NMR spectrum of a given Pt(N(H)6-Medpa)G adduct]. If G lacks a chiral
group (e.g., 9-EtG), only one syn and one anti rotamer are possible. Thus, only two 1H NMR
signals (one for each rotamer) can be resolved for each type of proton in the spectrum of the
Pt(N(H)6-Medpa)(9-EtG) mono adduct. In the presence of an excess of G, Pt(N(H)6-Medpa)G
formed only small amounts of the Pt(N(H)6-Medpa)G2 bis adduct in comparison to Pt(N(H)6,6!Me2dpa)G mono adducts, which convert readily and completely to the Pt(N(H)6,6!-Me2dpa)G2
bis adduct. Thus, bis adducts are less favored and form in lower abundance when the carrier
ligand has lower bulk. Also, the ease of interconversion of Pt(N(H)6-Medpa)G rotamers is less
facile than for rotamers of Pt(N(H)dpa)G adducts, which have a smaller carrier ligand.31
Intermediate properties of adducts are expected when the carrier ligand has intermediate bulk.
However, it is surprising that the syn rotamer is much more favored in Pt(N(H)6-Medpa)G than
in either Pt(N(H)dpa)G or Pt(N(H)6,6!-Me2dpa)G adducts. An important goal of the current
study is to elucidate the reasons for the high abundance of the syn rotamer for all Pt(N(H)6Medpa)G adducts studied.
4.2 EXPERIMENTAL SECTION
4.2.1 Starting materials
K2[PtCl4],

5!-guanosine

monophosphate

disodium

salt

(5!-GMP),

3!-guanosine

monophosphate disodium salt (3!-GMP), 5!-guanosine triphosphate disodium salt (5!-GTP), and
9-EtG were obtained from Aldrich. cis-Pt(DMSO)2Cl239 and N(H)6-Medpa40 were synthesized as
described in the literature, and the 1H NMR chemical shifts observed matched the reported
values.
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4.2.2 NMR Measurements
NMR spectra were recorded on an Avance-III Prodigy 500 MHz Bruker spectrometer,
typically with 10 mM samples in DMSO-d6 or in a D2O/DMSO-d6 (64:36) mixture (pH adjusted
with 0.5 M solutions of DNO3 or NaOD in D2O). For 1H and 13C NMR spectra in D2O/DMSO-d6,
peak positions are referenced relative to TMS by using the signals of DMSO-d6 at 2.50 ppm
(residual) and 39.5 ppm, respectively.41 A presaturation pulse to suppress the water peak was
used when necessary. ROESY experiments were performed at 15 °C by using a 200 ms mixing
time. 1H–13C HSQC NMR spectra were recorded in order to assign the signals of the Pt(N(H)6Medpa)G adducts. NMR data were processed with TopSpin and MestreNova software.
4.2.3 X-ray Data Collection and Structure Determination
Single crystals were placed in a cooled nitrogen gas stream at 100 K on a Bruker Kappa
Apex-II DUO diffractometer equipped with Mo Ka radiation (λ = 0.71073 Å). Refinement was
performed by full-matrix least squares methods using SHELXL,42 with H atoms in idealized
positions. The entire cation of [Pt(N(H)6-Medpa)Cl]PF6•H2O is disordered over a mirror plane.
4.2.4 Synthesis of [Pt(N(H)6-Medpa)Cl]Cl
Acetonitrile solutions of cis-Pt(Me2SO)2Cl2 (10.6 mg, 0.025 mmol in 1 mL) and N(H)6Medpa (5.33 mg, 0.025 mmol in 1 mL) were mixed and kept at 25 °C. After 2 h, the white
precipitate that had formed was collected on a filter and washed with acetonitrile; yield, 9.16 mg
(76%). 1H NMR signals (ppm) upon dissolution of the precipitate in DMSO-d6: 8.93 (d, J = 6.0
Hz, 1H, H6!), 8.90 (bs, 1H, NH), 8.23 (t, J = 7.8 Hz, 1H, H4!), 8.06 (t, J = 7.8 Hz, 1H, H4), 7.71
(d, J = 7.9 Hz, 1H, H3!), 7.64 (t, J = 7.1 Hz, 1H, H5!), 7.57 (d, J = 7.6 Hz, 1H, H3), 7.49 (d, J =
7.9 Hz, 1H, H5), 5.05 (dd, J = 15.5, 9.8 Hz, 1H, endo-H7), 4.61 (dd, J = 15.5, 4.6 Hz, 1H, exo-
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H7), 4.91 (dd, J = 16.5, 8.1 Hz, 1H, endo-H7!), 4.53 (dd, J = 16.5, 5.8 Hz, 1H, exo-H7!), 2.88 (s,
3H, 6-CH3). ESI-MS m/z : [M+] calcd. for C13H15ClN3Pt, 443.060; found, 443.051.
4.2.5 Crystallization of [Pt(N(H)6-Medpa)Cl]PF6•H2O
Aqueous solutions (2.5 mM) of [Pt(N(H)6-Medpa)Cl]Cl (2.39 mg in 2 mL) and NaPF6
(0.85 mg in 2 mL) were mixed, and the resulting solution became slightly cloudy. The thin,
white, X-ray quality crystals that formed after one day at room temperature were collected by
filtration and washed with water. Upon dissolution of the crystals in DMSO-d6, the sample gave
1

H NMR signals identical to those of the chloride salt except for the NH signal (bs, 1H, 8.56

ppm). The signal is more downfield for the chloride salt because the chloride ion interacts with
the NH, a feature we have discussed previously.28,43
4.2.6 Adduct Formation of [Pt(N(H)6-Medpa)Cl]Cl with G = 9-EtG, 3!-GMP, and 5!-GMP
A 10 mM solution of [Pt(N(H)6-Medpa)Cl]Cl in 600 mL of a 65/35 D2O/DMSO-d6 (390
mL/210 mL) mixture] was treated with 2.5 equiv of G to give a 1:2.5 ratio (10 mM:25 mM) of
Pt:G, and the solution (pH ~4) was kept at 25 °C. (The D2O/DMSO-d6 mixture was employed to
improve the solubility of the reactants.) An excess of G was used to ensure that the reaction went
to completion. The reaction, which was repeated several times, was monitored by 1H NMR
spectroscopy until there was no change in the bound vs free G H8 signal intensity, or until the
[Pt(N(H)6-Medpa)Cl]Cl signals completely disappeared. The reaction was usually complete at
1.5 h.
4.3 RESULTS AND DISCUSSION
4.3.1 Structural results for [Pt(N(H)6-Medpa)Cl]+. Overall aspects
Summarized in Table 4.1 are the crystal data and details of the structural refinement of
[Pt(N(H)6-Medpa)Cl]PF6•H2O. Selected bond lengths and angles are reported in Table 4.2. The
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ORTEP plot of the cation and the numbering scheme used to describe the solid-state data are
shown in Figure 4.5. All other references (e.g., NMR discussion) to this ligand and complex will
employ the atom-numbering scheme shown in Figure 4.2, which will also be used to discuss
related complexes.
Table 4.1: Crystal data and structural refinement for [Pt(N(H)6-Medpa)Cl]PF6•H2O.
empirical formula [C13H15ClN3Pt]PF6•H2O"
fw

606.80

crystal system

monoclinic

space group

C2/m

a (Å)

10.7680(7)

b (Å)

23.591(2)

c (Å)

6.9710(4)

α

90

β (deg)

106.283(3)

γ

90

V (Å3)

1699.8(2)

T (K)

100

Z

4

ρcalc (Mg/m3)

2.371

abs coeff (mm-1)

8.58

2θmax (°)

52.8

R indicesa

0.036

wR2 =[I > 2σ(I)]b

0.079

data/parameters

1804/203

res. dens. (eÅ-3)

0.96, -1.17

a

R = (∑||Fo| - |Fc||)/∑|Fo|. b wR2 = [∑[w(Fo2 - Fc2)2]/∑[w(F 2)2]]1/2, in which w = 1/[σ2(Fo2) + (dP)2 + (eP)]
and P = (Fo2 + 2Fc2)/3.
ο
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4.3.2 Coordination Parameters
The [Pt(N(H)6-Medpa)Cl]+ cation exhibits pseudo square planar geometry, with a
tridentate ligand bound to the Pt with its three N atoms; a Cl atom trans to the N(2) atom
completes the coordination around Pt (Figure 4.5). The entire [Pt(N(H)6-Medpa)Cl]+ cation is
disordered over a mirror plane, and all bond lengths and angles discussed below for the cation are
from the A form. The N(1)–Pt–N(3) bite angle of [Pt(N(H)6-Medpa)Cl]+ is similar to the ~166°
bite angle reported for [Pt(N(H)dpa)Cl]Cl•H2O,44 [Pt(N(H)dpa)(OH2)]ClO4,44 and [Pt(N(H)6,6!Me2dpa)Cl]Cl32 (Tables 4.2 and C.1). The Pt–N(1) and Pt–N(3) bond distances (Table 4.2) for
[Pt(N(H)6-Medpa)Cl]+ compare well with other Pt–N(sp2) bond distances ranging from 1.99–
2.08 Å.45,46
Table 4.2: Selected bond distances (Å) and angles (deg) for [Pt(N(H)6-Medpa)Cl]PF6•H2O.
bond distance

bond angles

Pt–N(1)

2.069(16)

N(1)–Pt–N(3)

164.3(6)

Pt–N(2)

1.96(2)

N(1)–Pt–Cl(1)

103.7(7)

Pt–N(3)

2.019(16)

N(2)A–Pt–Cl(1)

169.4(5)

Pt–Cl(1)

2.316(3)

N(3)–Pt–Cl(1)

92.0(6)

N(2)A–Pt–N(1)

83.4(6)

N(2)A–Pt–N(3)

81.4(4)

The trans N(2)–Pt–Cl bond angles of [Pt(N(H)6-Medpa)Cl]PF6•H2O (169.4(5)°) and of
[Pt(N(H)dpa)Cl]Cl•H2O (169.5(2)°)44 differ from 180° significantly more than does the
corresponding trans N(2)–Pt–O bond angle in [Pt(N(H)dpa)(OH2)](ClO4)2 (176.4(3)°, Table
C.1).44 The departure from 180° of the trans N–Pt–Cl bond angle in [Pt(N(H)6Medpa)Cl]PF6•H2O and in [Pt(N(H)dpa)Cl]Cl can be attributed to the larger steric interactions
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between the coordinated Cl and the H6/6! protons and 6-Me groups than the steric interactions
with the aqua ligand of [Pt(N(H)dpa)(OH2)](ClO4)2. The H6/6! signals have relatively downfield
shifts because of the inductive effect of the nearby Pt(II)-coordinated ring nitrogen. Thus, these
+

protons bear a partial positive charge (δ ), which would create an attractive electrostatic
interaction with both the Cl and the aqua ligands. For [Pt(N(H)6-Medpa)Cl]PF6•H2O, the steric
interaction between the Cl and the 6-Me group is not reflected in a statistically longer Pt–Cl bond
in [Pt(N(H)6-Medpa)Cl]PF6•H2O (2.316(3) Å) than in [Pt(N(H)dpa)Cl]Cl•H2O (2.301(2) Å)
(Table C.1). However, the steric effect displaces the Cl toward the unsubstituted pyridyl ring,
making the cis N(1)–Pt–Cl bond angle (103.7(7)°) much larger than the cis N(3)–Pt–Cl angle
(92.0(6)°) (Table 4.2). For [Pt(N(H)dpa)Cl]Cl•H2O 44, in contrast, the cis N(1)–Pt–Cl bond angle
was not significantly different from the cis N(3)–Pt–Cl angle.

Figure 4.5: Ortep plot of the [Pt(N(H)6-Medpa)Cl]+ cation. Thermal ellipsoids are drawn with
50% probability. The crystal is disordered, and the cation in only one of the positions is shown.
The Pt–N(2) bond distance for [Pt(N(H)6-Medpa)Cl]PF6•H2O (1.96(2) Å) is at the short
end of the range (2.01 to 2.12 Å) of most Pt–N(sp3) bond distances.30,47,48 This situation is
probably caused by the nature of the di(2-picolyl)amine chelate ring system. Similar Pt–N(2)
bond distances (Table C.1) were reported for [Pt(N(H)dpa)Cl]Cl•H2O (2.009(12) Å) and
[Pt(N(H)dpa)(OH2)](ClO4)2 (1.952(7) Å),44 a finding that is not statistically significant but is
suggestive of a weak trans influence of the Cl ligand. Taken together, all response to steric strain
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in [Pt(N(H)6-Medpa)Cl]PF6•H2O appears to be reflected in the bond angles, notably the cis N–
Pt–Cl angles, rather than in the bond distances (Table 4.2).
4.3.3 [Pt(N(H)6-Medpa)Cl]Cl NMR Signal Assignments
The protons of the bound chelate ligand are labeled H3, H4, H5, and 6-Me for the
methyl-substituted pyridyl group and H3!, H4!, H5!, H6! for the unsubstituted pyridyl group. This
labeling scheme of using primes to designate the half of the ligand with the unsubstituted pyridyl
group is also used for the 13C NMR signals and for signals of the endo and exo protons as shown
in Figure 4.3. The 1H NMR signals for [Pt(N(H)6-Medpa)Cl]+ in a 64:36 D2O/DMSO-d6 mixture
are reported in Table 4.3, and the aromatic region is shown in Figure 4.6.
syn H8

free G H8

H4'

anti H8

H4
H3'

syn
anti
H6'
H6' H3

H5/5'

H3 H5
H4'

H6'

8.8

8.6

8.4

8.2

8.0

H4

7.8

H3'

7.6

H5'

7.4

7.2

"

Figure 4.6: Aromatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of
the reaction mixture forming the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct (top) recorded at 1.5 h
after mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm). No bis adduct was
detectable at this time.
The H6! signal must be a doublet, and also it must be the most downfield pyridyl signal
because of the proximity of the H6! proton to the Pt(II)-bound endocyclic nitrogen, as noted
above. By using this H6! doublet at 8.75 ppm, a COSY experiment permitted assignment of the
other signals of the unsubstituted ring (Table 4.3). The remaining aromatic signals belong to the
substituted pyridyl ring. The triplet at 7.82 ppm is assigned to the H4 signal, the only aromatic
proton that can give a triplet. A peak at 7.29 ppm contains overlapped H3 and H5 signals. In a
ROESY spectrum (not shown), an NOE cross-peak from the 6-Me signal (2.74 ppm) to the
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signal at 7.28 ppm assigns the H5 signal, and the peak at 7.30 ppm is assigned to H3. The 1H
NMR shift of the H6! signal (8.75 ppm) for [Pt(N(H)6-Medpa)Cl]+ is farther downfield than the
shift of the H6/6! signal (8.61 ppm) for [Pt(N(H)dpa)Cl]+ (Table C.2), a consequence of the
deshielding Cl ligand being pushed closer toward the H6! proton (2.58 Å non-bonded distance)
in [Pt(N(H)6-Medpa)Cl]+ than in [Pt(N(H)dpa)Cl]+ (2.76 Å non-bonded distance).
Table 4.3: 1H NMR shifts (ppm) for [Pt(N(H)6-Medpa)Cl]Cl and Pt(N(H)6-Medpa)G adducts (G
= 9-EtG, 3!-GMP, 5!-GMP, and 5!-GTP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
protons

Cl

9-EtG

3!-GMP

5!-GMP

5!-GTP

H4

7.82

7.86a

7.86a

7.83a

7.81a

H4!

8.02

8.01b, 7.99c

7.99a

7.98a

7.94a

H3

7.30

7.38b, 7.36c

7.37b, 7.36c

7.35a

7.32a

H3!

7.43

7.51b, 7.49c

7.49a

7.47a

7.45a

H5

7.28

7.18b, 7.22c

7.18b, 7.23c

7.14b, 7.19c

7.13b, 7.17c

H5!

7.42

7.28b, 7.21c

7.28b, 7.20c

7.28b, 7.18c

7.27b, 7.18c

endo-H7

4.86

4.93b, 4.88c

4.94b, 4.90c

4.94a

5.02a

endo-H7!

4.69

4.78b, 4.74c

4.76a

4.78b, 4.77c

4.84a

exo-H7

4.50

4.56d

4.57d

4.56d

4.57d

exo-H7!

4.46

4.58d

4.58d

4.59d

4.58d

6-Me

2.74

1.80b, 1.73c

1.84b, 1.82b

1.81b, 1.84b

1.81b, 1.83b

1.75c

1.73c, 1.76c

1.72c, 1.75c

7.50b, 7.28c

7.47b,
7.30b, 7.24c

7.44b, 7.28c
7.22c

H6!

8.75

7.48b, 7.23c

a

anti and syn signals are overlapped. bSignals from the anti rotamer. cSignals from the syn
rotamer. dSignals are overlapped with the HOD signal.
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The methylene protons of the unsymmetrical carrier ligand of [Pt(N(H)6-Medpa)Cl]+ are
designated as endo-H7, exo-H7, endo-H7!, and exo-H7! (Figure 4.3). The related signals of the
parent [Pt(N(H)dpa)Cl]Cl31 complex were assigned by applying the Karplus equation to the H–
N–C–H coupling constants measured in DMSO-d6, a solvent used because the carrier-ligand N–
H proton exchanges with deuterium from D2O in D2O/DMSO-d6 mixtures.31 Similarities in the
NH–CH coupling constants for [Pt(N(H)6-Medpa)Cl]+ and [Pt(N(H)dpa)Cl]+ in DMSO-d6 allow
us to assign the signals of [Pt(N(H)6-Medpa)Cl]+ in DMSO-d6 at 5.05 (9.8 Hz), 4.91 (8.1 Hz),
4.61 (4.6 Hz), and 4.53 ppm (5.8 Hz) to the endo-H7, endo-H7!, exo-H7, and exo-H7! protons,
respectively. Because the exo-H7 and exo-H7! protons are closer to the H3 and H3! protons than
are the endo-H7 and endo-H7! protons, a ROESY experiment (Figure C.1) was used to confirm
the assignments in DMSO-d6 (Experimental Section). Strong NOE cross-peaks from the H3
doublet (at 7.57 ppm) and the H3! doublet (at 7.71 ppm) assign the signals at 4.61 ppm and at
4.53 ppm to the exo-H7 and exo-H7! protons, respectively. Weak H3-endo-H7 (7.57–5.05 ppm)
and H3!-endo-H7! (7.71–4.91 ppm) NOE cross-peaks complete the methylene proton
assignments. From these chemical shifts in DMSO-d6, we can assign the endo-H7, endo-H7!,
exo-H7, and exo-H7! signals for [Pt(N(H)6-Medpa)Cl]+ in D2O/DMSO-d6 (Table 4.3). These
assignments in D2O/DMSO-d6 were also confirmed with ROESY data (not shown).
Assignments of the 13C NMR signals for [Pt(N(H)6-Medpa)Cl]+ in D2O/DMSO-d6 were
made through an HSQC experiment (Figure 4.7 and Table C.3). Cross-peaks (ppm) involving H3
(7.30-121.1), H3! (7.43-123.7), H4 (7.82-142.2), H4! (8.02-142.6), H5 (7.28-128.4), H5! (7.42126.3), H6! (8.75-149.7), 6-Me (2.74-27.9) signals assign the C3, C3!, C4, C4!, C5, C5!, C6!, and
C(6-Me)

13

assign the

C NMR signals, respectively. Cross-peaks from the endo-H7 and exo-H7 signals
13

C NMR signal at 62.8 ppm to C7. Cross-peaks from the endo-H7! and exo-H7!
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signals assign the 13C NMR signal at 60.7 ppm to C7!. The 1D 13C NMR spectrum (Figure 4.7)
contains three very downfield 13C NMR signals that do not have HSQC cross-peaks, features
expected for C2, C2!, and C6, the carbons attached to the pyridyl nitrogen. HMBC cross-peaks
from these 13C NMR signals at 166.5, 168.3, and 165.3 ppm to the H3, H3!, and H5 signals
(Figure C.2) allow assignment to C2, C2!, and C6 (Table C.3). Except for the H6/6! and (to a
lesser extent) the methyl 1H NMR shifts, the 1H and 13C NMR signals of the unsubstituted (u) and
methyl-substituted (s) pyridyl rings of [Pt(N(H)6-Medpa)Cl]Cl have shifts that compare very
well to shifts of the corresponding u and s signals of [Pt(N(H)dpa)Cl]Cl31 and [Pt(N(H)6,6!Me2dpa)Cl]Cl32 (Tables C.2 and C.3).
H4
H6'

H3'

H4'

H5'

H3
H5

endo-H7'
endo-H7

exo-H7
exo-H7'

6-Me

C(6-Me)
40
C7'

60

C7
80
100
C3
C3'
C5'
C5
C4
C4'
C6'
C6
C2'
C2

120
140
160
8

7

6

5

4

3

Figure 4.7: HSQC spectrum of [Pt(N(H)6-Medpa)Cl]Cl (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C,
shifts in ppm). Peaks labeled X are a mixture of solvated species and impurities.
4.3.4 [Pt(N(H)6-Medpa)(9-EtG)]2+ Adduct
The reaction of [Pt(N(H)6-Medpa)Cl]Cl with 2.5 molar equiv of 9-EtG in D2O/DMSO-d6
64:36) monitored by 1H NMR spectroscopy at 10 min, 1.5 h, and 1 d reached completion after
~1.5 h, as evidenced by the complete disappearance of the [Pt(N(H)6-Medpa)Cl]+ signals (Figure
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4.6). In contrast, under identical conditions, complete disappearance of the starting
[Pt(N(H)dpa)Cl]Cl signals required ~49 h.31 The spectrum exhibited two new, sharp singlets at
8.80 and 8.43 ppm (Table 4.4). These are clearly Pt(II)-bound 9-EtG H8 singlets. H8 is the only
type of aromatic proton in the reaction mixture that can give a singlet, and the downfield shift
change relative to the free 9-EtG H8 singlet (7.72 ppm) is consistent with coordination of 9-EtG
to Pt(II) via N7.25,28,31 The singlets maintained a constant ratio, indicating the formation of syn
and anti rotamers of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct in dynamic equilibrium.
Table 4.4: Selected 1H NMR shifts (ppm) for G in Pt(N(H)6-Medpa)G adducts in D2O/DMSO-d6
(64:36, pH 4.0, 25 °C).
G

free H8

anti H8

syn H8

free H1!

anti H1!

syn H1!

9-EtGa

7.72

8.80

8.43

-

-

-

3!-GMP

7.87

9.05, 9.04

8.67

5.72

5.96, 5.95

5.87, 5.85

5!-GMP

7.99

9.13

8.77, 8.76

5.72

5.95, 5.94

5.87, 5.86

5!-GTP

8.06

9.22, 9.21

8.84, 8.81

5.73

5.95

5.87

a

CH2: 4.15 (anti), 4.03 (syn), and 3.91 ppm (free); CH3: 1.39 (anti), 1.30 (syn), and 1.24 ppm
(free).
The presence of two sharp, well-resolved H8 signals from [Pt(N(H)6-Medpa)(9-EtG)]2+
(Figure 4.6) provides evidence for restricted guanine base rotation in this adduct. We attribute
the cause of this restricted rotation in this and related adducts to the steric impedance of
nucleobase rotation by the carrier-ligand Me groups or protons at the 6/6! pyridyl ring positions;
these project toward the coordinated guanine nucleobase and would clash with the guanine O6
during guanine rotation about the Pt–N7 bond. In the ROESY spectrum of [Pt(N(H)6-Medpa)(9EtG)]2+ at 15 °C, H8-H8 EXSY cross-peaks are absent (Figure 4.8), whereas H8-H8 EXSY
cross-peaks are present in the ROESY spectrum for the [Pt(N(H)dpa)(9-EtG)]2+ analogue under
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similar conditions.31 As might be expected, the 6-methyl-substitutent on one carrier-ligand
pyridyl ring of [Pt(N(H)6-Medpa)(9-EtG)]2+ impedes interconversion between the syn and anti
rotamers.

Figure 4.8: 1H-1H ROESY spectrum showing H8-H6! and H8-6-Me NOE cross-peaks and the
absence of H8-H8 EXSY cross-peaks of [Pt(N(H)6-Medpa)(9-EtG)]2+ (D2O/DMSO-d6 (64:36),
pH 4.0, 15 °C, shifts in ppm). The spectrum was recorded 2 h after initiation of the adduct
formation reaction. Peak labeled X is from solvent impurity.
Using reasoning discussed above and in previous work,31 we assign the H8 singlets of
[Pt(N(H)6-Medpa)(9-EtG)]2+ to the syn and anti rotamers (Table 4.4). The shift of the syn H8
signal (8.43 ppm) is similar to the syn H8 shift (8.40 ppm) of [Pt(N(H)dpa)(9-EtG)]2+, but the
anti H8 shift of [Pt(N(H)6-Medpa)(9-EtG)]2+ is more downfield (8.80 ppm) than the anti H8 shift
of [Pt(N(H)dpa)(9-EtG)]2+ (8.73 ppm)31 (Table C.4). The Δδ (the chemical shift difference
between the syn and anti H8 signals) is 0.37 ppm for [Pt(N(H)6-Medpa)(9-EtG)]2+, a value
comparable to the Δδ ~ 0.33 ppm found for [Pt(N(H)dpa)(9-EtG)]2+ 31 (Table 4.5). For the
[Pt(N(H)dpa)(9-EtG)]2+ adduct,31 the syn rotamer was favored, with a syn H8:anti H8 ratio of
1.28:1 (Table 4.5), but the syn rotamer was more favored for [Pt(N(H)6-Medpa)(9-EtG)]2+, with
a syn H8:anti H8 intensity ratio of 2.10:1 (Figure 4.6 and Table 4.5). In contrast, the anti rotamer
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of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct was highly favored (Figure 4.9). The unusual
dependence of the syn H8:anti H8 ratio on the carrier-ligand bulk (Figure 4.9) is discussed later.
Table 4.5: Selected 1H NMR shifts (ppm), syn H8:anti H8 intensity ratios, and Δδ for the
Pt(N(H)dpa)G and Pt(N(H)6-Medpa)G adducts (G = 9-EtG, 5!-GMP, 3!-GMP, and 5!-GTP) in
D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
adducts

free H8

syn H8

anti H8

syn H8:anti H8

Δδ

[Pt(N(H)dpa)(9-EtG)]2+a

7.72

8.40

8.73

1.28:1

0.33

Pt(N(H)dpa)(3!-GMP)b

7.87

8.64

8.98

1.35:1

0.34

Pt(N(H)dpa)(5!-GMP)a

7.96

8.72

9.08

1.14:1

0.36

Pt(N(H)dpa)(5!-GTP)a

7.97

8.79

9.21

1:1.22

0.42

[Pt(N(H)6-Medpa)(9-EtG)]2+

7.73

8.43

8.80

2.10:1

0.37

Pt(N(H)6-Medpa)(3!-GMP)

7.87

8.67

9.05, 9.04

2.27:1

0.38

Pt(N(H)6-Medpa)(5!-GMP)

7.97

8.77, 8.76

9.13

2.19:1

0.36

Pt(N(H)6-Medpa)(5!-GTP)

7.98

8.84, 8.81

9.22, 9.21

1.96:1

0.41

a

Ref 31. b This work, adduct was prepared in a similar manner as in Ref 31.

Figure 4.9: Plot of the syn H8:anti H8 ratios of Pt(N(H)dpa)G, Pt(N(H)6-Medpa)G, and
Pt(N(H)6,6-Me2dpa)G adducts [G = 9-EtG (blue), 5!-GMP (red), and 3!-GMP (green)]. Dotted
line represents the point at which the syn H8:anti H8 ratio is 1:1.
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1

H and 13C NMR data for the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct (Figures 4.10 and C.3)

and the [Pt(N(H)6-Medpa)Cl]Cl complex (Figure 4.7) are collected in Tables 4.3, C.2, C.3, C.4,
and C.5. The carrier-ligand signal assignments for [Pt(N(H)6-Medpa)(9-EtG)]2+ are explained in
Appendix C. From the assignments, the 1H and 13C NMR shifts of the signals of the methylsubstituted pyridyl group of [Pt(N(H)6-Medpa)(9-EtG)]2+ compare well with the methylsubstituted pyridyl group signals of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+, and the 1H and 13C NMR
shifts of the signals of the unsubstituted pyridyl ring of [Pt(N(H)6-Medpa)(9-EtG)]2+ compare
well with the shifts of the unsubstituted pyridyl group signals of [Pt(N(H)dpa)(9-EtG)]2+31 (Tables
C.4 and C.5).
free G H8

syn H8
H4

anti H8

H4

anti
H6'

H3

syn
H5'
H6'
H3'

H5

C3
C3'

125

C5'
C5
130

135
free G C8
140
C4
C4'
G C8

145

anti C6'
syn C6'
8.5

8.0

7.5

Figure 4.10: Aromatic region of the HSQC spectrum of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct
(D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm). Peak labeled free H8 is from an excess of
free 9-EtG. The spectrum was recorded 5 h after initiation of the adduct formation reaction.

A ROESY experiment was performed to confirm the assignments of the syn and anti H6!
and 6-Me signals of [Pt(N(H)6-Medpa)(9-EtG)]2+ (Figure 4.8). The NOE cross-peak between the
syn H8 signal at 8.43 ppm and the signal at 7.23 ppm (overlapped with the H5 and H5! signals)
confirms the assignment of this signal to the syn H6! (Figure 4.8). An NOE cross-peak between
the anti H8 signal at 8.80 ppm and the signal at 7.48 ppm (overlapped with the H3! signals)
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confirms the anti H6! assignment. The anti H8 signal had an NOE cross-peak to the 6-Me signal
at 1.80 ppm, and the syn H8 signal had an NOE cross-peak to the 6-Me signal at 1.73 ppm
(Figure 4.8). The results that the more downfield H6! and 6-Me signals from the anti rotamer are
downfield from those of the syn rotamer are similar to the findings for the H6/6! signals of the
syn and anti rotamers of [Pt(N(H)dpa)(9-EtG)]2+.31 Compared to the shifts of the respective
chloro complex at 8.75 and 8.61 ppm, the upfield shift changes of the syn (7.23 ppm) and anti
(7.48 ppm) H6! signals for [Pt(N(H)6-Medpa)(9-EtG)]2+ are larger than those for the syn (7.48
ppm) and anti (7.56 ppm) H6/6! signals for [Pt(N(H)dpa)(9-EtG)]2+ (Tables 4.3, C.2 and C.4).
The relationships of these shift changes to the structure of the rotamers are explained next.
As mentioned, the greater bulk of the 6-Me group than the H6! proton causes the Cl
ligand to move closer to the unsubstituted pyridyl ring H6! proton (2.58 Å) of [Pt(N(H)6Medpa)Cl]+ (Figure 4.5) than the corresponding distance (2.76 Å) in [Pt(N(H)dpa)Cl]+.44 The 6Me group is expected to force the nucleobase toward the H6! protons in both the syn and anti
rotamers of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct. The resulting closer position of the
anisotropic guanine to the H6! proton causes a more upfield shift of the H6! signals of the syn
and anti rotamers of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct, as compared to the syn and anti
H6/6! signals of the [Pt(N(H)dpa)(9-EtG)]2+ adduct (Tables 4.3 and C.4).
In order to assess the degree of base canting for the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct,
NOE cross-peak intensities were compared. Relative to its abundance, the syn rotamer of
[Pt(N(H)6-Medpa)(9-EtG)]2+ should have weaker H8-6-Me and H8-H6! NOE cross-peaks
because of the longer distances of H8 to the 6-Me group and the H6! proton (Figure 4.11 C) as
compared to these distances in the anti rotamer (Figure 4.11 D). In the ROESY spectrum, the
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H8-6-Me NOE cross-peak intensities are very similar for the syn and anti rotamers of [Pt(N(H)6Medpa)(9-EtG)]2+ (Figure 4.8).
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Figure 4.11: Models of the syn (A) and anti (B) rotamers of the Pt(N(H)dpa)G adducts, syn (C)
and anti (D) rotamers of the Pt(N(H)6-Medpa)G adducts, and of the syn (E) and anti (F) rotamers
of the Pt(N(H)6,6!-Me2dpa)G adducts. The R group of G is omitted for clarity. The van der
Waals radii of all atoms were taken into account in constructing these models. Note that the 6membered guanine ring in the syn conformers is pointing up, allowing favorable electrostatic
+
attraction between the G 6-membered ring δ O6 and the δ H6/6! and H6! protons in A and C,
but causing steric repulsion of the G 6-membered ring with the 6-Me and 6!-Me groups in E and
with the 6-Me group in C. The latter interaction is alleviated by canting. Note that the 6membered guanine ring in the anti conformers is pointing down, alleviating the crowding but
+
+
increasing electrostatic repulsion between the G 5-membered ring δ H8 and the δ H6/6! and
H6! protons in B and D. This repulsion is not an issue for the anti rotamer (F) in the Pt(N(H)6,6!Me2dpa)G adducts, possibly accounting for the high abundance of the anti rotamer of these
adducts.32
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A syn H8-6-Me NOE cross-peak comparable in intensity to the anti H8-6-Me NOE crosspeak despite the longer syn H8-6-Me distance is consistent with the syn H8:anti H8 ratio of
2.10:1 for the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct. Although the syn rotamer is highly abundant,
the syn H8-H6! NOE cross-peak has a much smaller intensity than the anti H8-H6! NOE crosspeak (Figure 4.8). From a comparison of the relative sizes of the H8-H6! and the H8-6-Me crosspeaks, it seems possible that the base is canted. (As discussed below, we believe such canting
could occur so as to minimize the H8-H6! electrostatic repulsion in the syn rotamer.)
4.3.5 Pt(N(H)6-Medpa)(5!-GMP) and Pt(N(H)6-Medpa)(5!-GTP) Adducts
The reactions of [Pt(N(H)6-Medpa)Cl]Cl with 2.5 molar equiv of 5!-GMP or 5!-GTP in
D2O/DMSO-d6 (64:36) were monitored by 1H NMR spectroscopy at 10 min, 1.5 h, and 1 d. The
reactions reached completion after ~1.5 h, as evidenced by the complete disappearance of the
[Pt(N(H)6-Medpa)Cl]+ signals by 1.5 h (Figures 4.12, 4.13, C.4 and C.5). Except as noted below,
the results for these two 5!-nucleotides were similar.

!
!
Figure 4.12: Aromatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of
the reaction mixture forming the Pt(N(H)6-Medpa)(5!-GMP) adduct (top) recorded at 1.5 h after
mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm).
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For Pt(N(H)6-Medpa)(5!-GMP), we assigned the H8 singlets to the syn (8.77 and 8.76
ppm) and anti (9.13 ppm) rotamers, respectively (Table 4.4). Only the syn rotamer exhibited
resolved H8 signals for the two NH chiralities of the carrier ligand and had a 1:1 ratio. The syn
H8:anti H8 intensity ratio is 2.19:1 (Figure 4.12 and Table 4.5). The Δδ between the two H8
signals (0.36 ppm) is comparable to the Δδ ~ 0.36 ppm found for Pt(N(H)dpa)(5!-GMP).31 The
absence of H8-H8 EXSY cross-peaks in the ROESY spectrum (Figure C.6) of Pt(N(H)6Medpa)(5!-GMP) at 15 °C indicates that interconversion between rotamers is slow compared to
the Pt(N(H)dpa)(5!-GMP)31 adduct, for which EXSY cross-peaks were observed. The carrierligand signals in the Pt(N(H)6-Medpa)(5!-GMP) adduct have shifts similar to those of the 9-EtG
adduct (Tables 4.3 and C.6, Figures 4.12 and C.4).

"
"
Figure 4.13: Aromatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of
the reaction mixture forming the Pt(N(H)6-Medpa)(5!-GTP) adduct, recorded at 10 min (middle)
and at 1.5 h (top) after mixing (25 °C, D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm)."
"
The Pt(N(H)6-Medpa)(5!-GTP) adduct has properties (Tables 4.3, 4.4, 4.5, and C.7 and
Figures 4.13 and C.5) that are very similar to those of the Pt(N(H)6-Medpa)(5!-GMP) adduct.
Both H8 singlets for both the syn (8.84 and 8.81 ppm) and the anti (9.22 and 9.21 ppm) rotamers
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were resolved for the Pt(N(H)6-Medpa)(5!-GTP) adduct. For each rotamer type, the H8 signals
had a 1:1 intensity ratio (Figures 4.13 and C.5), indicating that the two chiral configurations at
the secondary amine have no influence on the relative stability of either the syn or the anti
rotamers.
4.3.6 Pt(N(H)6-Medpa)(3!-GMP) Adduct
The reaction of [Pt(N(H)6-Medpa)Cl]Cl with 2.5 molar equiv of 3!-GMP in D2O/DMSOd6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 3 h, and 1 d. The reaction reached
completion after ~3 h, as evidenced by the complete disappearance of the [Pt(N(H)6-Medpa)Cl]+
signals by 3 h (Figures 4.14 and C.7). We assigned the H8 singlets to the syn (8.67) and anti
(9.05 and 9.04 ppm) rotamers. In this case, the H8 signals of the syn rotamer were not resolved,
but the anti rotamers exhibited two H8 signals in a 1:1 ratio. The syn H8:anti H8 intensity ratio is
2.27:1 (Figure 4.14 and Table 4.5).

!
Figure 4.14: Aromatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of
the reaction mixture forming the Pt(N(H)6-Medpa)(3!-GMP) adduct, recorded at 10 min (middle)
and at 3 h (top) after mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm).
The Δδ between the two H8 signals (0.38 ppm) is comparable to the Δδ = 0.34 ppm
found for Pt(N(H)dpa)(3!-GMP) (Table 4.5 and C.8). The carrier-ligand signals in the Pt(N(H)6Medpa)(3!-GMP) adduct have shifts similar to those observed for the other adducts (Tables 4.3
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and C.8, Figures 4.14 and C.7). Thus, the location of the phosphate groups at the 3! or 5! position
of the ribose groups does not appear to have a major effect on the properties of the adducts.
4.3.7 Factors Influencing the Syn:Anti Ratio of the Pt(N(H)dpa)G, Pt(N(H)6-Medpa)G, and
Pt(N(H)6,6!-Me2dpa)G Adducts
In this section, we assess how changes in the features of the carrier ligand could explain
the unusual trend of the syn:anti ratio of rotamers for the following Pt(Ltri)G mono adducts:
Pt(N(H)6-Medpa)G >> Pt(N(H)dpa)G > Pt(N(H)6,6!-Me2dpa)G (Figure 4.9). We focus on three
factors in order of perceived importance that appear to influence this unusual trend. First, we
discuss the electrostatic repulsion between protons bearing relatively high partial positive
charges, the G H8 proton in the smaller 5-membered nucleobase ring and carrier-ligand H6/6! or
H6! protons. Second, we consider the steric interactions between the carrier-ligand 6/6!-Me or 6Me groups and the larger G six-membered ring. Third, we mention the favorable electrostatic
attraction between G O6 and carrier-ligand H6/6! or H6! protons. The Pt(Ltri)G adducts,
[Pt(N(H)dpa)(9-EtG)]2+, [Pt(N(H)6-Medpa)(9-EtG)]2+, and [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+, are
discussed first because these adducts have the simplest G derivative used in this study.
The pyridyl ring tilting, as discussed in the Introduction and in previous reports,31,32 is a
consequence of the sp3 geometry of the central NH group of the tridentate ligand. The methylene
carbons are positioned on the opposite side of the coordination plane as the NH group. The two
bonds from the pyridyl ring, one to the methylene groups and one to the Pt(II), require that the
pyridyl ring tilts in such a manner as to project the pyridyl H6/6! atoms and the pyridyl 6/6!-Me
groups upward toward the same side of the coordination plane as the NH group. In the
Pt(N(H)dpa)G, Pt(N(H)6,6!-Me2dpa)G, and Pt(N(H)6-Medpa)G mono adducts, the bulky
guanine 6-membered ring in the syn rotamer is on the same side of the coordination plane as the
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pyridyl H6/6! atoms, the pyridyl 6/6!-Me groups, and the pyridyl H6! atom and the pyridyl 6-Me
group, respectively (Figure 4.11).
In the anti rotamer of [Pt(N(H)dpa)(9-EtG)]2+ as well as all other related Pt(Ltri)G mono
+

adducts, the nucleobase δ H8 proton is on the same side of the coordination plane as the
+

δ H6/6! protons (Figures 4.3 and 4.11). The resulting proximity of H8 to the H6/6! protons
(Figure 4.11) causes unfavorable electrostatic repulsion between the partial positive charges of
these protons, and this repulsion leads to a lower abundance of the anti rotamer (Table 4.5). In
contrast, the H8 of the syn rotamer is on the opposite side of the coordination plane to the H6/6!
protons (Figures 4.3 and 4.11). Thus, the greater separation between these protons in the syn
rotamer decreases H8-H6/6! electronic repulsions. Also, the partially negative O6 of guanine is
on the same side of the coordination plane as the partially positive H6/6! protons of the carrier
ligand, a juxtaposition possibly leading to favorable electrostatic interactions in the syn rotamer.
These factors help to account for the syn H8:anti H8 ratio of 1.28:1 for [Pt(N(H)dpa)(9-EtG)]2+
(Table 4.5). For the syn rotamer of [Pt(N(H)6-Medpa)(9-EtG)]2+, the guanine base can cant in the
direction that positions the 6-membered ring away from the bulky 6-Me group. Such canting also
+

+

-

positions the guanine δ H8 proton away from the δ H6! proton and the guanine δ O6 closer to
+

the δ H6! proton. Therefore, electrostatic interactions become more favorable and increase the
abundance of the syn rotamer (syn H8:anti H8 ratio = 2.10:1) compared to this ratio for
[Pt(N(H)dpa)(9-EtG)]2+. [This reasoning also applies to other Pt(N(H)6-Medpa)(G) adducts and
could account for the high syn H8:anti H8 ratio for these adducts in all cases, see below]. For the
+

[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct, which has no δ H6! protons, the rotamer abundance is
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influenced by repulsive steric interactions between the 9-EtG 6-membered ring and the chelate
ligand 6/6!-Me groups. Favorable electrostatic interactions are less likely to play a role because
the methyl protons bear a relatively low partial positive charge. Thus, the syn rotamer is now less
favored than the anti rotamer for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct (Figure 4.11) with a
"reversed" syn H8:anti H8 ratio of 1:1.42.
According to the combined results for adducts of all G studied in this work or recent
previous reports,31,32 the trend in the syn H8:anti H8 ratio, namely Pt(N(H)6-Medpa)G >>
Pt(N(H)dpa)G > Pt(N(H)6,6!-Me2dpa)G (Figure 4.9), reflects primarily the nature of the carrier
ligand. These newer studies are consistent with findings in very early studies of other Pt(Ltri)(5!GMP) adducts with polyamine ligands; in these older investigations, a phosphate group on the
N-9 substituent was shown to influence significantly the syn:anti ratio only when the terminal
donor groups of Ltri had NH groups that could form H-bonds with a 5!-phosphate group.25,26
4.3.8 Pt(N(H)6-Medpa)G2 Adducts
In addition to the signals of the [Pt(N(H)6-Medpa)(9-EtG)]2+ mono adduct, the spectrum
of the 9-EtG reaction mixture at 24 h contained new signals including two methyl signals (Figure
4.15). The shifts at 2.11 (major) and 2.12 (minor) ppm and the ratio (1.6:1) of these signals
resemble the dangling pyridyl methyl signal shifts (~2.14 ppm) and the ratio (1.6:1) for the
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ bis adduct.32 However, unlike the latter bis adduct, which forms
at 100%, only ~20% of the total product was the [Pt(N(H)6-Medpa)(9-EtG)2]2+ bis adduct, and
the mono adduct dominated at ~80%. The 1H NMR spectrum recorded after 3 months (not
shown) showed no further formation of the bis adduct. The formation of the bis adduct is
probably a result of the repulsive steric interaction between the 6-Me and the guanine base in the
[Pt(N(H)6-Medpa)(9-EtG)]2+ adduct; however, the presence of just one methyl substituent creates
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only moderate steric crowding and thus leads to only ~20% of the [Pt(N(H)6-Medpa)(9-EtG)2]2+
bis adduct.

syn
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Figure 4.15: 1H NMR spectra of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct (D2O/DMSO-d6 (64:36),
pH 4.0, 25 °C, shifts in ppm) at 1 day after mixing. Labeled peaks show the formation of the bis
adduct [Pt(N(H)6-Medpa)(9-EtG)2]2+. X = solvent impurity.
1

H NMR spectra of the other Pt(N(H)6-Medpa)G solutions in D2O/DMSO-d6, pH ~ 4 (G

= 5!-GMP, 5!-GTP, and 3!-GMP) taken after 24 h and after 1 month all had small signals
attributable to bis adducts with ~5–15% abundance. The new signals attributable to a small
amount of the Pt(N(H)6-Medpa)(5!-GMP)2 and Pt(N(H)6-Medpa)(3!-GMP)2 adducts are shown
in Figures C.8 and C.9. 1H NMR spectra (not shown) of these Pt(N(H)6-Medpa)G solutions in
D2O/DMSO-d6 pH ~8 (taken 24 h after the pH was raised) contained slightly stronger signals
consistent with ~20% of the bis adduct, especially for G = 5!-GMP and 5!-GTP. This increased
abundance of these bis adducts could result from interactions between the deprotonated
phosphate group(s) of one nucleotide interacting with the nucleobase NH groups of the cis
nucleotide.34,37,38,49-55
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4.4 CONCLUSIONS
The bulk of the 6-Me group and the H6! proton are sufficient to impede rotation of the
guanine base about the Pt–N7 bond of the Pt(N(H)6-Medpa)G adducts; thus, H8 signals for the
syn and anti rotamers could be resolved and assigned. We also conclude from the absence of H8H8 EXSY cross-peaks for the Pt(N(H)6-Medpa)G adducts that the bulk of only one methyl group
is sufficient to significantly decrease the ease of interconversion between rotamers as compared
to the Pt(N(H)dpa)G adducts, for which H8-H8 EXSY cross-peaks were observed in a previous
study.31
All G adducts formed with [Pt(N(H)6-Medpa)Cl]+ in this study favored highly the mono
adducts, Pt(N(H)6-Medpa)G. The trend in increasing carrier-ligand bulk is reflected, as
expected, in the following order from lowest to highest abundance of bis adducts: Pt(N(H)dpa)G2
<< Pt(N(H)6-Medpa)G2 < Pt(N(H)6,6!-Me2dpa)G2.
The syn:anti ratio of rotamers for the Pt(Ltri)G mono adducts compared here follows an
unusual trend: Pt(N(H)6-Medpa)G >> Pt(N(H)dpa)G > Pt(N(H)6,6!-Me2dpa)G. In the anti
rotamer of Pt(N(H)6-Medpa)G adducts, the H8 appears to be already close to the 6-Me group, as
shown by the strong H8-6-Me NOE cross-peak (Figure 4.8). Thus, the base may not be able to
+

+

cant in order to minimize the δ H8-to-δ H6! electrostatic repulsion, consistent with a close H8H6! distance and thus accounting for the strong H8-H6! NOE cross-peak (Figure 4.8). We
+

+

believe this unfavorable δ H8-to- δ H6! repulsion in the anti rotamer (uncompensated by any
-

+

δ O6-to- δ H6! attraction) explains why the anti rotamer is less favored. For the syn rotamer of
Pt(N(H)6-Medpa)G adducts, the guanine base cants in the direction such that the 6-membered
ring is positioned away from the bulky 6-Me group. Such canting relieves the H8-H6!
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-

+

electrostatic repulsion and places the guanine δ O6 closer to the δ H6! proton, creating a
favorable electrostatic attraction. Therefore, electrostatic interactions become more favorable and
increase the abundance of the syn rotamer when the carrier ligand has a combination of one
+

sterically hindering methyl group and one δ proton at the 6/6! positions.
Because, unlike Pt(N(H)6-Medpa)G adducts, there are no bulky methyl groups in the
+

Pt(N(H)dpa)G adducts, δ H6/6! proton electrostatic interactions play the larger role in
influencing rotamer abundance. For Pt(N(H)dpa)G adducts, electrostatic repulsions are stronger
in the anti rotamer and weaker in the syn rotamer. As a result, the syn rotamer is more abundant
+

for Pt(N(H)dpa)G adducts.31 In contrast, because there are no δ H6/6! protons and instead there
are bulky methyl groups in the Pt(N(H)6,6!-Me2dpa)G adducts, steric interactions play a larger
role in influencing rotamer abundance. For Pt(N(H)6,6!-Me2dpa)G adducts, steric repulsions are
weaker in the anti rotamer and stronger in the syn rotamer. As a result, the anti rotamer is more
abundant also for Pt(N(H)6,6!-Me2dpa)G adducts.32
This research program was motivated by the desire to understand the effect of steric bulk
of the carrier ligand on the interligand interaction of the carrier ligand with Pt(II)-bound guanine
derivatives. The present work, invoking electrostatic contributions to interligand interactions to
explain the trend in syn:anti ratios, points to the possible consideration of such electrostatic
contributions in the design of potential monofunctional Pt(II) anticancer agents.
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CHAPTER 5. PT(DI-(2-PICOLYL)AMINE)Cl]+ COMPLEXES DERIVATIZED WITH
ALKYL SUBSTITUENTS ON THE CENTRAL NITROGEN ATOM OR PICOLYL
RING ATOMS. DRAMATICALLY DIFFERENT REACTIVITY TOWARD N-9
GUANINE DERVIATIVES CAUSED BY N-SUBSTITUENTS.
5.1 INTRODUCTION
Compounds of the type cis-Pt(Lbi)X2 (Lbi = one bidentate or two cis-unidentate N-donor
ligands, X2 = anionic leaving ligands), including cisplatin (cis-Pt(NH3)2Cl2) are among the most
widely used clinical anticancer agents.1-7 Pt(II) anticancer compounds target DNA and bind
preferentially at the N7 atom of two adjacent guanine bases forming an G*pG* intrastrand crosslink (G* = N7-platinated G residue).5,6,8-11 An molecular structure of an HMG bound 16-oligomer
G*pG* adduct9,10 was used to derive a starting structure of a duplex 9-oligomer G*pG* adduct.9
The oligomer exhibited an unusual XpG* base pair step. When G* is an adduct of a rather bulky
monofunctional Pt anticancer drug, a closely related base pair step with a large positive shift and
slide exists in the solid state.11,12 Unlike for monofunctional Pt(II) agents, where high carrierligand bulk increases anticancer activity,10,11,13-17 bifunctional Pt(II) agents, Pt(Lbi)X2, have higher
toxicity and lower activity when the carrier-ligand bulk is greater.5,18-21
Monofunctional Pt(II) agents, Pt(Ltri)X (Ltri = a tridentate, one bidentate and one
monodentate, or three monodentate ligands; X = a monodentate, monoanionic leaving group),
also bind to G residues in DNA and have been shown to have similar biological effects as
bifunctional agents.22 Thus, for Pt(Ltri)G models (G = guanine derivative bound to platinum, but
not tethered to another nucleobase, Figure 5.1),6,23-28 assessment of the effects of steric
interactions between the carrier ligand and the guanine base is important to the understanding of
the fundamental factors influencing these types of adducts. We previously studied the
interactions of several G derivatives (e.g. 5!-GMP, 3!-GMP, and 5!-GTP) in Pt(Ltri)G mono
adducts with the carrier ligand having low in-plane bulk, di-(2-picolyl)amine (N(H)dpa),29 a

!
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carrier ligand with moderate in-plane bulk, N-(6-methyl-2-picolyl)-N-(2-picolyl)amine (N(H)6Medpa),30 and a carrier ligand with high in-plane bulk, di-(6-methyl-2-picolyl)amine (N(H)6,6!Me2dpa),31 Figure 5.2.

Figure 5.1: Possible conformers for Pt(Lbi)G2 adducts with two bound monodentate guanine N9
derivatives (referred to with bold G). A generic version of G is depicted in the center, along with
the guanine base numbering scheme. R can be ribose or a ribose phosphate. Note that the
nucleobase is represented by an arrow with the tip at the guanine H8 atom. N and N! represent a
nitrogen donor ligand. When (N ≠ N!), four conformers (HHu, HHd, ΛHT, ΔHT) are possible,
whereas when (N = N!), only three conformers (HH, ΛHT, ΔHT) are possible because HHu =
HHd. The same number of conformers can exist regardless of whether the nitrogen donors are
unidentate ligands or are part of a chelate (N–N or N–N!).
In Pt(Ltri)G mono adducts (Figure 5.3), the two orientations of the guanine base with
respect to the coordination plane lead to syn and anti rotamers, which can interconvert by
rotation about the Pt–N7 bond. As shown in Figure 5.3, the rotamer with the H atom of the
central N-H group and the guanine O6 on the same side of the coordination plane is designated
as syn, and the rotamer with these groups on opposite sides of this plane is designated as anti.24,29
The observation of two sharp 1H NMR G H8 signals for all Pt(N(H)dpa)G, Pt(N(H)6-Medpa)G,
and Pt(N(H)6,6!-Me2dpa)G mono adducts indicated that these rotamers do indeed exist and that
!
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guanine base rotation about the Pt–N7 bond was impeded by the bulk of the tridentate carrier
ligands.

Figure 5.2: Line drawing and numbering scheme for [Pt(Ltri)Cl]+ cations.
We noted in the study of the Pt(N(H)dpa)G adducts29 that the tilting of the pyridyl rings
relative to the Pt(II) coordination plane positions the anisotropic pyridyl ring shielding region
closer to the H8 of the syn conformer than to the H8 of the anti conformer (Figure 5.3). The syn
H8 signal is upfield relative to the anti H8 signal. Correlating the abundance of the set of H1!
signals with that of the H8 signals established that the anti rotamer has the more downfield
signals for all of the protons associated with the five-membered guanine ring.29
In the presence of an excess of G, the Pt(N(H)dpa)G29 mono adduct was the final
product. In contrast, Pt(N(H)6,6!-Me2dpa)G mono adducts were unexpectedly found to convert
readily and completely to the Pt(N(H)6,6!-Me2dpa)G2 bis adduct (Figure 5.4).31 The Pt(N(H)6Medpa)G mono adducts were highly stabile, but small amounts of the Pt(N(H)6-Medpa)G2 bis
adduct were detected.30 Formation of this bis adduct (Figure 5.4) involved an unusual
!
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transformation of the Pt-bound N(H)6,6!-Me2dpa ligand from the tridentate to the bidentate
coordination mode. Pt(Lbi)G2 adducts can have as many as two head-to-head (HHu and HHd)
and two head-to-tail (ΛHT and ΔHT) conformers, depending on the bulk and symmetry of the
carrier ligands (Figure 5.1). 5,32-38
exo-H7/7!!

H8
endo-H7/7!!

exo-H7/7!!

H8

endo-H7/7!!

Figure 5.3: The two possible rotamers (syn, top; anti, bottom) for Pt(Ltri)G complexes with
tridentate ligands unsymmetrical with respect to the coordination plane but symmetrical about a
plane perpendicular to the coordination plane are illustrated for Ltri = N(H)6,6!-Me2dpa and G =
5!-GMP. Protons in the chelate ligand N–CH2 groups are called endo if they project down and
away from the chelate ligand NH proton and exo if they project up toward this NH proton. The
NH proton and the H8 proton of 5!-GMP are highlighted with a magenta circle.
In this study, we examined Pt(N(R)6,6!-Me2dpa)G mono adducts (R = methyl, propionoic
acid, and 6-methyl-2-picolyl) formed from [Pt(N(R)6,6!-Me2dpa)Cl]Cl (N(R)6,6!-Me2dpa) = N(Me)-di-(6-methyl-2-picolyl)amine, N-(propionoic acid)-di-(6-methyl-2-picolyl)amine, and tris(6-methyl-2-picolyl)amine, Figure 5.2). We have employed NMR techniques to assess the
influence of bulky R groups on the central nitrogen on the properties of Pt(N(R)6,6!-Me2dpa)G
mono adducts, as compared to the properties of Pt(N(H)6,6!-Me2dpa)G mono adducts. In the
presence of an excess of G, the Pt(N(Me)6,6!-Me2dpa)G mono adducts were always present,
unlike Pt(N(H)6,6!-Me2dpa)G mono adducts which converted readily to the Pt(N(H)6,6!!
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Me2dpa)G2 bis adduct. As the bulk is increased on the central nitrogen (as for Pt(N(prop)6,6!Me2dpa)G and Pt(6,6!,6!!-Me3tpa)G), the abundance of bis adducts became small to
undetectable. A previous study,29 revealed that the anti rotamer was more abundant for
Pt(N(H)dpa)(5!-GTP) because of a weak hydrogen bond between the 5!-GTP γ-phosphate group
and the N(H)dpa central N-H. In this study, the Pt(N(H)6-Medpa)(5!-GTP) and Pt(N(H)6,6Me2dpa)(5!-GTP) adducts show similar results and the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) and
Pt(6,6!,6!!-Me2dpa)(5!-GTP) adducts show no change in the syn H8:anti H8 ratio at various pH
values. Thus, providing further evidence of the role of a trans NH ligand group influencing
rotamer abundance.

Figure 5.4: Possible transformation of Pt(N(R)6,6!-Me2dpa)G mono adducts to Pt(N(R)6,6!Me2dpa)G2 bis adducts in the presence of excess G.
5.2 EXPERIMENTAL SECTION
5.2.1 Starting Materials
K2[PtCl4],

5!-guanosine

monophosphate

disodium

salt

(5!-GMP),

3!-guanosine

monophosphate disodium salt (3!-GMP), and 5!-guanosine triphosphate disodium salt (5!-GTP)
were obtained from Aldrich. cis-Pt(DMSO)2Cl2,39 di-(6-methyl-2-picolyl)amine (N(H)6,6!Me2dpa),40 N-(Me)-di-(6-methyl-2-picolyl)amine (N(Me)6,6!-Me2dpa),41 N-(propionic acid)-di(6-methyl-2-picolyl)amine

(N(prop)6,6!-Me2dpa),42

N-(propionic

acid)-di-(2-picolyl)amine

(N(prop)dpa),43 tris-(6-methyl-2-picolyl)amine (6,6!,6!!-Me3tpa),44 tris-(2-picolyl)amine (tpa),44
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N-(Me)-di-(2-picolyl)amine

(N(Me)dpa),41

[Pt(N(H)6-Medpa)Cl]Cl,30

and

Pt(N(H)6,6!-

Me2dpa)Cl]Cl31 were synthesized as described in the literature, and the 1H NMR chemical shifts
observed matched the reported values. The known complexes, [Pt(N(Me)dpa)Cl]Cl45 and
[Pt(tpa)Cl]Cl,46 were synthesized using Method A in this study, and the 1H NMR chemical shifts
observed matched the reported values (Appendix D).
5.2.2 NMR Measurements
NMR spectra were recorded on an Avance-III Prodigy 500 MHz Bruker spectrometer,
typically with 10 mM samples in DMSO-d6 or in a D2O/DMSO-d6 (64:36) mixture (pH adjusted
with 0.5 M solutions of DNO3 or NaOD in D2O). For 1H and 13C NMR spectra in D2O/DMSO-d6,
peak positions are referenced relative to TMS by using the signals of DMSO-d6 at 2.50 ppm
(residual) and 39.5 ppm, respectively.47 A presaturation pulse to suppress the water peak was
used when necessary. ROESY experiments were performed at 15 °C by using a 200 ms mixing
time. 1H–13C HSQC NMR spectra were recorded in order to assign the signals of the adducts.
NMR data were processed with TopSpin and MestreNova software.
5.2.3 X-ray Data Collection and Structure Determination
Single crystals were placed in a cooled nitrogen gas stream at 90, 95, or 100 K (see Table
1) on a Bruker Kappa Apex-II DUO diffractometer equipped with Mo Κα radiation (λ = 0.71073
Å). Refinement was performed by full-matrix least squares methods using SHELXL,48 with H
atoms in idealized positions.
5.2.4 Synthesis of New [Pt(Ltri)Cl]+ Complexes
Methanol solutions (15 ml) of the ligand (0.12 mmol) and cis-Pt(Me2SO)2Cl2 (0.12
mmol) were heated at reflux and stirred overnight. The solvent was removed by rotary
evaporation and the residue was washed with H2O and diethyl ether and required no further
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purification (Method A). X-ray quality crystals were obtained by mixing equal volumes (1 mL)
of cis-Pt(Me2SO)2Cl2 (12.5 mM) and the ligand (12.5 mM) in acetonitrile and allowing mixture
to stand at room temperature. Yellow to orange, block-like crystals were obtained within 5 days
(Method B).
5.2.4.1 [Pt(N(Me)6,6!-Me2dpa)Cl]Cl. With N(Me)6,6!-Me2dpa (29 mg, 0.12 mmol) and
cis-Pt(Me2SO)2Cl2 (51 mg, 0.12 mmol), Method A afforded [Pt(N(Me)6,6!-Me2dpa)Cl]Cl as a
yellow precipitate (50 mg, 83% yield). Method B afforded yellow block-shaped crystals that
were characterized by single-crystal X-ray crystallography. 1H NMR signals (ppm) in DMSO-d6:
8.07 (t, J = 7.8 Hz, 2H, H4/4!), 7.55 (d, J = 7.7 Hz, 2H, H5/5!), 7.51 (d, J = 7.8 Hz, 2H, H3/3!),
5.54 (d, J = 15.7 Hz, 2H, endo-H7/7!), 4.59 (d, J = 15.7 Hz, 2H, exo-H7/7!), 2.94 (s, 6H, 6/6!CH3), 2.80 (s, 3H, N-CH3). NMR shifts were identical for both methods.
5.2.4.2 [Pt(N(prop)6,6!-Me2dpa)Cl]Cl. With N(prop)6,6!-Me2dpa (36 mg, 0.12 mmol)
and cis-Pt(Me2SO)2Cl2 (51 mg, 0.12 mmol), Method A afforded [Pt(N(prop)6,6!-Me2dpa)Cl]Cl as
a yellow precipitate (60 mg, 89% yield). Method B afforded yellow block-shaped crystals that
were characterized by single-crystal X-ray crystallography. 1H NMR signals (ppm) upon
dissolution of the crystals in DMSO-d6: 8.08 (t, J = 7.8 Hz, 2H, H4/4!), 7.51 (d, J = 7.8 Hz, 4H,
H3/3! and H5/5!), 5.61 (d, J = 16.0 Hz, 2H, endo-H7/7!), 4.78 (d, J = 16.2 Hz, 2H, exo-H7/7!),
3.02 (t, J = 6.5 Hz , 2H, N-CH2), 2.93 (s, 6H, 6/6!-CH3), 2.16 (t, J = 6.4 Hz, 2H, OC-CH2). NMR
shifts were identical for both methods.
5.2.4.3 [Pt(6,6!,6!!-Me3tpa)Cl]Cl. With 6,6!,6!!-Me3tpa (40 mg, 0.12 mmol) and cisPt(Me2SO)2Cl2 (51 mg, 0.12 mmol), Method A afforded [Pt(6,6!,6!!-Me3dpa)Cl]Cl as an orange
precipitate (58 mg, 81% yield). Method B afforded orange block-shaped crystals that were
characterized by single-crystal X-ray crystallography. 1H NMR signals (ppm) in DMSO-d6: 7.98
!
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(t, J = 7.8 Hz, 2H, H4/4!), 7.71 (d, 1H, H3!!), 7.59 (t, 1H, H4!!) 7.48 (d, J = 7.7 Hz, 2H, H3/3!),
7.32 (d, J = 7.9 Hz, 2H, H5/5!), 5.62 (d, J = 16.0 Hz, 2H, endo-H7/7!), 4.97 (d, J = 16.0 Hz, 2H,
exo-H7/7!), 4.09 (s, 2H, H7!!), 2.77 (s, 6H, 6/6!-CH3), 2.24 (s, 3H, 6!!-CH3). NMR shifts were
identical for both methods.
5.2.4.4 [Pt(N(prop)dpa)Cl]Cl. With N(prop)dpa (33 mg, 0.12 mmol) and cisPt(Me2SO)2Cl2 (51 mg, 0.12 mmol), Method A afforded [Pt(N(prop)dpa)Cl]Cl as a yellow
precipitate (59 mg, 92% yield). 1H NMR signals (ppm) in DMSO-d6: 8.78 (d, J = 4.9 Hz, 2H,
H6/6!), 8.28 (t, J = 7.8 Hz, 2H, H4/4!), 7.76 (d, J = 7.9 Hz, 2H, H3/3!), 7.67 (t, J = 6.2 Hz, 2H,
H5/5!), 5.32 (d, J = 15.7 Hz, 2H, endo-H7/7!), 4.85 (d, J = 15.7 Hz, 2H, exo-H7/7!), 3.25 (t, J =
7.4 Hz, 2H, N-CH2), 2.53 (t, J = 7.3 Hz, 2H, OC-CH2). NMR shifts were identical for both
methods. ESI-MS m/z : [M+] calcd. for C13H15ClN3Pt, 501.846; found, 501.066.
5.2.5 Adduct Formation of [Pt(N(R)6,6!-Me2dpa)Cl]Cl with 5!-GMP, 3!-GMP, and 5!-GTP
(R = Me, propionic acid, and 6-methyl-2-picolyl)
A 10 mM solution of [Pt(N(R)6,6!-Me2dpa)Cl]Cl in 600 µL of a 64:36 D2O/DMSO-d6
(385 µL/215 µL) mixture] was treated with 3.5 equiv of G to give a 1:3.5 ratio (10 mM:35 mM)
of Pt:GMP, and the solution (pH ~4) was kept at 25 °C. (The D2O/DMSO-d6 mixture was
employed to improve the solubility of the reactants.) An excess of G was used to ensure that the
reaction went to completion. The reaction, which was repeated several times, was monitored by
1

H NMR spectroscopy until there was no change in the bound vs free G H8 signal intensity. In

general the [Pt(N(R)6,6!-Me2dpa)Cl]+ signals usually did not completely disappear and no futher
reaction was noted after 8 d. Because of limited solubility of the nucleotides, ~ 5 % of
unchanged starting material, [Pt(Ltri)Cl]+, was usually present.
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5.2.6 Adduct Formation of [Pt(N(R)dpa)Cl]Cl with 5!-GMP, 3!-GMP and 5!-GTP (R =
Me, prop, and 2-picolyl)
A 10 mM solution of [Pt(N(R)dpa)Cl]Cl in 600 µL of a 64:36 D2O/DMSO-d6 (385
µL/215 µL) mixture] was treated with 2.5 equiv of G to give a 1:2.5 ratio (10 mM:25 mM) of
Pt:5!-GMP, and the solution (pH ~4) was kept at 25 °C. (The D2O/DMSO-d6 mixture was
employed to improve the solubility of the reactants.) An excess of G was used to ensure that the
reaction went to completion. The reaction, which was repeated several times, was monitored by
1

H NMR spectroscopy until there was no change in the bound vs free G H8 signal intensity, or

until the [Pt(N(R)dpa)Cl]+ signals completely disappeared. No further reaction occurred after 2 d.
5.3 RESULTS AND DISCUSSION
5.3.1 Structural Results for [Pt(N(R)6,6!-Me2dpa)Cl]+ Complexes. Overall Aspects
Summarized in Table 5.1 are the crystal data and details of the structural refinement of
[Pt(N(Me)6,6!-Me2dpa)Cl]Pt(DMSO)Cl3 (1), [Pt(N(prop)6,6!-Me2dpa)Cl]Cl (2), and [Pt(6,6!,6!!Me3tpa)Cl] Pt(DMSO)Cl3 (3). Selected bond lengths and angles are reported in Table 5.2. The
ORTEP plots of the cations of these three complexes and the numbering scheme used to describe
the solid-state data are shown in Figure 5.5. All other references (e.g., NMR discussion) to these
ligands and complexes will employ the atom-numbering scheme shown in Figure 5.2.
5.3.2 Coordination Parameters
The [Pt(N(Me)6,6!-Me2dpa)Cl]+ (1), [Pt(N(prop)6,6!-Me2dpa)Cl]+ (2), and [Pt(6,6!,6!!Me3tpa)Cl]+ (3) cations exhibit pseudo square planar geometry, with a tridentate ligand bound to
the Pt with its three N atoms; a Cl atom trans to the N(2) atom completes the coordination around
Pt (Figure 5.2). All three complexes have comparable N(1)–Pt–N(3) bite angles (Table 5.2),
which are similar to the 166° bite angle reported for [Pt(N(H)dpa)Cl]Cl•H2O,49 [Pt(N(H)6Medpa)Cl]PF6•H2O,30 and [Pt(N(H)6,6!-Me2dpa)Cl]Cl.31 The Pt–N(1) and Pt–N(3) bond
!
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distances for all complexes in this study (Table 2) compare well with other Pt–N(sp2) bond
distances ranging from 1.99–2.08 Å.50,51
Table 5.1: Crystal Data and Structure Refinement for [Pt(N(Me)6,6!-Me2dpa)Cl]Pt(DMSO)Cl3
(1), [Pt(N(prop)6,6!-Me2dpa)Cl]Cl (2), and [Pt(6,6!,6!!-Me3tpa)Cl]Pt(DMSO)Cl3 (3).
!
empirical formula C15H19ClN3Pt•C2H6Cl3OPtS C17H21ClN3O2Pt•Cl C21H24ClN4Pt•
C2H6Cl3OPtS
fw

851.44

565.36

942.55

crystal system

monoclinic

monoclinic

triclinic

space group

P21/n

P21/n

Pī

a (Å)

8.6313(4)

8.644(2)

6.8378(3)

b (Å)

17.6564(9)

13.405(3)

13.2929(5)

c (Å)

14.7003(7)

15.603(3)

15.5886(6)

α

90

90

82.065(2)

β (deg)

96.666(3)

90.049(10)

82.090(2)

γ

90

90

87.019(2)

V (Å3)

2222.15(19)

1808.0(7)

1389.21(10)

T (K)

100

95

90

Z

4

4

2

ρcalc (Mg/m3)

2.542

2.077

2.253

abs coeff (mm-1)

13.15

8.07

10.54

2θmax (°)

66.2

80.2

72.6

R [I> 2σ(I)]a

0.032

0.029

0.027

wR2b

0.081

0.062

0.067

data/param

8452/258

11195/229

13465/321

Res. dens (eÅ-3)

3.31, -4.83

4.47, -4.03

2.97, -4.49

a

R = (∑||Fo| - |Fc||)/∑|Fo|. b wR2 = [∑[w(Fo2 - Fc2)2]/∑[w(Fo2)2]]1/2, in which w = 1/[σ2(Fo2) + (dP)2
+ (eP)] and P = (Fo2 + 2Fc2)/3.
!
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For

[Pt(N(Me)6,6!-Me2dpa)Cl]+,

[Pt(N(prop)6,6!-Me2dpa)Cl]+,

and

[Pt(6,6!,6!!-

Me3tpa)Cl]+, the Pt–Cl bond lengths (Table 5.2) are comparable to the Pt–Cl bond length
(2.301(2) Å) of [Pt(N(H)dpa)Cl]Cl•H2O,49 whereas for [Pt(N(H)6,6!-Me2dpa)Cl]Cl steric
interaction between the Cl and the Me groups is reflected in a slightly longer [2.421(3) Å] Pt–Cl
bond. All three complexes have comparable trans N(2)–Pt–Cl bond angles similar to that
reported for [Pt(N(H)dpa)Cl]Cl•H2O [168.7(6)°],49 but larger than that in [Pt(N(H)6,6!Me2dpa)Cl]+ [159.1(3)°].31
Table 5.2: Selected Bond Distances (Å) and Angles (deg) for [Pt(N(Me)6,6!Me2dpa)Cl]Pt(DMSO)Cl3
(1),
[Pt(N(prop)6,6!-Me2dpa)Cl]Cl
(2),
and
[Pt(6,6!,6!!Me3tpa)Cl]Pt(DMSO)Cl3 (3).
!
1
2
3
bond distances
Pt–N(1)

2.047(3)

2.0507(18)

2.0256(11)

Pt–N(2)

2.026(4)

2.0188(17)

2.0341(11)

Pt–N(3)

2.063(3)

2.046(2)

2.0232(11)

Pt–Cl

2.3060(10)

2.3121(7)

2.3111(3)

bond angles
N(1)–Pt–N(3)

164.16(14)

165.04(9)

165.29(5)

N(1)–Pt–Cl

95.56(11)

97.21(5)

97.58(3)

N(2)–Pt–Cl

166.41(10)

169.22(5)

163.53(3)

N(3)–Pt–Cl

100.28(10)

97.65(7)

97.13(3)

N(1)–Pt–N(2)

82.01(14)

82.24 (7)

82.87(4)

N(2)–Pt–N(3)

82.67(14)

82.83(9)

83.15(4)

When an aliphatic substituent is present on N(2), the geometry of N(2) changes, becoming more
tetrahedral. The Pt–N–C6 and Pt–N–C7 bond angles for 1, 2, and 3 are ~105°, compared to the
Pt–N–C6 and Pt–N–C7 bond angles (~110°) of [Pt(N(H)6,6!-Me2dpa)Cl]Cl31 and of ~ 110° of

!

120

[Pt(N(H)dpa)Cl]Cl•H2O.49 This change in geometry of the central nitrogen causes the pyridyl
rings to tilt up above the coordination plane (Figure D.1), reducing the steric strain between the
coordinated Cl and the bulky methyl groups; consequently, the Pt–Cl bond distances and N(2)–
Pt–Cl bond angles are comparable to those found for [Pt(N(H)dpa)Cl]Cl•H2O.49
The trans N(2)–Pt–Cl bond angles for 1 and 3 are smaller than the corresponding bond
angles of [Pt(N(Me)dpa)Cl]Cl•H2O (179.53(9)°)45 and [Pt(tpa)Cl]Cl•2H2O (176.8(2)°)46 (Table
D.1). The Pt–N(2) bond distance for all of the complexes is comparable to most Pt–N(tertiary
sp3) bond distances, ranging from 2.01–2.14 Å.45,46,52,53 The slightly longer Pt–N(2) bond
distances found for 1, 2, and 3 (Table 5.2) vs the 1.973(8) Å distance for [Pt(N(H)6,6!Me2dpa)Cl]Cl,31 suggest the role of steric interactions.

!(2)

(1)

(3)
Figure 5.5: Ortep plots of the cations [Pt(N(Me)6,6!-Me2dpa)Cl]+ (1), [Pt(N(prop)6,6!Me2dpa)Cl]+ (2), and [Pt(6,6!,6!!-Me3tpa)Cl]+ (3). Thermal ellipsoids are drawn with 50%
probability.
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5.3.3 [Pt(N(Me)6,6!-Me2dpa)Cl]Cl, [Pt(N(prop)6,6!-Me2dpa)Cl]Cl, [Pt(6,6!,6!!Me3tpa)Cl]Cl, and [Pt(N(prop)dpa)Cl]Cl NMR Signal Assignments
The 1H NMR signals for [Pt(N(Me)6,6!-Me2dpa)Cl]+ in a 64:36 D2O/DMSO-d6 mixture
are presented in Table 5.3, and the aromatic region is shown in Figure 5.6. The equivalent
[Pt(N(Me)6,6!-Me2dpa)Cl]+ methylene groups have equivalent carbon atoms (C7 and C7!), but
each carbon bears inequivalent methylene protons (designated as endo-H7/7! and exo-H7/7!,
Figure 3). Because the exo-H7/7! protons are closer to the N-Me group than are the endo-H7/7!
protons, a ROESY experiment was used to assign these signals. A strong NOE cross-peak from
the N-Me signal (2.70 ppm) to the signal at 4.40 ppm assigns the exo-H7/7! signals. A weak NMe-endo-H7/7! NOE cross-peak (2.70-5.23 ppm) assigns the endo-H7/7! signal.
Table 5.3: Selected 1H NMR Shifts (ppm) for the [Pt(N(Me)6,6!-Me2dpa)Cl]Cl, [Pt(N(prop)6,6!Me2dpa)Cl]Cl, and [Pt(6,6!,6!!-Me3tpa)Cl]Cl adducts in D2O/DMSO-d6 (64:36, pH ~4, 25 °C).

H4/4!

[Pt(N(Me)6,6!-Me2dpa)Cl]
Cla
7.84

[Pt(N(prop)6,6!-Me2dpa)Cl]
Clb
7.86

[Pt(6,6!,6!!-Me3tpa)Cl]
Clc
7.77

H3/3!

7.32

7.31

7.26

H5/5!

7.32

7.33

7.16

endo-H7/7!

5.23

5.34

5.34

exo-H7/7!

4.40

4.59

4.49

6/6!-CH3

2.81

2.78

2.64

a

N-Me signal: 2.70 ppm. b propionic signals (ppm): 3.01 N-CH2, and 2.04 OC-CH2. c Dangling
signals (ppm): 7.52 H4!!, 7.64 H3!!, 6.91 H5!!, 3.96 H7!!, and 2.15 6!!-CH3.
In the 1H NMR spectrum of [Pt(N(Me)6,6!-Me2dpa)Cl]+ in D2O/DMSO-d6 (64:36
mixture), the triplet at 7.84 ppm (Figure 5.6) is assigned to H4/4!, the only type of aromatic
proton that can give a triplet. The H3/3! and H5/5! signals are overlapped into a single doublet at
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7.32 ppm. In a ROESY spectrum (not shown), an NOE cross-peak from the H3/3! signal to the
singlet at 2.70 ppm confirms the N-Me signal. The NOE cross-peak from the H5/5! signal to the
signal at 2.81 ppm assigns the 6/6!-Me signal (Table 5.3).

Figure 5.6: Aromatic region of the 1H NMR spectra of [Pt(N(Me)6,6!-Me2dpa)Cl]+ (a) and of the
reaction mixture 3 d after adding 3.5 equiv of G to form the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) (b),
Pt(N(Me)6,6!-Me2dpa)(3!-GMP) (c), and Pt(N(Me)6,6!-Me2dpa)(5!-GTP) (d) adducts (25 °C,
D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm). Peaks labeled with an * are from the bis adduct.
Assignments of the 13C NMR signals for [Pt(N(Me)6,6!-Me2dpa)Cl]+ were made through
an HSQC experiment (Table 5.4 and Figure D.2, Appendix D). Cross-peaks (ppm) involving
H3/3! (7.32-122.0), H4/4! (7.84-142.2), H5/5! (7.32-128.8), 6/6!-Me (2.81-2.74), and N-Me
(2.70-49.9) signals assign the C3/3!, C4/4!, C5/5!, C(6/6!-Me), N-C(Me)

13

C NMR signals,

respectively. Cross-peaks from the endo-H7/7! and exo-H7/7! signals assign the 13C NMR signal
at 72.8 ppm to C7/7! (Table 5.4).
The two very downfield signals in the

13

C NMR spectrum of [Pt(N(Me)6,6!-

Me2dpa)Cl]Cl (Figure D.2) do not have HSQC cross-peaks; these features are expected for C2/2!
and C6/6!. The shifts for these carbons attached to the pyridyl nitrogen are expected to be
downfield, and they are not directly attached to a proton, accounting for the absence of an HSQC
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cross-peak. The C2/2! and C6/6! signals were assigned with HMBC cross-peaks to H7/7! and
6/6!-Me signals (Figure D.3, Table 5.4). The 1H and

13

C NMR signals for [Pt(N(prop)6,6!-

Me2dpa)Cl]Cl, and [Pt(6,6!,6!!-Me3tpa)Cl]Cl were assigned in a similar manner as above and are
listed in Tables 5.3, 5.4, and D.2 and D.3 and shown in Figure D.4, D.5, and D.6.
Table 5.4: Selected 13C NMR Shifts (ppm) for the [Pt(N(Me)6,6!-Me2dpa)Cl]Cl, [Pt(N(prop)6,6!Me2dpa)Cl]Cl, and [Pt(6,6!,6!!-Me3tpa)Cl]Cl adducts in D2O/DMSO-d6 (64:36, pH ~4, 25 °C).

C4/4!

[Pt(N(Me)6,6!-Me2dpa)Cl]
Cla
142.2

[Pt(N(prop)6,6!-Me2dpa)Cl]
Clb
142.4

[Pt(6,6!,6!!-Me3tpa)Cl]
Clc
141.8

C3/3!

122.0

121.4

121.4

C5/5!

128.8

128.7

128.3

C7/7!

72.8

72.9

73.3

6/6!-CH3

27.4

27.1

27.0

C2/2!

165.3

165.3

165.3

C6/6!

164.8

165.1

164.4

a

N-Me signal: 49.9 ppm. b Propionic signals (ppm): 60.0 N-CH2, 34.0 OC-CH2, 174.7 CO. c
Dangling signals (ppm): 139.3 C4!!, 126.3 C3!!, 125.9 C5!!, 67.8 C7!!, 24.2 6!!-CH3, 152.0 C2!!,
and 159.7 C6!!.
5.3.4 Pt(N(Me)6,6!-Me2dpa)(5!-GMP) and Pt(N(Me)6,6!-Me2dpa)(3!-GMP) Adducts
The reaction of [Pt(N(Me)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!-GMP or 3!-GMP
in D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 2.5 h, and 3 d.
The 1H NMR spectrum taken after 10 min exhibited two new sharp, downfield, undoubtedly
mono G H8 singlets and a group of H8 signals attributable to the bis adduct (Figure 5.6). H8 is
the only type of aromatic proton in the reaction mixture that can give a singlet, and the downfield
shift changes relative to the free 5!-GMP H8 singlet (7.98) and free 3!-GMP H8 singlet (7.87) are
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consistent with coordination of 5!-GMP or 3!-GMP to Pt(II) via N7. No change in the free vs
bound H8 signal intensity was seen after 3 d (Figure 5.6).
Table 5.5: Selected 1H NMR Shifts (ppm) for the Pt(N(Me)6,6!-Me2dpa)G, Pt(N(prop)6,6!Me2dpa)G, and Pt(6,6!,6!!-Me3tpa)G adducts (G = 5!-GMP, 3!-GMP, and 5!-GTP) in
D2O/DMSO-d6 (64:36, pH ~4, 25 °C).

Pt(N(Me)6,6!-Me2dpa)(5!-GMP)

H8
free
7.99

anti
H8
9.09

syn
H8
9.06

free
H1!
5.73

anti
H1!
5.87

syn
H1!
5.85

Pt(N(Me)6,6!-Me2dpa)(3!-GMP)

7.87

9.00

8.86

5.72

5.87

5.81

Pt(N(Me)6,6!-Me2dpa)(5!-GTP)

8.07

9.10

9.12

5.72

5.86

5.83

Pt(N(prop)6,6!-Me2dpa)(5!-GMP)a

7.97

9.03

9.03

5.71

5.89

5.83

Pt(N(prop)6,6!-Me2dpa)(3!-GMP)

7.89

8.98

8.82

5.72

5.87

5.80

Pt(N(prop)6,6!-Me2dpa)(5!-GTP)

8.06

9.00

9.11

5.72

5.86

5.83

Pt(6,6!,6!!-Me3tpa)(5!-GMP)

7.98

9.03

8.98

5.71

5.82

5.79

Pt(6,6!,6!!-Me3tpa)(3!-GMP)

7.89

9.00

8.78

5.71

5.84

5.76

Pt(6,6!,6!!-Me3tpa)(5!-GTP)

8.06

9.09

9.05

5.73

5.81

5.79

a

H8 signals at pH 7.3: 9.13 (anti) and 8.98 (syn) ppm.
Using reasoning discussed above and in previous work,29-31 we assign the two downfield

H8 singlets (Figure 6) to the syn (9.06 ppm) and anti (9.09 ppm) rotamers of the Pt(N(Me)6,6!Me2dpa)(5!-GMP) adduct (Table 5.5). The syn H8:anti H8 intensity ratio is 1:2.02, similar to the
syn:anti H8 ratio of 1:2.04 of Pt(N(H)6,6!-Me2dpa)(5!-GMP). The Δδ between the two H8
signals (0.03 ppm) is much smaller than the Δδ ~ 0.22 ppm found for Pt(N(H)6,6!-Me2dpa)(5!-
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GMP) (Table 5.6). The N(Me)6,6!-Me2dpa carrier-ligand signals of Pt(N(Me)6,6!-Me2dpa)(5!GMP) are reported in Table 5.7 and Figures 5.6 and D.7.
Table 5.6: Syn H8:Anti H8 Intensity Ratios for Pt(N(Me)6,6!-Me2dpa)G, Pt(N(prop)6,6!Me2dpa)G, and Pt(6,6!,6!!-Me3tpa)G Adducts (G = 5!-GMP, 3!-GMP, and 5!-GTP) in
D2O/DMSO-d6 (64:36, 25 °C).
Pt(N(Me)6,6!-Me2dpa)(5!-GMP)
Pt(N(Me)6,6!-Me2dpa)(3!-GMP)
Pt(N(Me)6,6!-Me2dpa)(5!-GTP)
Pt(N(prop)6,6!-Me2dpa)(5!-GMP)e
Pt(N(prop)6,6!-Me2dpa)(3!-GMP)e
Pt(N(prop)6,6!-Me2dpa)(5!-GTP)e
Pt(6,6!,6!!-Me3tpa)(5!-GMP)f
Pt(6,6!,6!!-Me3tpa)(3!-GMP)f
Pt(6,6!,6!!-Me3tpa)(5!-GTP)f

pH
4.0
4.0
2.7a
4.0
7.3b
4.1
7.3c
4.1
7.3d
2.7e
4.1
7.3f
4.0
4.0
2.7g
4.0
7.3h

syn H8:anti H8 ratio
1:2.02
1:2.28
1:2.03
1:2.13
1:2.08
1:8.53
1:5.77
1:7.97
1:6.01
1:6.64
1:6.32
1:3.97
1:1.42
1:2.43
1:1.49
1:1.53
1:1.57

Δδ
0.03
0.14
0
0.02
0.01
0
0.15
0.16
0.28
0.10
0.11
0.07
0.05
0.22
0.07
0.04
0.03

a

H8: 9.07 (syn and anti signal overlapped). b H8: 9.11 (anti), and 9.12 (syn) ppm. c H8: 9.13
(anti), and 8.98 (syn) ppm. d H8: 9.07 (anti), and 8.79 (syn) ppm. e H8: 8.98 (syn), and 9.08 (anti)
ppm. f H8: 9.12 (anti), and 9.05 (syn) ppm. g H8: 9.10 (anti), and 9.03 ppm (syn). h H8: 9.08
(anti), and 9.05 ppm (syn).
For the Pt(N(H)6-Medpa)G30 and Pt(N(H)6,6!-Me2dpa)G31 adducts, the syn 6/6!-Me
signals were more upfield than the anti 6/6!-Me signals because these 6/6!-Me groups are on the
same side of the coordination plane as the more shielding guanine six-membered ring. From this
information, we assign the upfield signals (1.96 and 1.93 ppm) and the downfield signals (2.24
and 2.21 ppm) of the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) adduct to the 6/6!-Me signals of the syn
and anti rotamers, respectively (Figure D.7). A ROESY experiment was performed to confirm
the syn and anti H8 assignments, NOE cross-peaks from the syn and anti 6/6!-Me signals to the
!
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Pt(6,6!,6!!-Me3tpa)(3!-GMP)k

Pt(6,6!,6!!-Me3tpa)(5!-GMP)j

Pt(N(prop)6,6!-Me2dpa)(5!-GTP)i

Pt(N(prop)6,6!-Me2dpa)(3!-GMP)h

Pt(N(prop)6,6!-Me2dpa)(5!-GMP)g

Pt(N(Me)6,6!-Me2dpa)(5!-GTP)f

Pt(N(Me)6,6!-Me2dpa)(3!-GMP)e

Pt(N(Me)6,6!-Me2dpa)(5!-GMP)a

7.01c, 6.93c

7.05c, 7.00d

7.03c, 6.98d

7.20c, 7.14d

7.21c, 7.18d

7.18c, 7.15d

7.17c, 7.11d

7.19c, 7.16d

H5/5!
7.16b

7.74b

7.79b

7.75b

7.85c, 7.81d

7.88c, 7.86d

7.88c, 7.83d

7.82b

7.85b

H4/4!
7.83b

7.31c, 7.27d

7.31c, 7.29d

7.30c, 7.26d

7.36c, 7.33d

7.38c, 7.37d

7.38c, 7.33d

7.35b

7.38b

H3/3!
7.36b

2.17c, 2.11c, 1.89d, 1.84d

2.16c, 2.13c, 1.84d, 1.83d

2.17c, 2.11c, 1.94d, 1.89d

2.25, 2.20, 1.98, 1.95

2.25c, 2.22c, 1.93d, 1.92d

2.20c, 2.16c, 2.03d, 1.99d

2.23c, 2.19c, 1.92d, 1.90d

2.21c, 2.18c, 1.88d, 1.87d

6/6!-Me
2.24c, 2.21c, 1.96d, 1.93d

Table 5.7: 1H NMR Shifts (ppm) for Pt(N(Me)6,6!-Me2dpa)(5!-GMP), Pt(N(prop)6,6!-Me2dpa)(5!-GMP) and Pt(6,6!,6!!-Me3tpa)(5!GMP) adducts in D2O/DMSO-d6 (64:36, pH ~4, 25 °C).

Pt(6,6!,6!!-Me3tpa)(5!-GTP)l
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a
N-Me signal: 2.75 (syn and anti signals overlapped) ppm. b Syn and anti signals are overlapped. c Signals from the anti rotamer. d Signals from the
syn rotamer. e N-Me signal: 2.68 (syn and anti signals overlapped) ppm. f N-Me signal: 2.71 (syn and anti signals overlapped) ppm. g Propionic
signals (ppm): 3.06 (anti) and 2.99 (syn) N-CH2, 2.14 (anti) and 2.12 (syn) OC-CH2. h Propionic signals (ppm): 3.07 (anti and syn signal
overlapped) N-CH2, 2.23 (syn and anti overlapped) OC-CH2. i Propionic signals (ppm): 3.08 (anti) and 3.05 (syn) N-CH2, 2.15 (anti) and 2.12 (syn)
OC-CH2. j Dangling signals (ppm): 8.08 (syn and anti signals overlapped) H3!!, 7.68 (anti) and 7.62 (syn) H4!!, 6.87 (syn and anti signals
overlapped) H5!!, 2.15 (syn and anti signals overlapped) 6!!-Me. k Dangling signals (ppm): 8.24 (syn and anti signals overlapped) H3!!, 7.57 (anti)
and 7.64 (syn) H4!!, 6.90 (syn) and 6.87 (anti) H5!!, 2.14 (syn and anti signals overlapped) 6!!-Me. l Dangling signals (ppm): 8.07 (syn) and 8.12
(anti) H3!!, 7.77 (anti) and 7.62 (syn) H4!!, 6.88 (anti) and 6.86 (syn) H5!!, 2.17 (syn and anti signals overlapped) 6!!-Me.

!

H8 signals at 9.06 (syn) and 9.09 (anti) ppm, confirm the assignments of the syn and anti H8
signals of the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) adduct. Correlating the abundance of the H8
signals with that of the H1! signals, we establish that the anti H1! signal is downfield from that of
the syn H1! signal.
For the Pt(N(Me)6,6!-Me2dpa)(3!-GMP) adduct, we assign the H8 singlets to the syn
(8.85 ppm) and anti (9.01 ppm) rotamers (Table 5.5) in a similar manner as above. The syn
H8:anti H8 intensity ratio is 1:2.28 (Figure 5.6), similar to the syn:anti ratio of 1:2.03 for
Pt(N(H)6,6!-Me2dpa)(3!-GMP).31 The Δδ between the two H8 signals (0.16 ppm) is smaller than
the Δδ ~ 0.27 ppm found for Pt(N(H)6,6!-Me2dpa)(3!-GMP) (Table 5.6). The N(Me)6,6!-Me2dpa
carrier-ligand signals in the Pt(N(Me)6,6!-Me2dpa)(3!-GMP) adduct have shifts similar to those
of the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) adduct (Table 5.7 and Figures 5.6 and D.7).
5.3.5 Pt(N(Me)6,6!-Me2dpa)(5!-GTP)
The reaction of [Pt(N(Me)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!-GTP in
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 2.5 h, and 3 d. No
change in the free vs bound H8 signal intensity was seen after 3 d (Figure 5.6). We assign the H8
singlets to the syn (9.12 ppm) and anti (9.10 ppm) rotamers; the syn H8:anti H8 intensity ratio is
1:2.13 (Figure 5.6 and Tables 5.5 and 5.6). The Δδ between the two H8 signals (0.02 ppm) is
smaller than the Δδ ~ 0.17 ppm found for Pt(N(H)6,6!-Me2dpa)(5!-GTP). The N(Me)6,6!-Me2dpa
carrier ligand signals in the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) adduct have shifts similar to those of
the adducts above (Table 5.7 and Figures 5.6 and D.7).
For Pt(N(Me)6,6!-Me2dpa)(5!-GTP), the syn H8 signal is more downfield from than the
anti H8 signal but the syn H1! signal is more upfield than the anti H1! signal. The anti H8 signal
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(9.10 ppm) of Pt(N(Me)6,6!-Me2dpa)(5!-GTP) is similar to the anti H8 signal (9.09 ppm) of
Pt(N(Me)6,6!-Me2dpa)(5!-GMP); therefore, the syn H8 signal is shifted downfield. A ROESY
experiment (not shown) confirms these syn and anti H8 assignments.
5.3.6 Pt(N(prop)6,6!-Me2dpa)(5!-GMP)
The reaction of [Pt(N(prop)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!-GMP in
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 8 d. The 1H
NMR spectrum taken after 10 min exhibited overlapped, downfield, undoubtedly G H8 singlets
and no bis adduct signals were detectable. No change in the free vs bound H8 signal intensity
was seen after 8 d (Figure 5.7 and D.8). We assign the singlet at 9.03 ppm to the overlapped syn
and anti rotamers (Figure 5.7 and Table 5.5).

anti
H8

H4/4!
H3/3! H5/5!
syn
H8

**

*

* *

*
free H4/4!
G H8

syn/anti
H8

H3/3!

H4/4!

9.0

8.5

8.0

H5/5!

7.5

H5/5!

H3/3!

7.0

Figure 5.7: Aromatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom) and
of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!-Me2dpa)(5!GMP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm).
Peaks labeled with an * are from the bis adduct.
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The resolved syn and anti H1! signals were used to determine the syn:anti rotamer ratio
because the two H8 signals were not resolved. The syn H1!:anti H1! ratio was 1:8.53, highly
favoring the anti rotamer, as discussed later (Table 5.6). The N(prop)6,6!-Me2dpa carrier-ligand
signals in the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) adduct have shifts similar to those observed for
other adducts (Table 5.7 and Figures 5.7 and D.8).
In order to resolve the two H8 signals, the pH of the Pt(N(prop)6,6!-Me2dpa)(5!-GMP)
solution was raised to ~7.3 to deprotonate the carboxylic acid group. The 1H NMR spectrum of
the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) solution at pH 7.3 exhibited two sharp H8 signals at 9.13
(anti) and 8.98 (syn) ppm and the syn H8:anti H8 ratio increased to 1:5.77 (Figure 5.7 and
Tables 5.5 and 5.6). A ROESY experiment (not shown) confirms these syn and anti H8
assignments.
5.3.7 Pt(N(prop)6,6!-Me2dpa)(3!-GMP)
The reaction of [Pt(N(prop)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 3!-GMP in
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 7 d. No
change in the free vs bound H8 signal intensity was seen after 7 d (Figures 5.8 and D.9). The two
closely spaced H8 singlets are assigned to the syn (8.82 ppm) and anti (8.98 ppm) rotamers
(Table 5.5). The syn H8:anti H8 intensity ratio is 1:7.96, highly favoring the anti rotamer, as seen
for the 5!-GMP adduct (Figure 5.8 and Table 5.6). The Δδ between the two H8 signals (0.16
ppm) is larger than the Δδ found for Pt(N(prop)6,6!-Me2dpa)(5!-GMP) (Table 5.6). The
N(prop)6,6!-Me2dpa carrier-ligand signals in the Pt(N(prop)6,6!-Me2dpa)(3!-GMP) adduct have
shifts similar to that observed for the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) adduct (Table 5.7 and
Figures 5.8 and D.9).
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H4/4!
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H8
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H8

H3/3!
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H8

H5/5!
*
* * *
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*

H4/4!
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H8

*

* *

*
H4/4!

8.6

H3/3!
H5/5!

*

*

9.0

* * *

* *

8.2

H3/3!

H5/5!

7.8

7.4

7.0

Figure 5.8: Aromatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom) and
of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!-Me2dpa)(3!GMP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm).
Peaks labeled with an * are from the bis adduct.
5.3.8 Pt(N(prop)6,6!-Me2dpa)(5!-GTP)
The reaction of [Pt(N(prop)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!-GTP in
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 7 d. No
change in the free vs bound H8 signal intensity was seen after 7 d (Figures 5.9 and D.10). We
assign the H8 singlets to the syn (9.11 ppm) and anti (9.00 ppm) rotamers; the syn H8:anti H8
intensity ratio is 1:6.32 (Figure 5.9 and Tables 5.5 and 5.6).
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H8
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H8

* * *
* * *

*
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H3/3!

H4/4!

H5/5!
* ** *

H3/3!

H5/5!

syn
H8
H4/4!
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8.5

8.0

H5/5!

7.5
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Figure 5.9: Aromatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom) and
of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!-Me2dpa)(5!GTP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm).
Peaks labeled with an * are from the bis adduct.
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The Δδ between the two H8 signals (0.11 ppm) is comparable to the Δδ ~ 0.17 ppm
found for Pt(N(H)6,6!-Me2dpa)(5!-GTP). The N(prop)6,6!-Me2dpa carrier-ligand signals in the
Pt(N(prop)6,6!-Me2dpa)(5!-GTP) adduct have shifts similar to those observed for the
Pt(N(prop)6,6!-Me2dpa)(5!-GMP) and Pt(N(prop)6,6!-Me2dpa)(3!-GMP) adducts (Table 5.7 and
Figures 5.9 and D.10), and as for the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) adduct, the syn H8 signal is
downfield from the anti H8 signal, and the syn H1! signal is upfield from the anti H1! signal.
However, in spectra taken of the solution of the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) adduct at pH
~7.3, the anti H8 signal is shifted downfield of the syn H8 signal, most likely because of the
overhanging deshielding phosphate chain of 5!-GTP (Figure 5.9 and Table 5.6).
5.3.9 Pt(6,6!,6!!-Me3tpa)(5!-GMP), Pt(6,6!,6!!-Me3tpa)(3!-GMP), and Pt(6,6!,6!!-Me3tpa)(5!GTP) Adducts
The reaction of [Pt(6,6!,6!!-Me3tpa)Cl]Cl with 3.5 molar equiv of 5!-GMP, 3!-GMP, or 5!GTP in D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 7 d.
No change in the free vs bound H8 signal intensity was seen after 7 d (Figures 5.10 and D.11).

Figure 5.10: Aromatic region of the 1H NMR spectra of [Pt(6,6!,6!!-Me3tpa)Cl]+ (a) and of the
reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(6,6!,6!!-Me3tpa)(5!-GMP) (b),
Pt(6,6!,6!!-Me3tpa)(3!-GMP) (c), and Pt(6,6!,6!!-Me3tpa)(5!-GTP) (d) adducts (25 °C,
D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm).
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For the Pt(6,6!,6!!-Me3tpa)(5!-GMP) adduct, we assign the H8 singlets to the syn (8.98
ppm) and anti (9.03 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1:1.42 (Figure 5.10 and
Tables 5.5 and 5.6). The Δδ between the two H8 signals is ~ 0.05 ppm. The 6,6!,6!!-Me3tpa
carrier-ligand signals in the Pt(6,6!,6!!-Me3tpa)(5!-GMP) adduct have shifts similar to those
observed for the Pt(N(R)6,6!-Me2dpa)G adducts above (Table 5.7 and Figures 5.10 and D.11).
For the Pt(6,6!,6!!-Me3tpa)(3!-GMP) adduct, we assign the H8 singlets to the syn (8.78
ppm) and anti (9.00 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1:2.43 (Figure 5.10 and
Tables 5.5 and 5.6). The Δδ between the two H8 signals (0.23 ppm) is larger than the Δδ ~ 0.05
ppm found for Pt(6,6!,6!!-Me3tpa)(5!-GMP). The 6,6!,6!!-Me3tpa carrier ligand signals in the
Pt(6,6!,6!!-Me3tpa)(3!-GMP) adduct have shifts similar to those observed for the other adducts
(Table 5.7 and Figures 5.10 and D.11).
For the Pt(6,6!,6!!-Me3tpa)(5!-GTP) adduct, we assign the H8 singlets to the syn (9.05
ppm) and anti (9.09 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1:1.53 (Figure 5.10 and
Tables 5.5 and 5.6). The Δδ between the two H8 signals (0.05 ppm) is comparable to the Δδ ~
0.05 ppm found for Pt(6,6!,6!!-Me3tpa)(5!-GMP). The 6,6!,6!!-Me3tpa carrier ligand signals in the
Pt(6,6!,6!!-Me3tpa)(5!-GTP) adduct have shifts similar to those observed for the other adducts
(Table 5.7 and Figure 5.10 and D.11).
5.3.10 Pt(N(Me)dpa)(5!-GMP) and Pt(N(Me)dpa)(3!-GMP) Adducts
The reaction of [Pt(N(Me)dpa)Cl]Cl with 2.5 molar equiv of 5!-GMP or 3!-GMP in
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 2 d. The
reaction reached completion after ~2 d, as evidenced by the complete disappearance of the
[Pt(N(Me)dpa)Cl]Cl signals by 2 d (Figures D.12 and D.13).
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For Pt(N(Me)dpa)(5!-GMP), we assign the H8 singlets to the syn (8.69 ppm) and anti
(9.03 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.55:1 (Figure D.12 and Table D.4).
The Δδ between the two H8 signals (0.34 ppm) is larger than the Δδ ~ 0.03 ppm found for
Pt(N(Me)6,6!-Me2dpa)(5!-GMP) but comparable to the Δδ ~ 0.36 ppm found for Pt(N(H)dpa)(5!GMP) (Table D.4).29 The N(Me)dpa carrier ligand signals in the Pt(N(Me)dpa)(5!-GMP) adduct
have shifts similar to those observed for the Pt(N(H)dpa)(5!-GMP) adduct (Table D.5 and Figure
D.12).
The Pt(N(Me)dpa)(3!-GMP) adduct has properties (Tables D.4, D.5 and Figure D.13) that
are very similar to those of the Pt(N(Me)dpa)(5!-GMP) adduct. We assign the H8 singlets to the
syn (8.60 ppm) and anti (8.97 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.65:1 (Figure
D.13 and Table D.4). The Δδ between the two H8 signals (0.37 ppm) is comparable to the Δδ ~
0.34 ppm found for Pt(N(Me)dpa)(5!-GMP).
5.3.11 Pt(tpa)(5!-GMP) and Pt(tpa)(3!-GMP) Adducts
The reaction of [Pt(tpa)Cl]Cl with 2.5 molar equiv of 5!-GMP in D2O/DMSO-d6 (64:36)
was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 2 d. The reaction reached
completion after ~2 d, as evidenced by the complete disappearance of the [Pt(tpa)Cl]Cl signals
by 2 d (Figure D.14 and D.15).
For Pt(tpa)(5!-GMP), we assign the H8 singlets to the syn (8.64 ppm) and anti (9.11 ppm)
rotamers; the syn H8:anti H8 intensity ratio is 1.28:1 (Figure D.14 and Table D.4). The Δδ
between the two H8 signals (0.47 ppm) is larger than the Δδ ~ 0.05 ppm found for Pt(6,6!,6!!Me3tpa)(5!-GMP). The tpa carrier ligand signals in the Pt(tpa)(5!-GMP) adduct are reported in
Table D.5 and shown in Figure D.14.
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The Pt(tpa)(3!-GMP) adduct has properties (Tables D.4 and D.5, and Figure D.15) that
are very similar to those of the Pt(tpa)(5!-GMP) adduct. We assign the H8 singlets to the syn
(8.60 ppm) and anti (8.97 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.32:1 (Figure
D.15 and Table D.4). The Δδ between the two H8 signals (0.37 ppm) is comparable to the Δδ ~
0.47 ppm found for Pt(tpa)(5!-GMP).
5.3.12 Pt(N(prop)dpa)(5!-GMP), Pt(N(prop)dpa)(3!-GMP), and Pt(N(prop)dpa)(5!-GTP)
Adducts
The reaction of [Pt(N(prop)dpa)Cl with 2.5 molar equiv of 5!-GMP, 3!-GMP, or 5!-GTP
in D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 2 d. The
reaction reached completion after ~2 d, as evidenced by the complete disappearance of the
[Pt(N(prop)Cl]Cl signals by 2 d (Figures D.16, D.17, D.18).
For Pt(N(prop)dpa)(5!-GMP), we assign the H8 singlets to the syn (8.66 ppm) and anti
(8.89 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1:1.32 favoring the anti rotamer
(Figure D.16 and Table D.4). The Δδ between the two H8 signals (0.33 ppm) is much larger than
that found for Pt(N(prop)6,6!-Me2dpa)(5!-GMP). The N(prop)dpa carrier-ligand signals in the
Pt(N(prop)dpa)(5!-GMP) adduct are reported in Table D.5 and shown in Figure D.16.
The Pt(N(prop)dpa)(3!-GMP) and Pt(N(prop)dpa)(5!-GTP) adducts have properties
(Tables D.4 and D.5, and Figures D.17 and D.18) that are very similar to those of the
Pt(N(prop)dpa)(5!-GMP) adduct. For Pt(N(prop)dpa)(3!-GMP), we assign the H8 singlets to the
syn (8.58 ppm) and anti (8.92 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.48:1 (Figure
D.17 and Table D.4). For Pt(N(prop)dpa)(5!-GTP), we assign the H8 singlets to the syn (8.74
ppm) and anti (8.97 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.23:1 (Figure D.18 and
Table D.4).
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5.3.13 Pt(N(H)6-Medpa)(5!-GTP), Pt(N(H)6,6!-Me2dpa)(5!-GTP), Pt(N(Me)dpa)(5!-GTP),
and Pt(N(R)6,6!-Me2dpa)(5!-GTP) Adducts
In past work, rotamer distribution was found to be influenced by H-bonding interactions
between phosphate and N–H groups. In addition, either the N-H group was cis to G in an amine
ligand of Pt(Ltri)G and Pt(Lbi)(G)2 adducts, or else the G N1-H group was on an adjacent cis G
residue in Pt(Lbi)(G)2 adducts.24,33,36,37,54-56!For the Pt(N(H)dpa)(5!-GTP) adduct, the presence of a
trans N–H group was found to influence the rotamer abundance. The long triphosphate chain of
the 5!-GTP in this adduct could extend far enough for the γ-phosphate group to form a weak
hydrogen bond with the trans N–H of the carrier ligand when the 5!-GTP nucleotide has the anti
conformation.29 The Pt(N(H)6-Medpa)(5!-GTP) and Pt(N(H)6,6!-Me2dpa)(5!-GTP) adducts were
studied in order to assess the role of the trans N–H group in influencing rotamer abundance. The
Pt(N(Me)dpa)(5!-GTP) adduct was used as a control because the trans N–H group is replaced by
a methyl group; therefore, no change in rotamer abundance should be observed.
The reactions of [Pt(N(H)6-Medpa)Cl]+ and [Pt(N(Me)dpa)Cl]+ with 2.5 molar equiv of
5!-GTP were essentially complete at 1.5 h and 2 d. The formation reaction of the Pt(N(H)6,6!Me2dpa)(5!-GTP) adduct was carried out with a 1:1 ratio of [Pt(N(H)6,6!-Me2dpa)Cl]:5!-GTP
because the Pt(N(H)6,6!-Me2dpa)(5!-GTP)2 adduct forms when more G is present in the mixture.
Formation of the Pt(N(H)6,6!-Me2dpa)(5!-GTP) adduct was complete at 10 min. For all three 5!GTP adducts, sharp product H8 singlets were observed for the anti rotamer (the downfield H8
and H1! signals) and the syn rotamer (the upfield H8 and H1! signals) (Figures 5.11 and D.19,
and Tables D.4 and D.6). For the solution of the Pt(N(H)6-Medpa)(5!-GTP) adduct at pH 4.3, the
syn:anti H8 ratio was 1.96:1 (Table D.6) with a δΔ of ~ 0.41 ppm. The slightly larger δΔ for the
5!-GTP rotamers than for the 5!-GMP rotamers (δΔ = ~ 0.36) is explained by the deshielding of
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the H8 by the overhanging phosphate groups of 5!-GTP.29 Similar results were seen for the
Pt(N(H)dpa(5-GTP) adduct with a δΔ of ~ 0.41.29 For the Pt(N(H)6,6!-Me2dpa)(5!-GTP) solution
at pH 4.1, the syn:anti H8 ratio was 1:2.01 (Table D.6) with δΔ of ~ 0.17 ppm, similar results
seen for the Pt(N(H)6,6!-Me2dpa)(5!-GMP) adduct. The smaller δΔ may arise from the reduced
canting of the syn rotamer, which shifts the syn H8 downfield. For the Pt(N(Me)dpa)(5!-GTP)
solution the syn:anti H8 ratio was 1.55:1 (Table D.4) with a δΔ of ~ 0.33 ppm.
To obtain further evidence that for Pt(N(H)6-Medpa)(5!-GTP) and Pt(N(H)6,6!Me2dpa)(5!-GTP) the anti rotamer could form a hydrogen bond from the γ-phosphate group to
the central N-H, the pH of the solution was raised from 4.3 to 7.3 to deprotonate more fully the
γ-phosphate group, favoring hydrogen bonding and thereby increasing the abundance of the anti
rotamer.

!
!
Figure 5.11: H8 and H1! regions of the 1H NMR spectra of the Pt(N(H)6-Medpa)(5!-GTP) and
Pt(N(H)6,6!-Me2dpa)(5!-GTP) adduct (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm) at pH 2.7
(bottom), 4.3 (middle) and 7.3 (top). The small peaks in the spectra are from 5!-GDP that forms
over time.
!

137

For Pt(N(H)6-Medpa)(5!-GTP), the syn:anti H8 ratio (1.96:1) was essentially the same at
both pH values. On the other hand, when the pH was lowered to 2.7, the ratio increased to
2.66:1, and the some signals shifted noticeably (Table D.7 and Figure 5.11). When the pH was
raised from 4.3 to 7.3 for Pt(N(H)6,6!-Me2dpa)(5!-GTP), the syn:anti H8 ratio (1:1.98) was
essentially unchanged. Upon lowering the pH to 2.8, the ratio decreased to 1:1.38, and some
signals shifted noticeably (Table D.7 and Figure 5.11). The Pt(N(Me)dpa)(5!-GTP) adduct was
used as a “control” because there is no trans N–H, and thus no H-bonding should occur. When
the pH was varied from 2.7 to 4.3 and to 7.4, the syn:anti H8 ratio remained unchanged (Table
D.7). In order to confirm that the syn rotamer is more favored at low pH owing to the lack of Hbonding from a protonated γ-phosphate group, the solution of Pt(N(H)6-Medpa)(5!-GMP) was
lowered to pH 2.7 because no H-bonding should occur and the syn H8:anti H8 ratio should
remain the same. Upon lowering the pH from 4.3 to 2.7 for Pt(N(H)6-Medpa)(5!-GMP), the syn
H8:anti H8 remained the same, confirming the formation of a weak hydrogen bond from the γphosphate group to the central N–H (Table D.7). For the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) and
Pt(6,6!,6!!-Me3tpa)(5!-GTP) adducts, the syn:anti H8 ratio remained unchanged upon varying the
pH, as expected because no trans N–H is present (Table 5.6).
5.3.14 Factors Influencing the syn:anti Ratio of the
Pt(N(prop)6,6!-Me2dpa)G, and Pt(6,6!,6!!-Me3tpa)G Adducts

Pt(N(Me)6,6!-Me2dpa)G,

In this section, we assess how changes in the features of the carrier ligand could explain
the trend of the syn:anti ratio of rotamers for the following Pt(Ltri)G mono adducts: Pt(6,6!,6!!Me3tpa)G > Pt(N(Me)6,6!-Me2dpa)G >>> Pt(N(prop)6,6!-Me2dpa)G.
In previous work, we pointed out that the anti rotamer of the Pt(N(H)dpa)G and
Pt(N(H)6-Medpa)G adducts has the nucleobase H8 proton on the same side of the coordination
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plane as the H6/6! protons (Figure 5.3). The resulting proximity of H8 to the H6/6! and H6!
protons leads to unfavorable electrostatic repulsion between the partial positive charges of these
protons and to a lower abundance of the anti rotamer (Figure 5.12). In contrast, the H8 of the syn
rotamer is on the side of the coordination plane opposite to the H6/6! and H6! protons. Thus, the
greater separation between these protons in the syn rotamer decreases H8-H6/6! and H8-H6!
electronic repulsions. Also, the partially negative O6 of guanine is on the same side of the
coordination plane as the partially positive H6/6! and H6! protons of the carrier ligand, a
juxtaposition possibly leading to favorable electrostatic interactions in the syn rotamer of
Pt(N(H)dpa)G and Pt(N(H)6-Medpa)G adducts (Figure 12). For the Pt(N(H)6,6!-Me2dpa)G
adducts, in which there are no H6! protons, the rotamer abundance is influenced by repulsive
steric interactions between the G 6-membered ring and the 6/6!-Me groups (Figure 5.12).
Consequently, in this study we assess the influences of the N-substituents of the carrier ligands
on the syn H8:anti H8 intensity ratio.
For all of the Pt(N(Me)6,6!-Me2dpa)G adducts studied, the syn H8:anti H8 intensity
ratios (Table 5.6) were very similar to the syn H8:anti H8 ratios of the Pt(N(H)6,6!-Me2dpa)G
adducts (Table D.6), as expected because of the non bulky methyl group. The syn H8:anti H8
ratios for the Pt(6,6!,6!!-Me3tpa)(5!-GMP) (1:1:42) and Pt(6,6!,6!!-Me3tpa)(5!-GTP) (1:1.53)
adducts were increased because the phosphate group is on the 5!-position and prefers the anti
conformation, in which the phosphate group points toward the overhanging 6-methyl-2-picolyl
chain (Table 5.6). This proximity creates a destabilizing interaction, therefore increasing the
abundance of the syn rotamers of these adducts. For the Pt(6,6!,6!!-Me3tpa)(3!-GMP) adduct, the
phosphate group is on the 3!-position, which points away from the coordination site, therefore
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relieving the steric interaction between the 6-methyl-2-picolyl chain of the carrier ligand and the
sugar phosphate group of 3!-GMP. This result explains the more favored anti rotamer with a syn
H8:anti H8 ratio (1:2.43, Table 5.6) favoring the anti rotamer for this 3!-GMP adduct.
δ-

δ+
δ+

δ+

δ+

δ+

δ-

δ+

(A)

(B)

δ-

δ+
δ+

δ+

δ-

δ+
(C)

(D)

δ-

δ+

δ+

δ-

(E)

(F)

Figure 5.12: Models of the syn (A) and anti (B) rotamers of the Pt(N(H)dpa)G adducts, syn (C)
and anti (D) rotamers of the Pt(N(H)6-Medpa)G adducts, and of the syn (E) and anti (F) rotamers
of the Pt(N(H)6,6!-Me2dpa)G adducts. The R group of G is omitted for clarity. The van der
Waals radii of all atoms were taken into account in constructing these models. The green arrows
indicate steric repulsions and red arrows indicate electrostatic repulsions, with thicker arrows
indicating stronger steric or electrostatic repulsions. Note that the 6-membered guanine ring in
the syn conformers is toward the top of the figure, putting the ring on the same side of the
coordination plane, allowing favorable electrostatic attraction (blue arrows) between the G 6+
membered ring δ O6 and the δ H6/6! and H6! protons in A and C. However, steric repulsion
between the G 6-membered ring and the 6-Me and 6!-Me groups in E and with the 6-Me group
in C. The latter interaction is alleviated by canting. Note that the 6-membered guanine ring in the
anti conformers is toward the bottom of the figure, alleviating the crowding in F but increasing
+
+
electrostatic repulsion between the G 5-membered ring δ H8 and the δ H6/6! and H6! protons
in B and D, respectively. Because for Pt(N(H)6,6!-Me2dpa)G adducts, there are no H6/6! protons,
electrostatic repulsion is not an issue for the anti rotamer (F), possibly accounting for the high
abundance of the anti rotamer of these adducts.31 By having an N-R group, steric repulsions
between the N-R group and 6-membered ring of G are introduced for the syn rotamers.
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For all of the Pt(N(prop)6,6!-Me2dpa)G adducts, the anti rotamer is highly favored. The syn
H8:anti H8 ratios for the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) (1:8.53) and Pt(N(prop)6,6!Me2dpa)(3!-GMP) (1:7.97) adducts were similar, whereas the Pt(N(prop)6,6!-Me2dpa)(5!-GTP)
adduct had a syn H8:anti H8 ratio of 1:6.32 (Table 5.6). For the Pt(N(prop)6,6!-Me2dpa)(5!-GTP)
adduct, the slightly increased abundance of the syn rotamer is the result of the steric interactions
between the carboxylate group of the carrier ligand and the triphosphate group of 5!-GTP in the
anti rotamer. Upon raising the pH of all Pt(N(prop)6,6!-Me2dpa)G solutions to ~7.3, the
abundance of the syn rotamer increased for all adducts. At pH ~ 7.3 the carboxylate group of the
carrier ligand and the γ-phosphate of 5!-GTP are deprotonated, therefore creating an electrostatic
repulsion between both negatively charged groups in the anti rotamer of Pt(N(prop)6,6!Me2dpa)(5!-GTP) and hence a higher abundance of the syn rotamer.
For the Pt(N(prop)dpa)(5!-GTP) and Pt(N(prop)dpa)(3!-GMP) adducts, the syn rotamer is
favored, but for the Pt(N(prop)dpa)(5!-GMP) adduct, the anti rotamer is favored. Upon raising
the pH of the Pt(N(prop)dpa)(5!-GMP) solution from pH 4.1 to 7.3, the syn:anti H8 ratio changed
from 1:1.32 to 1:1.09, showing an increased abundance of the syn rotamer (Table D.4), as found
for the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) adduct discussed above. The syn H8:anti H8 ratio for
the Pt(N(prop)dpa)(3!-GMP) adduct was essentially unchanged when the pH was changed from
4.1 to 7.3 (Table D.4). Upon raising the pH of the Pt(N(prop)dpa)(5!-GTP) solution from 4.1 to
7.3, the syn H8:anti H8 increased dramatically from 1.23:1 to 2.91:1 (Table D.4). As seen also
for Pt(N(prop)6,6!-Me2dpa)(5!-GTP), the electrostatic repulsion between the negatively charged
carboxylate and the γ-phosphate destabilizes the anti rotamer, therefore highly favoring the syn
rotamer for the Pt(N(prop)dpa)(5!-GTP) adduct.
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5.3.15 Pt(N(Me)6,6!-Me2dpa)G2, Pt(N(prop)6,6!-Me2dpa)G2, and Pt(6,6!,6!!-Me3tpa)G2
Adducts
In addition to the signals of the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) mono adduct, the
spectrum of the 5!-GMP reaction mixture also contained signals attributable to the bis adduct,
Pt(N(Me)6,6!-Me2dpa)(5!-GMP)2 (Figure 5.6). At 3 d the 1H NMR spectrum showed ~60% of
the total product to be in the form of the mono adduct, Pt(N(Me)6,6!-Me2dpa)(5!-GMP).
However, unlike Pt(N(H)6,6!-Me2dpa)(5!-GMP),31 which forms at 100%, only ~40% of the total
product was the Pt(N(Me)6,6!-Me2dpa)(5!-GMP)2 bis adduct, and the mono adduct dominated at
~60%. The Pt(N(Me)6,6!-Me2dpa)(3!-GMP) and Pt(N(Me)6,6!-Me2dpa)(5!-GTP) adducts also
converted to the Pt(N(Me)6,6!-Me2dpa)(3!-GMP)2 (Figure 5.6) and Pt(N(Me)6,6!-Me2dpa)(5!GTP)2 (Figure 5.6) adducts with total product intensity percentages of 44 and 49, respectively.
The Pt(N(prop)6,6!-Me2dpa)G2 adducts were essentially non-existent with a total product
intensity of less than 15% (Figures 5.7, 5.8, and 5.9). The Pt(6,6!,6!!-Me3tpa)G2 adducts were
never detected for all adducts formed (Figure 5.10). This result indicates that the amount of bis
adduct formed depends on the bulk of the N-substituent, with higher bulk resulting in low
amounts of bis adduct formed.
5.4 CONCLUSIONS
The bulk of the 6/6!-Me group is sufficient to impede rotation of the guanine base about
the Pt–N7 bond of the Pt(N(R)6,6!-Me2dpa)G adducts; as was found for the Pt(N(H)6,6!Me2dpa)G adducts.31 The syn:anti ratio of rotamers for the Pt(Ltri)G mono adducts studied
follows the trend: Pt(6,6!,6!!-Me3tpa)G ~ Pt(N(Me)6,6!-Me2dpa)G <<< Pt(N(prop)6,6!Me2dpa)G, all favoring the anti rotamer for adducts formed.!The lack of change, upon changing
the pH, in the syn H8:anti H8 intensity ratio for the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) and
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Pt(6,6!,6!!-Me3tpa)(5!-GTP) adducts further supports the proposal that a weak hydrogen bond
between the γ-phosphate group of 5!-GTP and the central N–H of the carrier ligand in the
Pt(N(H)dpa)(5!-GTP) adduct.29 The increase in the syn H8:anti H8 ratio of Pt(N(prop)6,6!Me2dpa)(5!-GTP), upon raising the pH, arises from the electrostatic repulsion between the
carboxylate group of the carrier ligand and the γ-phosphate group of 5!-GTP, therefore
increasing the abundance of the syn rotamer. The trend in increasing bulk of the N-substituent of
the carrier ligand is reflected in the order of abundance of bis adducts: Pt(6,6!,6!!-Me3tpa)G2 <<<
Pt(N(prop)6,6!-Me2dpa)G2 < Pt(N(Me)6,6!-Me2dpa)G2.
This study was motivated by the desire to understand the effect of more steric bulk of the
N-substituent of the carrier ligand on the bound guanine derivative. The dramatically different
stability of the Pt(N(R)6,6!-Me2dpa)G mono adducts compared to that of the Pt(N(H)6,6!Me2dpa)G31 mono adducts can be explained by the increased bulk of the N-substituent, making
the bidentate coordination mode of the carrier ligand unfavorble. Furthermore, our work
identifies a monofunctional Pt(II) complex with a bulky carrier ligand that has Pt–N bonds of
normal lengths and strong enough to prevent bifunctional binding to DNA.
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CHAPTER 6. SUMMARY AND CONCLUSIONS
Pt(N(H)dpa)(G) adducts were used to assess whether a tridentate carrier ligand having
bulk concentrated in the coordination plane can impede guanine nucleobase rotation. The
observation of two sharp, comparably intense guanine H8 NMR signals provided evidence that
these Pt(N(H)dpa)(G) adducts exist as mixtures of syn and anti rotamers, that rotational
interchange is impeded by N(H)dpa, and that the key interactions involved steric repulsions
between the pyridyl and guanine rings. The relative proximity of the guanine H8 to the
anisotropic pyridyl rings allowed us to conclude that the syn rotamer was usually more abundant.
However, the anti rotamer was more abundant for the Pt(N(H)dpa)(5!-GTP) adduct, in which a
hydrogen bond between the 5!-GTP γ-phosphate group and the N(H)dpa central N–H is
geometrically possible. In all previous examples of the influence of hydrogen bond formation on
rotamer abundance in Pt(II) guanine adducts, these hydrogen bonding interactions occurred
between ligand groups in cis positions. Thus, the role of a trans ligand group in influencing
rotamer abundance, as found here, is unusual.
When 9-EtG was added to [Pt(N(H)6,6!-Me2dpa)Cl]Cl. not only the expected
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ mono adduct having syn and anti conformers formed, but also a
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ bis adduct consisting of ΛHT and ΔHT conformers (HT =
head-to-tail). For both adducts, the two conformers exist as a dynamic equilibrium mixture.
Concomitant with formation of the bis adduct, the binding mode of the N(H)6,6!-Me2dpa ligand
converts from tridentate to bidentate. The secondary nitrogen is an asymmetric center, and each
conformer exists as a racemic mixture of two enantiomers. For a given configuration at the
secondary amine of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, the more abundant HT
conformer can form a hydrogen bond between the NH of the bidentate ligand and the cis 9-EtG
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O6. [Pt(N(H)6,6!-Me2dpa)Cl]Cl forms the mono adduct in ~1/20 the time for its parent,
[Pt(N(H)dpa)Cl]Cl, which exhibited typical behavior in forming only a mono adduct. We
attribute the unusual new findings for [Pt(N(H)6,6!-Me2dpa)Cl]Cl to Pt–N bond weakening
induced by the steric bulk of 6/6!-Me groups.
The steric effects of the tridentate carrier ligand, N(H)6-Medpa, bearing a 6-methyl group
and a 6!-proton projecting toward the nucleobase, in Pt(N(H)6-Medpa)G adducts formed syn and
anti rotamers with the guanine O6 and the central N–H of N(H)6-Medpa on the same or opposite
side of the coordination plane, respectively. Pt(N(H)6-Medpa)G adducts have some properties
(ease of rotamer interchange and extent of conversion to bis adducts, Pt(N(H)6-Medpa)G2)
intermediate to properties reported for analogues having a tridentate ligand with zero or two
methyl groups. However, in comparison, the syn rotamer of Pt(N(H)6-Medpa)G adducts have an
unexpectedly high abundance. This high abundance of the syn rotamer is attributable to guanine
base canting, such that the 6-membered guanine ring is positioned away from the bulky 6-Me
group. This canting both relieves electrostatic repulsion between the partially positive H6! and
the guanine H8 protons and creates a favorable electrostatic attraction between the H6! proton
and the partially negative guanine O6.
The steric effects of the coordinated tridentate carrier ligands [N-(Me)-di-(6-methyl-2picolyl)amine

(N(Me)6,6!-Me2dpa),

N-(propionic

acid)-di-(6-methyl-2-picolyl)amine

(N(prop)6,6!-Me2dpa), and tris(6-methyl-2-picolyl)amine (6,6!,6!!-Me2dpa), all ligands with two
6-methyl groups in the coordination plane and bearing a bulky the substituents on the central N],
in Pt(N(R)6,6!-Me2dpa)G mono adducts (G = 5!-GMP, 5!-GTP, 3!-GMP formed syn and anti
rotamers that have the guanine O6 and the central N–R of N(R)6,6!-Me2dpa on the same or
opposite side of the coordination plane, respectively. The Pt(N(prop)6,6!-Me2dpa)G adducts
!
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highly favor the anti rotamer. A high abundance of the anti rotamer at high pH for the
Pt(N(H)6,6!-Me2dpa)(5!-GTP) adduct compared to the Pt(N(H)6,6!-Me2dpa)(5!-GMP) adduct and
the absence of change in the syn H8:anti H8 ratio of the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) and
Pt(6,6!,6!!-Me2dpa)(5!-GTP) further supports the proposal that a trans NH ligand group
influences rotamer abundance. The increased bulk of the N-substituents of Pt(N(R)6,6!Me2dpa)G adducts dramatically changes the stability of these adducts, highly favoring the mono
adducts. The Pt(N(prop)6,6!-Me2dpa)G and Pt(6,6!,6!!-Me2dpa)G adducts highly favor mono
adduct stability, with the formation of the bis adduct being essentially undetectable. This high
stability of the mono adduct arises from the unfavorable bidentate coordination mode of the
carrier ligand.

!

149

APPENDIX A. SUPPLEMENTARY MATERIAL FOR CHAPTER 2

Figure A.1: HSQC spectrum of [Pt(N(H)dpa)Cl]Cl (shifts in ppm).
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Figure A.2: The aromatic and H1! region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming Pt(N(H)dpa)(5!-GMP) after 10 min,
7 h, and 49 h (shifts in ppm).
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Figure A.3: HSQC spectrum of the Pt(N(H)dpa)(5!-GMP) adduct (shifts in ppm).
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Figure A.4: Aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming Pt(N(H)dpa)(5!-GDP) after 10 min,
22 h, and 45 h (shifts in ppm).
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Figure A.5: Aromatic and H1! region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming Pt(N(H)dpa)(5!-GTP) after 10 min,
6 h, and 30 h (shifts in ppm).
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Figure A.6: 1H-1H ROESY spectrum of the aromatic region of the Pt(N(H)dpa)(5!-GTP) adduct
(shifts in ppm).
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Figure A.7: Aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming Pt(N(H)dpa)(5!-IMP) after 10 min,
5.5 h, and 50 h (shifts in ppm).
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Figure A.8: Aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming [Pt(N(H)dpa)(Guo)]2+ after 10 min,
45 h, and 6 d (shifts in ppm).
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Figure A.9: 1H NMR spectra (25 °C, D2O/DMSO-d6) of [Pt(N(H)dpa)Cl]+ (bottom) and the
reaction mixture forming [Pt(N(H)dpa)(9-EtG)]2+ after 10 min, 5.5 h, and 49 h (shifts in ppm).
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Figure A.10: Part of the aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of
[Pt(N(H)dpa)Cl]+ (bottom) and of the reaction mixture forming Pt(N(H)dpa)(5!-GMP) after 10
min, 7 h, and 49 h (shifts in ppm).
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APPENDIX B. SUPPLEMENTARY MATERIAL FOR CHAPTER 3
Synthesis of [Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O. [Pt(N(H)dpa)Cl]Cl (9.23 mg in 2 mL of H2O)
was treated with an aqueous solution of NaPF6 (3.40 mg in 2 mL of H2O) until the solution
became slightly cloudy. The solution was left at room temperature and a small yellow crystal
was obtained after 3 weeks. The hydrolysis of NaPF6 over time yielded a salt with the unusual
H2PO4- anion. 1H NMR signals (ppm) DMSO-d6: 8.81 (d, 2H, H6/6!), 8.67 (bs, 1H, NH), 8.24 (t,
2H, H4/4!), 7.76 (d, 2H, H3/3!), 7.61 (t, 2H, H5/5!), 4.93, 4.90 (dd, 2H, CH2), 4.62, 4.58 (dd, 2H,
CH2). The 1H NMR signals agree with the previously reported values for [Pt(N(H)dpa)Cl]Cl,1
except for the NH signal. As explained in other reports, in solvents such as DMSO-d6 the counter
ion can form a weak hydrogen bond to coordinated proton-bearing amine donors; the effect of
the hydrogen bonding interaction is to cause an anion-dependent downfield shift of the NH
signal.2,3
Supporting NMR Assignments and Experiments. All experiments utilized 64:36 D2O/DMSO-d6
solutions (385 μL/215 μL). For all NMR spectra, the complex concentration was 10 mM and the
solution pH was generally 4.0 or 4.1 unless noted otherwise.
Carrier-Ligand Signal Assignments for [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+. For the bis adduct, the
atoms in the chelate half of the N(H)6,6!-Me2dpa ligand are numbered with no prime, whereas
those in the dangling half are designated with a prime (Figure 3.4). As stated in the main text, the
ΛHT:ΔHT conformer ratio was 63:37. Therefore, we can assign the 1H and 13C NMR signals of
the dangling pyridyl protons by using the fact that the intensities of the ΛHT signals are higher
than those of the ΔHT signals. The bound pyridyl H4 signal should be the most downfield triplet
(as seen for [Pt(N(H)6,6!-Me2dpa)Cl]+), thus assigning the triplets at 7.86 and 7.85 ppm (Figure
3.7) to the H4 signals of the ΛHT and ΔHT conformers, respectively (Table 3.5). In an expanded
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region of the HSQC spectrum (Figure B.9), the overlapped triplets have a cross-peak to the 13C
NMR peak at 142.0 ppm, assigning this C4 13C NMR signal to both HT conformers. The triplet
at 7.65 ppm (overlapped with an H8 singlet) has a cross-peak to the
ppm. This same

13

13

C NMR peak at 139.8

C NMR peak has a cross-peak to the peak at 7.56 ppm (overlapped with a

doublet). Thus the 13C NMR peak is assigned to overlapped C4! signals of both HT conformers
and the triplets at 7.65 and 7.56 ppm to ΛHT and ΔHT conformers, respectively (Table 3.5).
With the H4 and H4! signals thus assigned, a COSY experiment (not shown) allowed us to assign
signals to bound and dangling pyridyl groups.
Because the H3, H3!, H5, and H5! signals are all doublets within the same chemical shift range
and have COSY cross-peaks to either H4 or H4!, the 6-Me-to-H5 and 6!-Me-to-H5! NOE crosspeaks in a ROESY spectrum (not shown) were used to assign and to distinguish H5 and H5!
doublets from the H3 and H3! doublets. The NOE cross-peaks from the 6-Me signals at 1.75
(ΛHT) and 1.88 (ΔHT) ppm (Table 5) assigns the doublet at 7.12 ppm to the H5 signal for both
HT conformers. The NOE cross-peaks from the ΛHT and ΔHT 6!-Me signals (Table 3.5) to
doublets at 7.07 and 7.03 ppm assign these doublets to H5! of the ΛHT and ΔHT conformers,
respectively.
From the HSQC spectrum (Figure B.9), the H5 signal at 7.12 ppm has a cross-peak to the 13C
NMR signal at 127.7 ppm, thus assigning this C5 signal to both HT conformers. The H5! signals
at 7.07 and 7.03 ppm have an elongated cross-peak to the 13C NMR signals at 125.0 and 124.8
ppm, thus assigning the C5! signals of the ΛHT and ΔHT conformers, respectively. The
remaining doublets are H3 or H3!. The H3 signals are overlapped at 7.48 ppm. These overlapped
signals have a cross-peak to the

13

C signals at 121.7 and 121.8 ppm, thus assigning the two

signals as the C3 signals; on the basis of intensity, these were assigned to the ΛHT and ΔHT
!
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conformers, respectively. The ΛHT H3! signal at 7.55 ppm (overlapped with the H4! signal) and
the ΔHT H3! signal at 7.28 ppm have HSQC cross-peaks, allowing the 13C NMR signals at 124.0
and 123.2 ppm to be assigned to the ΛHT and ΔHT C3! signals, respectively.
In Figure B.13, the chelate ring methylene protons are designated as endo-H7 and exo-H7 for
protons projecting toward and away from platinum, respectively. Because the methylene group
in the dangling 6-methyl-2-picolyl chain is not in a fixed position, we do not use these
designations. The C7 signal at a characteristic shift (63.2 ppm) has HSQC cross-peaks (Figure
S10) to the signals at 5.12, 5.00, and 4.57 ppm (masked by the HOD signal), thus allowing
assignment of the peaks at 5.12 and 5.00 ppm to the ΔHT and ΛHT endo-H7 signals,
respectively, on the basis of shift and intensity. The peak at 4.57 ppm is assigned to the exo-H7
signals for both HT rotamers, again according to signal shift and intensity. The C7! signals at
59.5 and 59.6 ppm have cross-peaks to 1H NMR signals at 3.72 and 3.68 ppm and to the signals
masked by the CH2 signals of 9-EtG at 3.86 and 3.82 ppm. H3!-H7! NOE cross-peaks in a
ROESY spectrum (not shown) allow us to assign the ΛHT and ΔHT H7! signals. The ΔHT H3!
signal at 7.28 ppm has cross-peaks to the signals at 3.82 (masked by the CH2 signal of 9-EtG)
and 3.68 ppm, thus assigning these as the two ΔHT H7! signals. The ΛHT H3! signal at 7.55 ppm
has cross-peaks to the signals at 3.86 (masked by the CH2 signal of 9-EtG) and 3.72 ppm, thus
assigning these as the two ΛHT H7! signals. An HMBC cross-peak from the H5 signal at 7.12
ppm to the

13

C signals at 162.4 and 162.5 ppm assign the ΛHT C6 and ΔHT C6 signals,

respectively (Figure B.11). HMBC cross-peaks from the ΛHT H5! (7.07 ppm) and ΔHT H5!
(7.03 ppm) signals to the 13C signals at 159.6 and 159.5 ppm assigns the latter to the ΛHT and
ΔHT C6! signals. An HMBC cross-peak from the overlapped ΛHT and ΔHT H3 signals at 7.48
ppm to the

!
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C signals at 162.8 and 162.6 ppm assign these to C2, and the relative intensity

162

allows assignment of the signals to the ΛHT and ΔHT conformers, respectively. HMBC crosspeaks from the ΛHT H3! (7.55 ppm) and ΔHT H3! (7.28 ppm) signals assign the 153.4 and 153.3
ppm

13

C signals to C2! of the ΛHT and ΔHT conformers, respectively (Figure B.11). This

completes the assignment of the 1H and

13

C NMR signals for the two [Pt(N(H)6,6!-Me2dpa)(9-

EtG)2]2+ conformers.
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Table B.1: Selected 1H NMR and 13C NMR Shifts (ppm) for N(H)6,6!-Me2dpa in D2O/DMSO-d6
(64:36) at pH 4.1 and 11.2 at 25 °C
carbons
C4/4!

C3/3!

C5/5!

C7/7!

C2/2!

C6/6!

6/6!-(C)Me

pH 4.1

140.8

122.9

125.9

52.0

151.1

159.8

24.3

pH 11.2

139.7

121.6

124.1

54.6

158.9

159.2

24.4

!
protons
H4/4!

H3/3!

H5/5!

H7/7!

6/6!-Me

pH 4.1

7.67

7.21

7.23

4.21

2.40

pH 11.2

7.54

7.03

7.07

3.67

2.31
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Figure B.1: Overlay of [Pt(N(H)6,6!-Me2dpa)Cl]+ (yellow) and [Pt(N(H)dpa)Cl]+
cations, illustrating the difference in the positioning of the coordinated Cl.
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4

(purple)

Figure B.2: HSQC spectrum of [Pt(N(H)6,6!-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6, pH 4.0, shifts
in ppm). Peaks labeled X are a mixture of solvated species and impurities. Peaks labeled S are
from solvent.
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HOD

H4/4'

6/6'-Me

H5/5'
X

X

endo-H7/7'

H3/3'

exo-H7/7'
X

X

X

X

X

X

S

6/6'-Me

40

S

C7/7'

80

120

C3/3'
C5/5'
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C6/6'
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13C

160

1H

8
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3

Figure B.3: HMBC spectrum of [Pt(N(H)6,6!-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6, pH 4.0,
shifts in ppm). Peaks labeled X are a mixture of solvated species and impurities. Peaks labeled S
are from solvent.
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Figure B.4: Models of the syn (A) and anti (B) rotamers of the [Pt(N(H)dpa)(9-EtG)]2+adduct and of the
syn (C) and anti (D) rotamers of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct. The van der Waals radii of
all atoms were taken into account in constructing these models. Note that the 6-membered guanine ring
in syn conformers (A and C) is close to H6,6! or 6,6!-Me, which leads to crowding in C, possibly
accounting for the syn:anti ratio of 1:1.42 for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct.
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Figure B.5: 1H-1H ROESY spectrum of the H8-6/6!-Me region of [Pt(N(H)6,6!-Me2dpa)(9EtG)]2+ (15 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm). Peak labeled X is a solvent impurity.
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Figure B.6: 1H-1H ROESY spectrum of the H8-H8 region of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ (15
°C, D2O/DMSO-d6, pH 4.0, shifts in ppm).
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Figure B.7: Aliphatic region of the 1H NMR spectra (shifts in ppm) of a solution of [Pt(N(H)6,6!Me2dpa)Cl]+ (25 °C, D2O/DMSO-d6 at pH 4.0) before (bottom), 15 min after (middle), and 4.5 h
after (top) mixing with 2.5 molar equiv of 9-EtG. Signals for the mono-adduct intermediate,
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+, are labeled in the middle trace, and those for the final bisadduct product, [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+, are labeled in the top trace. Detailed
assignments of signals to the ΛHT and ΔHT conformers appear in Table 5. In figure, G = 9-EtG,
X = solvent impurity, and S = DMSO-d6.
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Figure B.8: Possible orientations of the guanine bases in the HHu (top) and HHd (bottom)
conformers of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adducts.
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Figure B.9: Aromatic region of the HSQC spectrum of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+
adduct (25 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm).
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Figure B.10: Aliphatic region of the HSQC spectrum of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+
adduct (25 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm). Peaks labeled X are a mixture of solvent
and solvent impurities.
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Figure B.11: HMBC spectrum of the aromatic region (A) of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+
and the 1D 13C NMR spectrum (B) of the C2, C2!, C6, and C6! regions of [Pt(N(H)6,6!Me2dpa)(9-EtG)2]2+ (25 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm).
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Figure B.12: HMBC spectrum of the aromatic (13C) and aliphatic (1H) cross-peak region of
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ (25 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm). Peaks labeled X
are a mixture of solvent and solvent impurities. The cross-peaks circled in the spectrum shows
the H7!-C2! cross-peaks used to assign the C2! signal.
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Figure B.13: Designation of the methylene endo-H7 and exo-H7 protons and the methylene H7!
protons of the chelating and dangling 6-methyl-2-picolyl chains of the [Pt(N(H)6,6!Me2dpa)G2]2+ bis adduct.
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Figure B.14: 1H NMR spectra (shifts in ppm) of a solution of [Pt(N(H)6,6!-Me2dpa)Cl]+ (25 °C,
D2O/DMSO-d6), 10 min (bottom), 1 h (middle), and 24 h (top) after mixing with 10 µL of
concentrated HCl. In the bottom trace, the assignments for the [Pt(N(H)6,6!-Me2dpa)Cl]+ original
signals are labeled. The bidentate intermediate signals are labeled with red and blue asterisks for
the dangling and the chelated 6-methyl-2-picolyl chains, respectively. The top trace shows the
assignments for the protonated free N(H)6,6!-Me2dpaHxm+ ligand.
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Figure B.15: 1H NMR spectra (shifts in ppm) of the aromatic region of a solution of
[Pt(N(H)dpa)Cl]+ (25 °C, D2O/DMSO-d6 ), 10 min (bottom) and 24 h (top) after mixing with 10
µL of concentrated HCl.
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Figure B.16: Aromatic region of the 1H NMR spectra (shifts in ppm) of a solution of
[Pt(N(H)6,6!-Me2dpa)Cl]+ (25 °C, D2O/DMSO-d6) 10 min after (bottom) and 6 h after (top)
mixing with 3.5 molar equivalents of 3!-GMP (pH 4.1). H8 signals for the mono-adduct
intermediate, Pt(N(H)6,6!-Me2dpa)(3!-GMP), are labeled in the bottom trace, and those for the
final bis-adduct product, Pt(N(H)6,6!-Me2dpa)(3!-GMP)2, are labeled in the top trace. Peaks
labeled with an asterisk (*) are from the carrier-ligand signals of Pt(N(H)6,6!-Me2dpa)(3!GMP)2.
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Figure B.17: 1H NMR spectrum of the H1! and 6/6!-Me regions of a solution of [Pt(N(H)6,6!Me2dpa)Cl]+ (25 °C, D2O/DMSO-d6, pH 4.1) 15 min after (bottom), and 3 d after (top) mixing
with 3.5 molar equiv of 5!-GMP. Signals for the mono-adduct intermediate, Pt(N(H)6,6!Me2dpa)(5!-GMP), are labeled in the bottom trace, and those for the final bis-adduct product,
Pt(N(H)6,6!-Me2dpa)(5!-GMP)2, are labeled in the top trace. Peaks labeled x are from solvent
impurity. For the Pt(N(H)6,6!-Me2dpa)(5'-GMP) adduct, the syn (5.83 ppm) and anti (5.88 ppm)
H1' signals are shifted downfield of the free 5'-GMP H1' signal at 5.71 ppm. The overlapped H1'
signals of the Pt(N(H)6,6!-Me2dpa)(5'-GMP)2 adduct are found between 5.70-5.60 ppm, upfield
of the free 5'-GMP H1' signal.
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APPENDIX C. SUPPLEMENTARY MATERIAL FOR CHAPTER 4
Supporting NMR assignments and experiments. For all NMR spectra, the complex concentration
was 10 mM, and data in all tables and figures were obtained at pH ~ 4 in 64:36 D2O/DMSO-d6
solutions (385 μL/215 μL).
Carrier-Ligand Signal Assignments for [Pt(N(H)6-Medpa)(9-EtG)]2+. As discussed in the main
text, the syn:anti ratio was found to be 2.10:1, with the syn rotamer being the major rotamer.
Therefore, we can assign the 1H and 13C NMR signals of the syn and anti rotamer signals by
using the relative signal intensities of the these signals, as the signal intensities are larger for the
syn rotamer signals than for the anti rotamer. In Figure 4.6, the bottom trace for [Pt(N(H)6Medpa)Cl]+ shows an H6! signal at 8.75 ppm (the H6! signal should be the most downfield
pyridyl signal because of the proximity of the endocyclic nitrogen), but the spectrum of the
[Pt(N(H)6-Medpa)(9-EtG)]2+ adduct (top) has no doublets in this region. As seen in similar
studies,1 the anisotropy of the N7-coordinated guanine nucleobase shifts the H6! doublet into the
same narrow shift region as the H3, H3!, H5, and H5! signals. The 13C NMR signals of C6!, C3,
C3!, C5, and C5! are widely dispersed in distinctive regions for the [Pt(N(H)6-Medpa)(9-EtG)]2+
adduct. We relied on [Pt(N(H)6-Medpa)Cl]Cl assignments (Figures 4.7, C.1, and C.2, Tables 4.3,
C.2, and C.3) to make the 1H and

13

C NMR assignments for the [Pt(N(H)6-Medpa)(9-EtG)]2+

adduct (Figures 4.10 and C.3, Tables 4.3, C.4, and C.5).
In contrast to the close H6! proton, the H3 and H3! protons are the pyridyl protons of the
[Pt(N(H)6-Medpa)(9-EtG)]2+ adduct farthest from the coordinated guanine nucleobase. The H3
and H3! doublets of the adduct are not influenced by the anisotropic guanine nucleobase and thus
have shifts (7.30–7.44 ppm) similar to the H3 and H3! signals of the starting [Pt(N(H)6Medpa)Cl]Cl complex. As a result, the H3, H3! and H6! doublets of the [Pt(N(H)6-Medpa)(9-
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EtG)]2+ adduct have similar shifts (Table 4.3). The 1D 13C NMR spectrum shows two resolved
C6! peaks at 149.0 and 148.2 ppm. In the HSQC spectrum of the [Pt(N(H)6-Medpa)(9-EtG)]2+
adduct, the H6!-C6! cross-peaks can be identified by the characteristic C6!

13

C NMR shift of

~149 ppm. One cross-peak involves the overlapped signal at ~7.48 ppm and the C6! signal at
148.2 ppm; both signals are attributable to the anti rotamer, on the basis of intensity. The other
cross-peak involves the overlapped signal at ~7.23 ppm and the C6! signal at 149.0 ppm; these
signals are attributable to the syn rotamer. The C3 pyridyl signals at characteristic shifts (121.5
and 121.6 ppm) of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct have an HSQC cross-peak to the
overlapping signals at 7.36 and 7.38 ppm, thus assigning these signals to the syn and anti H3 and
C3 signals, respectively. The C3! pyridyl signals at characteristic shifts (124.0 and 124.1 ppm)
have a cross-peak with the overlapping signals at 7.49 and 7.51 ppm, thus assigning the syn and
anti H3! and C3! signals, respectively.
The C5 pyridyl signals at characteristic shifts (128.2 and 128.4 ppm) have an elongated crosspeak to the overlapped signals at 7.18 and 7.28 ppm, thus assigning the two signals to the H5
signals; on the basis of intensity these were assigned to the syn and anti rotamers, respectively.
The C5! pyridyl signals at characteristic shifts (126.5 and 128.8 ppm) have cross-peaks to the
overlapped signals at 7.21 and 7.28 ppm, thus assigning these signals to the syn and anti H5 and
C5 signals, respectively. This multiplet peak at ~7.22 ppm also had a cross-peak to the syn C6!
signal, indicating that the H5, H5!, and syn H6! signals are all overlapped. The C4 and C4!
pyridyl signals at a characteristic shift (142.7 and 142.8, respectively) show cross-peaks to the
peaks at 7.86 and 7.99 ppm, assigning these peaks to the H4 and H4! signals for both rotamers,
respectively.
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The C7 signal of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct at a characteristic shift (62.2 ppm)
has HSQC cross-peaks (Figure C.2) to the overlapped signals at 4.93, 4.88, and to the signal at
4.56 ppm (masked by the HOD signal), thus allowing assignment of the peaks at 4.93 and 4.88
ppm to the syn and anti endo-H7 signals, respectively, on the basis of shift and intensity. The
peak at 4.56 ppm is assigned to the exo-H7 signals for both rotamers. The overlapped C7! signal
at 60.5 ppm has cross-peaks to the overlapped 1H NMR signals at 4.78 and 4.74 ppm and to the
signal masked by the HOD signal at 4.58 ppm, thus allowing the assignment of the peaks at 4.78
and 4.74 ppm to the syn and anti endo-H7! signal signals, respectively, on the basis of shift and
intensity. The peak at 4.58 ppm is assigned to the exo-H7 signals for both rotamers. HMBC
cross-peaks from the H5 signals at 7.18 (syn) and 7.22 (anti) ppm to the 13C signals at 162.8 and
163.2 ppm assign the syn and anti C6, respectively. HMBC cross-peaks from the overlapped H3
signals at 7.36 (syn) and 7.38 (anti) ppm to the 13C signals at 166.7 and 166.5 ppm assign these
to C2, and the relative intensity allows assignment of the signals to syn and anti rotamers,
respectively. HMBC cross-peaks from the overlapped H3! signals at 7.49 (syn) and 7.51 (anti)
ppm to the 13C signals at 168.1 and 168.4 ppm assign the syn and anti C2! signals, respectively.
The discussion here and in the main text complete the assignment of the 1H and 13C NMR signals
for the two [Pt(N(H)6-Medpa)(9-EtG)]2+ rotamers.
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Table C.1: Selected Bond Distances (Å) and Angles (deg) for [Pt(N(H)6,6!-Me2dpa)Cl]Cl,
[Pt(N(H)6-Medpa)Cl]PF6•H2O, [Pt(N(H)dpa)Cl]Cl•H2O, and [Pt(N(H)dpa)(OH2)](ClO4)2•2H2O.
[Pt(N(H)6,6!Me2dpa)Cl]Cla

[Pt(N(H)6[Pt(N(H)dpa)Cl]Cl
Medpa)Cl]PF6 •H2Ob
•H2O

[Pt(N(H)dpa)(OH2)]
(ClO4)2•2H2Ob

bond distances
Pt–N(1)

2.048(7)

2.069(16)

2.008(6)

2.010(5)

Pt–N(2)

1.973(8)

1.96(2)

2.009(12)

1.952(7)

Pt–N(3)

2.047(7)

2.019(16)

2.011(5)

2.014(6)

Pt–Cl(1)

2.421(3)

2.316(3)

2.301(2)

-

Pt–O(1)

-

2.069(16)

2.008(6)

2.048(7)

bond angles
N(1)–Pt–N(3)

166.3(3)

164.3(6)

166.0(2)

166.7(2)

N(1)–Pt–Cl(1)

95.96(18)

103.7(7)

97.2(2)

-

N(2)A–Pt–Cl(1)

159.1(3)

169.4(5)

168.7(6)

-

N(3)–Pt–Cl(1)

95.34(18)

92.0(6)

97.8(2)

-

N(2)A–Pt–N(1)

83.2(3)

83.4(6)

83.3(3)

83.6(2)

N(2)A–Pt–N(3)

83.4(3)

81.4(4)

83.3(3)

83.2(2)

N(2)A–Pt–O(1)

-

-

-

176.4(3)

N(1)–Pt–O(1)

-

-

-

93.4(3)

N(3)–Pt–O(1)

-

-

-

99.8(3)

a

!

Ref 2. b Ref 3.
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Table C.2: 1H NMR Shifts (ppm) for [PtN(H)dpa)Cl]Cl, [Pt(N(H)6-Medpa)Cl]Cl, and
[Pt(N(H)6,6!-Me2dpa)Cl]Cl!in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
protona
H4(s) or H4!(u)

[Pt(N(H)dpa)Cl]
Clb
7.98(u)

[Pt(N(H)6-Medpa)Cl]
Cl
8.02(u), 7.82(s)

[Pt(N(H)6,6!-Me2dpa)Cl]
Clc
7.80(s)

H3(s) or H3!(u)

7.48(u)

7.43(u), 7.30(s)

7.23(s)

H5(s) or H5!(u)

7.34(u)

7.42(u), 7.28(s)

7.27(s)

endo-H7(s) or H7!(u)

4.73(u)

4.69(u), 4.86(s)

4.87(s)

exo-H7(s) or H7!(u)

4.49(u)

4.46(u), 4.50(s)

4.47(s)

6/6!-CH3 or 6-CH3

-

2.74

2.80

H6/6! or H6!

8.61

8.75

-

a

(s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b Ref 1. c Ref 2.

Table C.3: 13C NMR Shifts (ppm) for [PtN(H)dpa)Cl]Cl, [Pt(N(H)6-Medpa)Cl]Cl, and
[Pt(N(H)6,6!-Me2dpa)Cl]Cl in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
carbona

[PtN(H)dpa)Cl]Clb

[Pt(N(H)6-Medpa)Cl]Cl

[Pt(N(H)6,6!-Me2dpa)Cl]Clc

C4(s) or C4!(u)

142.5(u)

142.6(u), 142.2(s)

142.0(s)

C3(s) or C3!(u)

124.1(u)

123.7(u), 121.1(s)

120.6(s)

C5(s) or C5!(u)

126.6(u)

126.3(u), 128.4(s)

128.5(s)

C7(s) or C7!(u)

60.8(u)

60.7(u), 62.8 (s)

63.3(s)

6/6!-CH3 or 6-CH3

-

27.9

27.5

C6(s) or C6!(u)

150.4(u)

149.7(u), 165.3(s)

164.8(s)

C2(s) or C2!(u)

167.5(u)

168.3(u), 166.5(s)

166.7(s)

a

!

(s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b Ref 1. c Ref 2.!
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Table C.4: 1H NMR Shifts (ppm) for [PtN(H)dpa)(9-EtG)]2+, [Pt(N(H)6-Medpa)(9-EtG)]2+, and
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
protona

[Pt(N(H)dpa)(9-EtG)]2+b,c

[Pt(N(H)6-Medpa)(9-EtG)]2+c

[Pt(N(H)6,6!Me2dpa)(9-EtG)]2+b,d

G H8

8.73e, 8.40f

8.80e, 8.43f

8.84e, 8.54f

H4(s) or H4!(u)

8.02g(u)

8.01e(u), 7.99f(u), 7.86g(s)

7.80g(s)

H3(s) or H3!(u)

7.56g(u)

7.51e(u), 7.49f(u), 7.38e(s), 7.36f(s)

7.31g(s)

H5(s) or H5!(u)

7.25g(u)

7.28e(u), 7.21f(u), 7.18e(s), 7.22f(s)

7.12g(s)

endo-H7(s) or H7!(u)

4.84e(u), 4.78f(u)

4.78d(u), 4.74f(u), 4.93e(s), 4.88f(s)

4.88e(s), 4.81f(s)

exo-H7(s) or H7!(u)

4.58g(u)

4.58g(u), 4.56g(s)

4.50g(s)

6/6!-CH3 or 6-CH3

-

1.80e, 1.73f

2.05e, 1.75f

H6/6! or H6!

7.56e, 7.48f

7.48e, 7.23f

-

e

9-EtG CH2

4.16 , 4.05

f

e

4.15 , 4.03

f

4.10e, 4.01f

9-EtG CH3

1.44e, 1.34f

1.39e, 1.30f

1.26e, 1.30f

a

(s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b Ref 1. c Free 9-EtG signals
(ppm): H8 7.72; CH2 3.91; CH3 1.25. d Ref 2. e Signals from the anti rotamer. fSignals from the
syn rotamer. g syn and anti signals are overlapped.!
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Table C.5: 13C NMR Shifts (ppm) for [PtN(H)dpa)(9-EtG)]2+, [Pt(N(H)6-Medpa)(9-EtG)]2+, and
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
carbona

[PtN(H)dpa)(9-EtG)]2+b,c

[Pt(N(H)6-Medpa)(9-

[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+b,d

EtG)]2+c
G C8

142.91e, 142.86f

142.9e, 143.1f

142.6e, 142.7f

C4(s) or C4!(u)

142.3g(u)

142.8 g(u), 142.7g(s)

142.0g(s)

C3(s) or C3!(u)

124.4e(u), 124.3f(u)

124.1e(u), 124.0f(u),

121.2e(s), 121.1f(s)

121.6e(s), 121.5f(s)
C5(s) or C5!(u)

126.8e(u), 126.9f(u)

126.5e(u), 126.8f(u),

128.6g(s)

128.4e(s), 128.2f(s)
C7(s) or C7!(u)

60.6e(u), 60.8f(u)

60.5g(u), 62.2g(s)

62.6e(s), 62.2f(s)

6/6!-CH3 or 6-CH3

-

24.7e, 25.2f

26.1e, 24.8f

C6(s) or C6!(u)

149.7e(u), 150.3f(u)

148.2e(u), 149.0f(u),

163.9e(s), 163.8f(s)

163.2e(s), 162.8f(s)
C2(s) or C2!(u)

167.4e(u), 167.2f(u)

168.4e(u), 168.1f(u),

167.3e(s), 167.7f(s)

166.5e(s), 166.7f(s)
9-EtG CH2

41.9e, 41.7f

41.8e, 41.6f

41.63e, 41.59f

9-EtG CH3

15.6g

16.1e, 15.8f

16.4e, 16.0f

a

(s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring.b Ref 1. c Free 9-EtG signals
(ppm): C8 140.8; CH2 40.2; CH3 16.2. d Ref 2. e Signals from the anti rotamer. fSignals from the
syn rotamer. g syn and anti signals are overlapped.
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Table C.6: 1H NMR Shifts (ppm) for Pt(N(H)dpa)(5!-GMP), Pt(N(H)6-Medpa)(5!-GMP), and
Pt(N(H)6,6!-Me2dpa)(5!-GMP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
protona

Pt(N(H)dpa)(5!-GMP)b,c

Pt(N(H)6-Medpa)(5!-GMP)c

Pt(N(H)6,6!-Me2dpa)(5!-GMP)c,d

G H8

9.08e, 8.72f

9.13e, 8.77f, 8.76f

9.14e, 8.95 f

H4(s) or H4!(u)

7.97g(u)

7.98g(u), 7.83g(s)

7.76g(s)

H3(s) or H3!(u)

7.51g(u)

7.47g(u), 7.35g(s)

7.26g(s)

H5(s) or H5!(u)

7.21g(u)

7.28e(u), 7.18f(u), 7.14e(s),

7.10g(s)

7.19f(s)
6/6!-CH3 or 6-CH3

-

1.84e, 1.81e, 1.76f, 1.73f

2.05e, 2.06e, 1.84f, 1.81f

H6/6! or H6!

7.57e, 7.51f, 7.44 f

7.47e, 7.30e, 7.24f

-

a

(s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b Ref 1. c Free 5!-GMP signals
(ppm): H8 7.97; H1! 5.71. d Ref 2. e Signals from the anti rotamer. f Signals from the syn rotamer.
g
syn and anti signals are overlapped.
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Table C.7: 1H NMR Shifts (ppm) for Pt(N(H)dpa)(5!-GTP), Pt(N(H)6-Medpa)(5!-GTP), and
Pt(N(H)6,6!-Me2dpa)(5!-GTP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
protona

Pt(N(H)dpa)(5!-GTP)b,c

Pt(N(H)6-Medpa)(5!-GTP)c

Pt(N(H)6,6!-Me2dpa)(5!-GTP)c,d

G H8

9.21e, 8.79f

9.22e, 9.21e, 8.84f, 8.81f

9.22e, 9.05f

H4(s) or H4!(u)

7.97g(u)

7.94g(u), 7.81g(s)

7.79g(s)

H3(s) or H5!(u)

7.49g(u)

7.45g(u), 7.32g(s)

7.29g(s)

H5(s) or H5!(u)

7.23g(u)

7.27e(u), 7.18f(u), 7.13e(s),

7.11g(s)

7.17f(s)
6/6!-Me or 6-Me

-

1.81e, 1.83f, 1.72e, 1.75f

2.05e, 2.07e, 1.84f, 1.81f

H6/6! or H6!

7.57e, 7.49f, 7.43f

7.44e, 7.28f, 7.22f

-

a

(s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b Ref 1. c Free 5!-GTP signals
(ppm): H8 7.97; H1! 5.71. d Ref 2. e Signals from the anti rotamer. f Signals from the syn rotamer.
g
syn and anti signals are overlapped.
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Table C.8: 1H NMR Shifts (ppm) for Pt(N(H)dpa)(3!-GMP), Pt(N(H)6-Medpa)(3!-GMP), and
Pt(N(H)6,6!-Me2dpa)(3!-GMP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
protona

Pt(N(H)dpa)(3!-GMP)b,c

Pt(N(H)6-Medpa)(3!-GMP)c

Pt(N(H)6,6!-Me2dpa)(3!-GMP)c,d

G H8

8.98e, 8.64f

9.05c, 9.04c, 8.76d

9.05c, 8.78d

H4(s) or H4!(u)

8.01g(u)

7.99g(u), 7.86g(s)

7.79g(s)

H3(s) or H3!(u)

7.54g(u)

7.49g(u), 7.37e(s), 7.36f(s)

7.31g(s)

H5(s) or H5!(u)

7.25g(u)

7.28e(u), 7.20f(u),

7.12g(s)

7.18e(s), 7.23f(s)
6/6!-CH3 or 6-CH3

-

1.84e, 1.82e, 1.75f

2.05c, 2.06c, 1.80d, 1.79d

H6/6! or H6!

7.62e, 7.60e, 7.50f

7.50e, 7.28f

-

a

(s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b This work; adduct was prepared
in a similar manner as reported in Ref 1. c Free 3!-GMP signals (ppm): H8 7.97; H1! 5.71. d Ref 2.
e
Signals from the anti rotamer. fSignals from the syn rotamer. g syn and anti signals are
overlapped.
!
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Figure C.1: 1H-1H ROESY spectrum showing H3-endo-H7, H3!-endo-H7!, H3-exo-H7, and H3!exo-H7! NOE cross-peaks of [Pt(N(H)6-Medpa)Cl]+ (DMSO-d6, 25 °C, shifts in ppm).
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Figure C.2: HMBC spectrum (top) of [Pt(N(H)6-Medpa)Cl]Cl and 1D 13C NMR spectrum
(bottom) of the C2, C2!, C6, C6!, C4, and C4! regions of [Pt(N(H)6-Medpa)Cl]Cl (D2O/DMSOd6 (64:36), pH 4.0, 25 °C, shifts in ppm). Peaks labeled X are a mixture of solvated species and
impurities.
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Figure C.3: Aliphatic region of the HSQC spectrum of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct
(D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm). Peak labeled free G H8 is from an excess
of free 9-EtG. The spectrum was recorded 5 h after initiation of the adduct formation reaction.
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Figure C.4: Aliphatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of
the reaction mixture forming the Pt(N(H)6-Medpa)(5!-GMP) adduct (top) recorded at 1.5 h after
mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm).
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Figure C.5: Aliphatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of
the reaction mixture forming the Pt(N(H)6-Medpa)(5!-GTP) adduct at 10 min (middle) and 1.5 h
(top) after mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm). Peaks labeled X are
from a mixture of solvent species and impurities. Peaks labeled S are from solvent.
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Figure C.6: 1H-1H ROESY spectrum showing H8-H6! NOE cross-peaks and absence of H8-H8
EXSY cross-peaks of Pt(N(H)6-Medpa)(5!-GMP) (D2O/DMSO-d6 (64:36), pH 4.0, 15 °C, shifts
in ppm). X = solvent impurity. The spectrum was recorded 2 h after initiation of the adduct
formation reaction.
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Figure C.7: Aliphatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of
the reaction mixture forming the Pt(N(H)6-Medpa)(3!-GMP) adduct at 10 min (middle) and 3 h
(top) after mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm).
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Figure C.8: 1H NMR spectrum of the Pt(N(H)6-Medpa)(5!-GMP) adduct (D2O/DMSO-d6
(64:36), pH 4.0, 15 °C, shifts in ppm) at 1 d after mixing. Labeled peaks show the formation of
the Pt(N(H)6-Medpa)(5-GMP)2 bis adduct. X = solvent impurity.
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Figure C.9: 1H NMR spectrum of the Pt(N(H)6-Medpa)(3!-GMP) adduct (D2O/DMSO-d6
(64:36), pH 4.0, 15 °C, shifts in ppm) at 1 d (top) after mixing. Labeled peaks show the
formation of the bis adduct Pt(N(H)6-Medpa)(3-GMP)2. X = solvent impurity.
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APPENDIX D. SUPPLEMENTARY MATERIAL FOR CHAPTER 5
Table D.1: Selected Bond Distances (Å) and Angles (deg) for [Pt(N(Me)6,6!Me2dpa)Cl]Pt(DMSO)Cl3, [Pt(N(Me)dpa)Cl]Cl•H2O, [Pt(6,6!,6!!-Me3tpa)Cl]Pt(DMSO)Cl3, and
[Pt(tpa)Cl]Cl•2H2O.
!
[Pt(tpa)Cl]Cl•2H2Ob
[Pt(N(Me)6,6!- [Pt(N(Me)dpa)Cl] [Pt(6,6!,6!!a
Me2dpa)Cl]Pt( Cl•H2O
Me3tpa)Cl]Pt
DMSO)Cl3
(DMSO)Cl3
bond distances
Pt–N(1)

2.047(3)

2.006(3)

2.0256(11)

2.004(6)

Pt–N(2)

2.026(4)

2.017(3)

2.0341(11)

2.022(5)

Pt–N(3)

2.063(3)

2.007(3)

2.0232(11)

2.007(6)

Pt–Cl(1)

2.3060(10)

2.3048(10)

2.3111(3)

2.293(2)

bond angles
N(1)–Pt–N(3)

164.16(14)

-

165.29(5)

166.7(2)

N(1)–Pt–Cl(1)

95.56(11)

96.62(9)

97.58(3)

-

N(2)A–Pt–Cl(1)

166.41(10)

179.52(9)

163.53(3)

176.8(2)

N(3)–Pt–Cl(1)

100.28(10)

96.82(9)

97.13(3)

-

N(2)A–Pt–N(1)

82.01(14)

83.35(12)

82.87(4)

83.5(2)

N(2)A–Pt–N(3)

82.67(14)

-

83.15(4)

83.2(2)

a

!

Ref 1. b Ref 2.
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Table D.2: Selected 1H NMR Shifts (ppm) for the [Pt(N(Me)dpa)Cl]Cl, [Pt(N(prop)dpa)Cl]Cl, and
[Pt(tpa)Cl]Cl adducts in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
[Pt(N(Me)dpa)Cl]Cla [Pt(N(prop)dpa)Cl]Clb [Pt(tpa)Cl]Clc
H4/4!

8.06

8.07

7.93

H3/3!

7.57

7.55

7.42

H5/5!

7.45

7.46

7.29

endo-H7/7!

5.02

5.08

5.14

exo-H7/7!

4.49

4.63

4.81

H6/6!

8.67

8.63

8.46

a

N-Me signal: 2.91 ppm. b Propionic signals (ppm): 3.23 N-CH2, and 2.40 OC-CH2. c Dangling
signals (ppm): 7.50 H4!!, 7.86 H3!!, 7.02 H5!!, and 4.27 H7!!.
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Table D.3: Selected 13C NMR Shifts (ppm) for the [Pt(N(Me)6,6!-Me2dpa)Cl]Cl,
[Pt(N(prop)6,6!-Me2dpa)Cl]Cl, and [Pt(6,6!,6!!-Me3tpa)Cl]Cl adducts in D2O/DMSO-d6 (64:36,
pH 4.0, 25 °C).
[Pt(N(Me)dpa)Cl]Cla [Pt(N(prop)dpa)Cl]Clb [Pt(tpa)Cl]Clc
C4/4!

142.9

143.0

142.5

C3/3!

125.5

124.9

124.8

C5/5!

127.0

127.0

126.5

C7/7!

70.8

70.5

70.6

C2/2!

165.7

166.0

166.1

C6/6!

151.0

150.9

150.6

a

N-Me signal: 52.0 ppm. b Propionic signals (ppm): 61.4 N-CH2, and 33.7 OC-CH2, and 174.6
CO. c Dangling signals (ppm): 139.3 C4!!, 126.3 C3!!, 130.1 C5!!, and 69.6 C7!!, 150.5 C6!!, and
151.9 C2!!.
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Table D.4: Selected 1H NMR Shifts (ppm) for the Pt(N(Me)dpa)G, Pt(N(prop)dpa)G, and
Pt(tpa)G adducts (G = 5!-GMP, 3!-GMP, and 5!-GTP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
H8 free

anti H8

syn H8

free H1!

anti H1!

syn H1!

syn:anti ratio

Pt(N(Me)dpa)(5!-GMP)

7.96

9.03

8.69

5.71

5.98

5.85

1.55:1

Pt(N(Me)dpa)(3!-GMP)

7.87

8.97

8.60

5.72

5.87

5.81

1.65:1

Pt(N(Me)dpa)(5!-GTP)

8.07

9.08

8.75

5.72

5.97

5.91

1.55:1

Pt(N(prop)dpa)(5!-GMP)a

7.99

8.89

8.66

5.72

6.00

5.90

1:1.32

Pt(N(prop)dpa)(3!-GMP)b

7.88

8.92

8.58

5.72

5.98

5.89

1.48:1

Pt(N(prop)dpa)(5!-GTP)c

8.17

8.97

8.74

5.74

5.98

5.91

1.23:1

Pt(tpa)(5!-GMP)

7.97

9.12

8.65

5.72

5.98

5.88

1.28:1

Pt(tpa)(3!-GMP)

7.88

9.01

8.55

5.71

6.00

5.86

1.32:1

a

pH 7.3 syn H8:anti H8 ratio: 1:1.09. b pH 7.3 syn H8:anti H8 ratio: 1.38:1. c pH 7.3 syn H8:anti
H8 ratio: 2.91:1.
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Table D.5: 1H NMR Shifts (ppm) for Pt(N(Me)dpa)G, Pt(N(prop)dpa)G and Pt(tpa)G adducts (G
= 5!-GMP, 3!-GMP, and 5!-GTP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
H5/5!

H4/4!

H3/3!

H6/6!

Pt(N(Me)dpa)(5!-GMP)a

7.31b, 7.27c

8.03d

7.59d

7.65b, 7.53c, 7.49c

Pt(N(Me)dpa)(3!-GMP)e

7.33b, 7.29c

8.05d

7.61d

7.67b, 7.65b, 7.54c, 7.51c

Pt(N(Me)dpa)(5!-GTP)f

7.33b, 7.26c

8.01d

7.57 d

7.65b, 7.51c, 7.45c

Pt(N(prop)dpa)(5!-GMP)g

7.33b, 7.27c

8.07b, 8.04c

7.57d

7.63b, 7.61b, 7.51c, 7.47c

Pt(N(prop)dpa)(3!-GMP)h

7.34b, 7.30c

8.08b, 8.06c

7.62b, 7.59c

7.65b, 7.63b, 7.54c, 7.51c

Pt(N(prop)dpa)(5!-GTP)i

7.36b, 7.26c

8.06b, 8.02c

7.60b, 7.56c

7.66b, 7.65b, 7.51c, 7.44c

Pt(tpa)(5!-GMP)j

7.20b, 7.13c

7.93b, 7.88c

7.46b, 7.39c

7.55b, 7.48b, 7.41c, 7.35c

Pt(tpa)(3!-GMP)k

7.18b, 7.16c

7.93b, 7.90c

7.48b, 7.41c

7.51b, 7.47b, 7.43c, 7.40c

a

N-Me signal: 2.95 (syn) and 2.97 (anti) ppm. b Signals from the anti rotamer. c Signals from the
syn rotamer. d Syn and anti signals are overlapped Signals from the anti rotamer. e N-Me signal:
2.97 (syn) and 2.96 (anti) ppm. f N-Me signal: 2.94 (syn) and 2.98 (anti) ppm. g Propionic signals
(ppm): 3.24 (anti) and 3.32 (syn) N-CH2, 2.32 (anti) and 2.86 (syn) OC-CH2. h Propionic signals
(ppm): 3.25 (syn) and 3.31 (anti) N-CH2, 2.89 (syn) and 2.42 (anti) OC-CH2. i Propionic signals
(ppm): 3.23 (syn) and 3.32 (anti) N-CH2, 2.43 (syn) and 2.90 (anti) OC-CH2. j Dangling signals
(ppm): 8.51 (syn and anti signals overlapped) H3!!, 7.43 (syn) and 7.60 (anti) H4!!, 7.00 (syn)
and 7.03 (anti) H5!!, 8.12 (syn) and 8.19 (anti) H6!!. k Dangling signals (ppm): 8.53 (syn and anti
signals overlapped) H3!!, 7.46 (syn) and 7.56 (anti) H4!!, 7.00 (syn) and 7.04 (anti) H5!!, 8.13
(syn) and 8.14 (anti) H6!!.
!
!
!
!

!
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Table D.6: Selected 1H NMR Shifts (ppm), Syn H8:Anti H8 Intensity Ratios, and Δδ for the
Pt(N(H)dpa)(G), Pt(N(H)6-Medpa)(G), and [Pt(N(H)6,6!-Me2dpa)(G) adducts (G = 9-EtG, 5!GMP, and 3!-GMP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).
adducts

free H8

syn H8

anti H8

syn H8:anti H8

Δδ

[Pt(N(H)dpa)(9-EtG)]2+a

7.72

8.40

8.73

1.28:1

0.33

Pt(N(H)dpa)(3!-GMP)b

7.87

8.64

8.98

1.35:1

0.34

Pt(N(H)dpa)(5!-GMP)a

7.96

8.72

9.08

1.14:1

0.36

Pt(N(H)dpa)(5!-GTP)a

7.97

8.79

9.21

1:1.22

0.42

[Pt(N(H)6-Medpa)(9-EtG)]2+b

7.73

8.43

8.80

2.10:1

0.37

Pt(N(H)6-Medpa)(3!-GMP)b

7.87

8.67

9.05, 9.04

2.27:1

0.38

Pt(N(H)6-Medpa)(5!-GMP)b

7.97

8.77, 8.76

9.13

2.19:1

0.36

Pt(N(H)6-Medpa)(5!-GTP)b

7.98

8.84, 8.81

9.22, 9.21

1.96:1

0.41

[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+c

7.72

8.54

8.84

1:1.42

0.30

Pt(N(H)6,6!-Me2dpa)(3!-GMP)c

7.87

8.78

9.05

1:2.03

0.27

Pt(N(H)6,6!-Me2dpa)(5!-GMP)c

7.97

8.92

9.14

1:2.04

0.22

Pt(N(H)6,6!-Me2dpa)(5!-GTP)

7.98

9.05

9.22

1:2.01

0.17

a

!

Ref 3. b Ref 4. c Ref 5.
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Table D.7: Syn H8:Anti H8 Intensity Ratios for Pt(N(H)dpa)G, Pt(N(Me)dpa)G, Pt(N(H)6Medpa)G, and Pt(N(H)6,6!-Me2dpa)G Adducts (G = 5!-GMP and 5!-GTP) in D2O/DMSO-d6
(64:36, 25 °C).
a

Pt(N(H)dpa)(5!-GMP)
Pt(N(H)dpa)(5!-GTP)a

Pt(N(Me)dpa)(5!-GMP)
Pt(N(Me)dpa)(5!-GTP)
Pt(N(H)6-Medpa)(5!-GMP)f
Pt(N(H)6-Medpa)(5!-GMP)f
Pt(N(H)6-Medpa)(5!-GTP)
Pt(N(H)6,6!-Me2dpa)(5!-GMP)i
Pt(N(H)6,6!-Me2dpa)(5!-GTP)

pH
4.0
2.7b
4.1
7.3c
4.3
2.7d
4.3
7.3e
2.7
4.1
2.7g
4.3
7.3h
4.3
2.7j
4.3
7.3k

syn:anti ratio
1.14:1
1.04:1
1:1.22
1:1.37
1.83:1
1.76:1
1.77:1
1.77:1
2.21:1
2.18:1
2.66:1
1.96:1
1.97:1
1:2.04
1:1.38
1:2.01
1:1.97

a

Ref 3. b H8: 9.16 (anti), and 8.75 ppm (syn). c H8: 9.22 (anti), and 8.79 ppm (syn). d H8: 9.06
(anti), and 8.71 ppm (syn). e H8: 9.07 (anti), and 8.73 ppm (syn). f Ref 4. g H8: 9.19, 9.18 (anti),
and 8.81, 8.78 ppm (anti). h H8: 9.22, 9.21 (anti), and 8.84, 8.81 ppm (syn). i Ref 5. j H8: 9.18
(anti), and 8.99 ppm (syn). k H8: 9.23 (anti), and 9.05 ppm (syn).
!
!
!
!
!
!
!
!
!
!
!
!
!
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Figure D.1: Overlap of [Pt(N(H)6,6!-Me2dpa)Cl]+ (red) and [Pt(N(Me)6,6!-Me2dpa)Cl]+ (blue)
cations, illustrating the bowing of the pyridyl rings.
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Figure D.2: HSQC spectrum of [Pt(N(Me)6,6-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6 (64:36), pH
4.0, shifts in ppm). Peaks labeled X are from solvent and solvent impurities.
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Figure D.3: HMBC spectrum of [Pt(N(Me)6,6!-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6 (64:36), pH
4.0, shifts in ppm). Peaks labeled X are from solvent and solvent impurities.
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Figure D.4: HSQC spectrum of [Pt(N(prop)6,6!-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6 (64:36),
pH 4.0, shifts in ppm). Peaks labeled X are from solvent and solvent impurities.
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Figure D.5: HSQC spectrum of [Pt(6,6!,6!!-Medpa)Cl]Cl (25 °C, D2O/DMSO-d6 (64:36), pH 4.0,
shifts in ppm). Peaks labeled X are from solvent and solvent impurities.
!

!

213

H3/3'
H6/6'

H4/4'

H5/5'

x OC-CH2

exo-H7/7'

endo-H7/7'

N-CH2

C(OC-CH2)

40
C(N-CH2)
60
C7/7'
80
100
C3/3'

120

C5/5'
140

C4/4'
C6/6'

160

C2/2'
CO
9.0

8.0

7.0

6.0

5.0

4.0

3.0

Figure D.6: HSQC spectrum of [Pt(N(prop)dpa)Cl]Cl (25 °C, D2O/DMSO-d6 (64:36), pH 4.0,
shifts in ppm). Peaks labeled X are from solvent and solvent impurities.
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Figure D.7: Aliphatic region of the 1H NMR spectra of [Pt(N(Me)6,6!-Me2dpa)Cl]+ (a) and of the
reaction mixture 3 d after adding 3.5 equiv of G to form the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) (b),
Pt(N(Me)6,6!-Me2dpa)(3!-GMP) (c), and Pt(N(Me)6,6!-Me2dpa)(5!-GTP) (d) adduct (25 °C,
D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm). Peaks labeled with an * are from the bis adduct.
Peaks labeled X are from solvent and solvent impurities.
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Figure D.8: Aliphatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom)
and of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!Me2dpa)(5!-GMP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts
in ppm). Peaks labeled with an * are from the bis adduct. Peaks labeled X are from solvent and
solvent impurities.

!

216

H1'

anti
6/6'-Me

exo-H7/7'

free
syn
H1'
'
anti H1

N-CH2

endo-H7/7'

x

*
*

* *

anti
H1'

syn
H1'

OC-CH2 syn
6/6'-Me
*

anti
6/6'-Me

free
H1'

exo-H7/7'

x
N-CH2

endo-H7/7'

OC-CH2

syn
6/6'-Me
*

6/6'-Me
exo-H7/7'
N-CH2

endo-H7/7'

5.5

3.5

4.5

x

2.5

OC-CH2

1.5

Figure D.9: Aliphatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom)
and of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!Me2dpa)(3!-GMP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts
in ppm). Peaks labeled with an * are from the bis adduct. Peaks labeled X are from solvent and
solvent impurities.

!

217

anti
'
syn H1
H1'

free
H1'

anti
6/6'-Me

exo-H7/7'
N-CH2

endo-H7/7'
*

OC-CH2 syn
6/6'-Me

x

**

*

*

anti
6/6'-Me
syn
H1'
anti
H1'

free
H1'

exo-H7/7'

OC-CH2
N-CH2

syn
6/6'-Me

x

endo-H7/7'
6/6'-Me
exo-H7/7'
N-CH2

endo-H7/7'

5.5

x
OC-CH2

3.5

4.5

2.5

1.5

Figure D.10: Aliphatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom)
and of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!Me2dpa)(5!-GTP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts
in ppm). Peaks labeled with an * are from the bis adduct. Peaks labeled X are from solvent and
solvent impurities.
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Figure D.11: Aliphatic region of the 1H NMR spectra of [Pt(6,6!,6!!-Me3tpa)Cl]+ (a) and of the
reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(6,6!,6!!-Me3tpa)(5!-GMP) (b),
Pt(6,6!,6!!-Me3tpa)(3!-GMP) (c), and Pt(6,6!,6!!-Me3tpa)(5!-GTP) (d) adduct (25 °C,
D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm). Peaks labeled X are from solvent and solvent
impurities.
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Figure D.12: Aromatic region of the 1H NMR spectra of [Pt(N(Me)dpa)Cl]+ (bottom) and of the
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(Me)dpa)(5!-GMP) adduct (top)
(25 °C, D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm).
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Figure D.13: Aromatic region of the 1H NMR spectra of [Pt(N(Me)dpa)Cl]+ (bottom) and of the
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(Me)dpa)(3!-GMP) adduct (top)
(25 °C, D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm).
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Figure D.14: Aromatic region of the 1H NMR spectra of [Pt(tpa)Cl]+ (bottom) and of the reaction
mixture 2 d after adding 2.5 equiv of G to form the Pt(tpa)(5!-GMP) adduct (top) (25 °C,
D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm).
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Figure D.15: Aromatic region of the 1H NMR spectra of [Pt(tpa)Cl]+ (bottom) and of the reaction
mixture 2 d after adding 2.5 equiv of G to form the Pt(tpa)(3!-GMP) adduct (top) (25 °C,
D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm).
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Figure D.16: Aromatic region of the 1H NMR spectra of [Pt(N(prop)dpa)Cl]+ (bottom) and of the
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(prop)dpa)(5!-GMP) adduct at
pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm).
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Figure D.17: Aromatic region of the 1H NMR spectra of [Pt(N(prop)dpa)Cl]+ (bottom) and of the
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(prop)dpa)(3!-GMP) adduct at
pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm).
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Figure D.18: Aromatic region of the 1H NMR spectra of [Pt(N(prop)dpa)Cl]+ (bottom) and of the
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(prop)dpa)(5!-GTP) adduct at
pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm).
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Figure D:19: Aromatic region of the 1H NMR spectra of [Pt(N(Me)dpa)Cl]+ (bottom) and of the
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(Me)dpa)(5!-GTP) adduct (top)
(25 °C, D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm).
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